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ABSTRACT 
In animal models of neuropathic pain, changes in afferent and spinal cord neurones 
after pe1ipheral nerve injury lead to hyperexcitability within the spinal dorsal horn, 
termed "central sensitisation". This causes a persistent pain state with enhanced 
responses to noxious stimuli (hyperalgesia) and pain-like responses to previously 
innocuous stimul i (allodynia). 
The role of the VP AC2 receptor in CCI was investigated. In VPAC2R c-t-) mice, the 
enhanced reflex responses to noxious heat and innocuous mechanical stimulation 
seen in wild type (WT) mke were attenuated. No morihological differences were 
seen between peripheral nerves of WT and VPAC2R c--) mice. Furthermore, 
intrathecal administration of a VPAC2R inhibitor attenuated the enhanced reflex 
withdrawal responses to noxious heat and innocuous mechanical stimuli in WT mice 
following CCI, with no effect in VPAC2R (-/-) mice. 
In normal rats, intrathecal administration of PKA inhibitors attenuated the enhanced 
reflex withdrawal responses due to CCI. In situ hybridisation for isofo1ms of PKA 
regulatory (R) and catalytic (C) subunits showed a spinal increase in C-subunit , but 
not R-subunit mRNA ipsilaterally at the peak of CCI sensitisation. Immunoblots 
confiimed an ipsilateral increase in C-subunits and showed a bilateral decrease in the 
RI~ subunit. 
The role of the proteasome in neuropathic sensitisation was studied. 
Electrophysiological recordings made from dorsal horn neurones in anaesthetised 
rats showed that proteasome inhibitors applied by ionophoresis inhibi ted activity 
evoked by innocuous brush and cold in CCI rats, while nociceptive responses were 
inhibited in CCI and normal animals. Intrathecal administration of proteasome 
inhibitors attenuated the enhanced paw withdrawal behaviours ipsilateral to CCI. 
The mRNA and protein levels for UCH-Ll , (a key enzyme in proteasomal function) 
were increased ipsilaterally. PKA enzymatic activity was increased in spinal cord 
ipsilateral to nerve injury and this increment was prevented by topical application of 
proteasome inhibitors. 
This investigation demonstrates the involvement of the VPAC2 receptor, the 
coJTesponding cAMP/PKA signal transduction cascade and the proteasome (a 
regu lator of PKA activity) in the spinal sensitisation caused by CCI. 
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CHAPTER 1: INTRODUCTION 
1.1 General Introduction 
One of the functions of the nervous system is to provide information about the 
occun-ence or threat of injury. The sensation of pain, by its inherent aversive nature, 
contributes to this function. Chronic pain due to nerve injury, termed neuropathic 
pain, leads to the development of abn01mal pain sensations which can in some cases 
last from months to decades (Scadding, 1984). The pathological conditions often 
persist long after heali ng of the damaged peripheral tissue or nerve and are thought to 
be indicative of a dysfunctional nervous system. This thesis is focused on 
neuropathic pain since its physiological basis is poorly understood and little is 
available as a satisfactory treatment. Clinically it represents a substantial problem, 
with approximately 1.5% of the U.S. population estimated to be afflicted and there 
are CUJTently no effective and acceptable analgesic regimens to treat these 
individuals. Before discussing the specific mechanisms of neuropathic pain, and 
focusing on potential targets, it is impo11ant to consider the anatomy, physiology and 
pharmacology of nociceptive processing in the peripheral and central nervous 
system. This should facilitate recognition and understanding of the changes, which 
occur both peripherally and centrally following nerve injury. The thesis will then 
focus on the central changes that occur in the spinal dorsal horn fo llowing peripheral 
nerve injury. 
1.2 Fibre Composition of Cutaneous Nerves 
There are various groups of primary afferent fibres, classified according to their axon 
diameter, conduction velocity and whether they are myelinated or not. The largest 
group of nerve fibres in cutaneous nerves is the myelinated A-fibre class. The rat 
sciatic nerve contains approximately twice 'as many of these rnyelinated sensory 
axons compared to unmyelinated fibres (Schmalbruch, 1986). Non-noxious inputs 
from the cutaneous surface are mediated principally by large myelinated (A~) fibres 
which have conduction velocities of greater than 30m/s. Noxious inputs are 
mediated by fine afferent fibres, both myelinated A8 and unmye1inated C fibres, with 
average conduction velocities of 5-30m/s and 0.5-2m/s respectively (Willis and 
Coggeshall, I 991 ). 
1.3 Classification of Cutaneous Sensory Receptors of Afferent Nerves 
The terminal regions of the primary afferent fibres, found in the peripheral tissue, 
constitute the receptive or dendritic part of the neurone, which have contact with well 
defined areas of skin from which the afferent fibres can be excited (receptive field). 
Cutaneous receptors transmit information about the external environment for 
example (heat, pressure, chemicals). There are clearly distinguishable classes of 
specialised nociceptors and mechanoreceptors (Lynn, 1994). 
1.3.1 Non-Nociceptive Mechanoreceptors 
Cutaneous mechanoreceptors are the most sensitive receptors, responding most 
readily to mechanical pressure stimuli of various intensities. They can be further 
subdivided according to their other characteristics. 
1.3.2 Hair Follicle Receptors 
These receptors are units that respond to hair movement. They are the predominant 
class of units with myelinated Ao axons within rat peripheral nerves (Lynn and 
Carpenter, 1982). They have been classified according to the hairs they innervate 
(Brown and Iggo, 1967). D-hair units are rapidly adapting receptors, typically 
activated by movement of down hairs but also responding to movement of guard 
hairs. They are supplied by nerve fibres ~4µm in diameter with conduction 
velocities from 12-30 m/s. Each fibre innervates many down hairs and have large 
receptive fields (~2cm2). G-hair units are rapidly adapting receptors associated with 
guard hair follicles only, each nerve fibre supplying ten or more follicles. These 
receptors are termed "basket endings" since the terminals surround the hair in a 
network that resembles a wicker basket. The afferent fibres are 5-lSµm in diameter, 
have conduction velocities from 20-90m/s and are activated by relatively fast 
movement of the guard hairs (Lynn and Carpenter, 1982). T-units are the least 
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numerous and tend to have high conduction velocities (mean about 65 m/s) and are 
activated by movement of the large tylot,ich hairs (Lynn and Carpenter, 1982). 
1.3.3 Field Receptors, Rapidly Adapting (RA) Cutaneous Receptors, 
Pacinian Corpuscles and Slowly Adapting (SA) (SA type I and 11) 
Mechanoreceptors. 
In glabrous skin there are two types of rapidly adapting (Meissner's and Pacinian 
corpuscles) as well as two types of slowly adapting (Merkel's and Ruffini corpuscle) 
touch receptors. The rapidly adapting cutaneous receptors respond to light pressure, 
stroking or vibration of the receptive field area. They are predominantly associated 
with large Af3 fibres and generally transmit only non-nociceptive information. 
Slowly adapting (SA type I or II) mechanoreceptors are also associated primarily 
with large Af3 fibres. SAJ mechanoreceptors are low threshold receptors associated 
with Merkel cell complexes in the epidermis. SAIJ mechanoreceptors are identified 
with Ruffini endings located in the dermis and so respond to small displacements of 
the skin usually as a result of the skin stretching (Willis and Coggeshall, 1991). 
1.3.4 Low Threshold C-Mechanoreceptors 
These unmyelinated C fibres are highly responsive to gentle mechanical stimulation 
such as light brushing (Bessou and Perl, 1969). They constitute between 15-30% of 
C fibres in peripheral nerves. They have a small receptive field primarily located in 
hairy skin and have been shown to respond to sudden cooling of the receptive field 
area (Bessou and Perl, 1969; Lynn and Carpenter, 1982; Leem et al., 1993). 
1.3.5 Non-Nociceptive Thermoreceptors 
Therrnoreceptors transmit innocuous changes in temperature, and are generally 
unresponsive to mechanical stimuli . They can generally be classified into two types: 
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1.3.6 Cold Thermoreceptors 
Innocuous cool sensations and cold pain are mediated by different populations of 
primary afferent fibre. Cool sensations are signalled by activity in cold specific Ao-
fibres (and to a lesser degree cold-specific C fibres) (Iggo, 1959; 1969), with specific 
cutaneous receptors in both the hairy and glabrous skin (Iggo, 1969). Cold 
thermoreceptors are characte1ised by their high sensitivity to small falls in skin 
temperature (as little as 0 .1 °C), and the most commonly studied in the rat are facial 
and scrotal thermoreceptors. The majority of these receptors have a relatively 
restricted range of innocuous cold temperatures (approximately 20-30°C) over which 
they give dynamic responses to small reductions in skin temperature (Heinz et al., 
1990; Iggo, 1969). 
1.3.7 Warm Thermoreceptors 
Warm thermoreceptors respond to slight wa1ming of the skin and are generally 
thought to be unmyelinated (Iggo, 1959). They are active at no1mal skin temperature 
(approximately 30°C) and are silenced by noxious levels of heat (+48°C). 
1.4 Nociceptors 
The earliest reports on single unit activity in peripheral nerves predicted the presence 
of nerve fibres responsive to tissue threatening or tissue damaging stimulation 
(Zottermann, 1933). However, it is only since detai led studies in the late 1960's that 
evidence for the existence of specific cutaneous nociceptors in numerous species has 
accumulated (Burgess and Perl, 1973, Price and Dubner, 1977). Nociceptors can be 
classified according to thei r responses to different forms of intense stimulation and 
the conduction velocity of their peripheral axons. There are two main groups of 
cutaneous nociceptors, the Ao mechanical nociceptor and the C-polymodal 
nociceptor. Microneurography and intraneural microstimulation of identified 
cutaneous p1imary afferent fibres in humans demonstrated that e lectrical stimulation 
of nociceptive Ao fibres evoked a sensation of sharp pain, whereas stimulation of 
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nociceptive C fibres produced a sensation of dull or burning pain (Torebjork and 
Ochoa, 1980; Ochoa and Torebjork, 1989). 
1.4.1 A8 Fibre Nociceptors 
Ao nociceptive fibres exist in both the glabrous and hairy skin and are mainly excited 
by high threshold mechanical stimulation. The majority of AO nociceptive fibres 
have been termed high threshold mechanoreceptors (HTM). Ao nociceptive primary 
afferents originating from high threshold mechanoreceptors terminate predominantly 
in laminae I, IV and V of the dorsal horn (Burgess and Perl, 1973). A distinctive 
feature of HTMs is the change in responsiveness produced by repeti tive heat 
stimulation (Burgess and Perl, 1973). Although rarely responsive to initial heat 
stimuli in the 45°C-55°C range, HTMs often respond to heat after repeated 
stimulation, a phenomenon termed "sensitisation" (Bessou and Perl, 1969). Leem et 
al. (1993) classed 70% of Ao nociceptors as mechanical nociceptors, 20% as 
mechanoheat nociceptors and 10% as mechanocold nociceptors. Recent work by 
Simone and Kajander, (1996; 1997) have shown that all mechanosensitive Ao 
nociceptors responded to noxious cold stimuli. It should be noted that activation 
thresholds for the majoiity of AO nociceptors was < 0°C and the physiological 
relevance of these interesting findings are unclear. 
1.4.2 C Fibre Nociceptors 
Fibres which respond to noxious thermal, mechanical, cold and chemical stimuli 
have been called polymodal nociceptors. Following classification by Burgess and 
Perl (1973) C fibre nociceptors are refeffed to as C-polymodal nociceptors (CPNs). 
CPNs are the most abundant form of primary afferent C fibre found within peripheral 
nerves of the rat (Lynn and Carpenter, 1982; Schmalbruck, 1986). They exist in the 
glabrous and hairy skin and typically have small receptive fields. CPNs generally 
respond to heat at initial temperatures of 42°C-55°C (ranging from borderline to 
overtly noxious and damaging). CPNs are also excited by initant or caustic chemical 
agents applied to the skin and typically respond to high threshold mechanical 
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stimulation (Perl, 1984). CPNs are excited by a wide range of cold stimuli, the only 
difference in cold evoked responses of Ao and CPNs is in their response thresholds. 
CPNs response threshold is lower and generally >0°C. CPNs have a 
characteristically low background level of activity unless the skin has been 
previously noxiously stimulated. The vast majority of cutaneous CPNs have been 
shown to terminate in laminae 1-11 of the spinal dorsal horn (Cervero and Iggo, 1980; 
McMahon et al., 1984). 
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Figure 1.1 Schematic Diagram of the Cutaneous Afferent Input to, and 
Neuronal Organisation of the Spinal Dorsal Horn of the Cat 
A hypothetical cross section of the spinal dorsal horn, illustrating the afferent fibres 
and neuronal elements presented in the first four laminae. The laminar divisions of 
Rexed (1952) are indicated on the right. Afferent fibre types are listed to the left of 
the diagram, shown projecting onto neuronal types typical of laminae I-IV. The 
neurones illustrated here are (from top to bottom): a marginal cell , an SG limiting 
cell, two SG central cells and two neurones of the nucleus proprius, the more 
superficial of which has dendrites penetrating lamina II. 
(Taken from Cervero and Iggo, 1980) 
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1.5 Laminar Organisation of the Dorsal Horn of the Spinal Cord 
The grey matter of the spinal cord, which comprises nerve cell bodies, fibres (axons 
and dend1ites) and associated non-neuronal cells can be grossly divided into two 
main sub-divisions, the ante1ior or ventral horn and the posterior or dorsal horn 
(Figure 1.2). These distinct anatomical characteristics were first documented by 
Rexed, (1952) who examined the feline spinal cord and classified the laminae 
according to their cryoarchitectonic characte1istics. Further anatomical studies have 
demonstrated a similar architectonic scheme in the rat (Molander et al., 1984). 
According to Rexed's nomenclature, the dorsal horn of the spinal cord is sub-divided 
into 6 distinct laminae. 
1.5.1 Lamina I (LI, The Marginal Zone) 
LI is the most superficial layer of the dorsal horn. It covers the dorsal surface of the 
dorsal horn, bends around its apex and extends about halfway down the lateral side 
(Molander et al., 1984). It is the thinnest of the laminae and contains small medium 
and large neurones. Cells are generally elongated and spindle shaped. The largest 
are very elongated (30-50µm x 10-15µm, Rexed, 1952), and are termed the marginal 
cells ofWaldeyer (1888). The marginal cells in LI send dendrites out over the 
surface of the dorsal horn, their disc like dendritic domains remaining within lamina 
I (Ralston, 1968). As well as these cells LI contains other cells, which merge with 
the outer layer of LII (Lima and Coimbra, 1983). In LI the orientation of neuronal 
processing is parallel to the dorsal border of the horn in the transverse plane (Ralston, 
1968). Both unmyelinated C fibres and myelinated A8- fibres te1minate in LI with 
the thinly myelinated A8 fibres predominating (Willis and Coggeshall, 1991). There 
is no evidence of the large myelinated A~ fibres terminating in LI (Brown, 1981). A 
number of reports suggest LI contains primarily noci-specific neurones which 
receive their projections from cutaneous, high threshold A8 mechanoreceptors and C 
fibre thennal nociceptors (Cervero et al., 1976; 1979; Ch1istensen and Perl, 1970; 
Light and Perl , 1979; Rethelyi et al. , 1983). However, more recent studies have 
revealed a large proportion of rat LI cells to be multireceptive (McMahon and Wall, 
1983; Menetrey and Besson. 1981). Overall then , the vast majority of lamina I 
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dorsal horn neurones have the ability to respond to nociceptive stimuli, highlighting 
the importance of LI in the transmission of noxious sensory information. 
1.5.2 Lamina II (LII, The Substantia Gelatinosa) 
Lamina II is well defined due to its gelatinous appearance. LII passes across the 
dorsal horn around the apex and down laterally. Covered dorsally and laterally by LI 
it has been described as the substantia gelatinosa (Rolando, 1824). LII contains 
tightly packed small cells ranging from (5 - lOµm in diameter). This lamina is 
believed to receive input primarily from unmyelinated primary afferents (Brown, 
1981; Light and Perl, 1979; Cervera and Iggo, 1980), A combination of degeneration 
and Golgi staining experiments have demonstrated that many C fibre afferents 
terminate in this lamina (Lamotte, 1977; Rethelyi, 1977; Ralston and Ralston, 1979), 
with PHA-L injection of single fibres, confirming this (Sugiura et al., 1989). In 
contrast to LI, in LII the dend1itic organisation is essentially in the long axis of the 
spinal cord (Sterling and Kuypers, 1967; Scheibe) and Scheibe!, 1968; Rethelyi and 
Szentagothai, 1969). The dend1ites in LII extend longitudinally through LII and LIII 
in the saggital plane, but are severely rest1icted in the transverse plane. In contrast, 
the axons of LII cells are confined for the most part within LII (Matsushita, 1969). 
LU has recently been fmther sub-divided into LU inner (LIii) and LII outer (LIIo) 
with LIIo the most supetficial containing a high concentration of very fine primary 
afferent fibres. LIIi is the more deeply positioned area of LII with less densely 
packed neurones (Light and Perl, 1979). 
1.5.3 Lamina Ill - IV (LIii-LiV, The Nucleus Proprius) 
Lill is broader than both LI and LII and runs parallel to them. The cells are less 
tightly packed than LII (Light and Perl, 1979) and generally larger, with a few being 
much larger although these may belong in LIV (Rexed 1952). LII-IV contains 
relatively large cells ranging from (7-8µ.m x 10-12µm). Myelinated axons terminate 
here and pass through the lamina both rostrally and caudally. LIII receives direct 
inputs from both AS and A~ fibres (Brown et al., 1977; Light and Perl, 1979). 
Lamina IV is a relatively thick layer, which also extends from the white matter of the 
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dorsal columns medially to where the ventral bend of LI-III runs down the lateral 
side of the dorsal horn. It is the first layer not to show the lateral bend. There is a 
less dense cellular distribution than Lill due to the large numbers of nerve fibres 
passing through it, and there is a huge heterogeneity of neurone size, ranging from 
very small to very large cells (Molander et al., 1984). It is predominantly the 
intermediate to thick diameter A-fibres which innervate these deeper dorsal horn 
laminae, including non-nociceptive AS fibres, originating from D-type hair follicles, 
and the large diameter A/3 axons of sensory, cutaneous mechanoreceptors (Brown 
and Iggo, 1967; Light and Perl, 1979). 
1.5.4 Lamina V-VI (LV-LVI) 
LV extends straight across the grey matter of the dorsal horn from the white matter 
of the dorsal columns medially to the white matter of the lateral columns. Some 
nociceptive (AS) afferents terminate in LV and both nocispecific and mulitreceptive 
neurones are found in this region (Kumazawa and Perl , 1977; Menetrey et al., 1977; 
Rethelyi et al., 1982). LV is divided into medial and lateral zones. The lateral zone 
contains more larger and fewer medium and small cells than the medial zone. In the 
lateral part of LV, the fibre bundles are large and numerous, giving the section a 
reticulated appearance (Light and Perl , 1979). LV contains a wide range of cel l sizes 
ranging from 8µm x lOµm - 30µm x 40µm. The final lamina of the dorsal horn , 
LVI, has a slightly curved ventral edge. Similar to lamina V, there are large cells, 
but the lamina is dominated by the large number of small neurones in the medial 
zone (Willis and Coggeshall, 1991; Rexed, 1952; Molander et al., 1984). Both of 
these layers receive direct inputs from large A/3 fibres (Molander et al., 1984). 
There are ten laminae in total named by Rexed (1952) and Molander et al. (1984) 
although the remaining laminae VII-X, represent the ventral horn and are beyond the 
scope of this study. Despite the distinct lamination pattern shown in figure 1.2 it is 
important to note that laminae are recognised primarily as zones of concentrations of 
particular cell types and may have intermingled edges. Also the borders between the 
laminae may differ between different segmental sections (Molander et al., 1984). 
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Figure 1.2 Schematic Diagram of the Cytoarchitectonic Organisation of 
Segments LI-VI of the Rat Spinal Cord 
Representation of the laminar divisions of Rexed (1952) as demonstrated in the 
lumbar (L) segments of the rat spinal cord. 
Abbreviations: 
I - X - spinal cord laminae; CC - column of Clarke; IL - intermedio-lateral nucleus; 
IM - intermedio-medial nucleus; LSN - lateral spinal nucleus; Liss -Lissauer's 
tract; LG - lateral group of large cells in the dorso-lateral part of the ventral horn; 
LM - latero-medial nucleus; MG - medial group of large neurones in the 
intermediate zone; Pyr - pyramidal tract; VM - ventro-medial nucleus. 
Note that LG, LM and VM are parts of lamjna IX. 
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1.6 Classification of Sensory Neurones 
The spinal dorsal horn represents an important site for the initial processing of 
sensory information from the periphery to the CNS, especially with regards the 
transmission and modulation of pain. The dorsal horn is characterised by a wide 
range of cells of varying sizes and characte1istics situated in specific layers, which 
can be classified according to their responsiveness to evoked sensory stimuli (Iggo, 
1974). 
1.6.1 Non-Nociceptive Neurones (Class I) 
These cells are innervated by sensitive mechanoreceptors and respond only to 
innocuous mechanical stimulation of the cutaneous receptive field (Dubner and 
Bennett, 1983). 
1.6.2 Multireceptive Neurones (Class 11) 
Also known as wide dynamic range neurones (WDR) (Mendell, 1966), these have 
convergent inputs a,ising from both peripheral nociceptors and sensitive 
mechanoreceptors, and therefore respond to both innocuous and noxious mechanical 
stimulation of the cutaneous receptive field as well as noxious thermal stimulation 
(Price et al., 1976; 1978). Wide dynamic range neurones tend to be situated in the 
deeper laminae of the dorsal horn (LIV-V) (Besson and Chaouch, 1987). However, 
they have also been reported in the superficial laminae (lggo, 1974; Menetrey and 
Besson, 1981; McMahon and Wall, 1983; Woolf and Fitzgerald, 1983). 
1.6.3 Nocispecific Neurones (Class 111) 
Nocispecific neurones are classified as a population of neurones that receive their 
inputs solely from nociceptive afferents (A8 and C - Fibres) and therefore only 
respond to high threshold, noxious stimuli (Cervera et al., 1976). A relatively high 
propo1tion of nocispecific neurones have been reported in lamina I, including cells 
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which project to thalamic and brain stem regions (Cervero et al., 1976; 1979; 
Christensen and Perl, 1970; Light and Perl, 1979). 
The location and type of neurones in the laminae of the dorsal horn will clearly 
influence the transmission of nociceptive information. In addition, the projection 
pattern of the different primary afferent fibre types will influence the type of 
response made by these dorsal horn neurones in different laminae, in particular the 
multireceptive neurones. Multireceptive dorsal horn neurones within the more 
superficial laminae of the dorsal horn are believed to be predominantly involved in 
the transmission of nociceptive information, since cutaneous A8 and C fibres 
terminate primarily in lamina I and II respectively. In contrast, A~ fibres project into 
the deeper dorsal horn (laminae III-IV). This preferential distribution rather than a 
strict lamination suppotts the laminar model of the dorsal horn being "zones of 
specialisation rather than absolute separate laminae of distinct specialisation" 
(Menetrey and Besson, 1981). 
1.7 Ascending Somatosensory Pathways 
As well as receiving descending inhibitory inputs from higher centres of the CNS, 
projection neurones ascend through distinct tracts in the spinal white matter and relay 
sensory infonnation to regions of the brain stem and thalamus. The main ascending 
tracts implicated in the transmission of nociceptive information in the rat spinal cord 
are: 
1.7.1 Spinothalamic Tract (STT) 
The SIT has been the subject of interest since its first description in the mammal by 
Mott (1895). Neurones in the spinal dorsal horn project to thalamic nuclei via the 
ventrolateral quadrant of the spinal cord, usually contralateral to the side of sensory 
input (Willis et al., 1979). Human studies have shown that lesions in this quadrant 
may lead to analgesia (Spiller and Martin, 1912), whereas stimulation may result in 
sensations that are painful (Mayer et al., 1975). Antidromically identified cells of the 
rat and primate SIT were found to be widely distributed throughout the lumbar 
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dorsal horn of the spinal cord arising primarily from cell bodies located in lamina I, 
IV, V and VI (Dilly et al. , 1968; Giesler et al., 1976). A wide range of 
somatosensory information is transmitted in the STI of the rat and primate, including 
responses to light touch, hair displacement, pressure, joint movement, heat and pinch 
(Willis et al. , 1983). Willis et al., (1983) characterised the neurones of the STI in 
the monkey, on the basis of their responses to peripheral stimuli to reveal a high 
proportion of STI neurones respond to noxious stimulation (55% were 
multireceptive, while 32% were nocispecific). Interestingly, STT neurones located 
within the ventral horn that appeared to respond to stimuli delivered to subcutaneous 
tissue, tended to be activated from midline thalamic structures. In contrast, STI 
neurones within the nucleus proprius and marginal zone, which responded to noxious 
and innocuous cutaneous stimuli , were activated from lateral thalamic structures 
(Giesler et al. , 1976). 
1.7.2 Spinoreticular Tract (SRT) 
The SRT projects from the dorsal horn of the spinal cord to the ventrnlateral 
quadrant to the brainstem reticular formation which in tum relays information to the 
thalamus (Kevetter and Willis, 1983). Horseradish peroxidase (HRP) labelling has 
shown that Laminae VII and VITI cells in the rat ventral horn are the main origin of 
SRT cells, although a minority of cells appear to originate in the more superficial 
layers (Chaouch et al., 1983). Activation of SRT neurones by reticular formation 
stimulation revealed it was possible to activate neurones in laminae III-IV, and a few 
in laminae I, V and VI. In this study they observed almost half of the cells to be 
multirecepti ve and a further fifth to be nocispecific (Menetrey et al., 1980). 
1.7.3 Spinomesencephalic Tract (SMT) 
SMT neurones project from Lamina I predominantly and Lamina V to the 
mesencephalic reticular formation and lateral periaquaductal grey matter (PAO) 
(Mehler et al. , 1960; Menetrey et al., 1982; Harmann et al., 1988). Whilst there are 
SMT cells that respond only to innocuous mechanical stimuli (Menetrey et al., 1980), 
electrophysiological studies have shown that a high proportion of SMT neurones, 
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originating in the marginal zone, are nociceptive (Menetrey et al., 1980), implicating 
the involvement of the SMT in the control of nociception and pain. 
1.7.4 Post-synaptic Dorsal Column (PSDC) 
The PSDC originates prima1ily from neurones on the Lamina II-III border of the rat 
spinal dorsal horn and projects through the dorsal funiculus to the nucleus gracilis 
and nucleus cuneatus (Giesler et al., 1984). Electrophysiological experiments have 
identified both multireceptive and nocispecific neurones in the PSDC (Angaut-Petit, 
1975; Brown et al., 1983). 
The STT, SRT, SMT and PSDC systems are the best understood, but not the only 
possible pathways for nociception. The spinocervical projection, for example may 
be involved in some aspects of the pain experience (Brown et al. , 1979; 1977; 1980). 
1.8 Functional Regulation of Dorsal Horn Neurones 
1.8.1 Descending Control of Nociceptive Transmission 
The existence of a specific pain modulatory system was first described clearly in 
1965 by Melzack and Wall in the "Gate Control Theory" of pain. Supraspinal 
influences on the "gate" were proposed but there was limited evidence for 
descending control of nociception. In 1965, Melzack and Wall demonstrated that 
structures in the brainstem tonically inhibit nociresponsive neurones in the spinal 
cord. 
Dorsal horn transmission is under the control of inhibitory mechanisms dtiven by 
mid-brain descending projections and segmental projections which synapse directly 
or indirectly onto p1imary afferent terminals, dorsal horn projection neurones and 
interneurones which can pre-synaptically reduce transmitter release from primary 
afferent terminals or hyperpolarise dorsal horn neurones. Both of these actions 
reduce the likelihood of dorsal horn neurone firing. These descending pathways are 
important in the maintenance of general inhibitory controls on dorsal horn neurones 
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either directly, or indirectly via excitatory or inhibitory intemeurones at the spinal 
cord level. A number of pharmacological agents have been found to effect the 
activity of dorsal horn intemeurones. Various transmitters are associated with 
inhibitory effects, including the opioid peptides, serotonin (5-HT), noradrenaline, 
dopamine and the inhibitory amino acids y-aminobutyric acid (GABA) and glycine 
(see Besson and Chaouch, 1987 for review). These inhibitory neurotransmitters may 
be released directly by descending control systems to exert inhibitory effects (in the 
case of monoamines) or indirectly by the activation of spinal interneurones (Besson 
and Chaouch, 1987). Although of interest, the monoamines are beyond the initial 
scope of this study and will not be discussed further, (for review see, Besson and 
Chaouch, 1987). 
1.8.2 Tonic Descending Inhibition 
Many areas of the brain exert a potent descending inhibition on spinal somatosensory 
mechanisms, in particular nociceptive transmission in the spinal dorsal horn. A tonic 
inhibitory system was found to affect flexion reflexes in limbs and other fo1ms of the 
flexion reflex, such as the tail flick reflex in the rat. The tail flick test is a 
nociceptive reflex , which is enhanced following spinal transection (Irwin et al., 
1951). A very useful method for producing a reversible cold block of tonic 
descending inhibition was introduced by Brown (1971). This technique revealed that 
a number of different dorsal horn neurones are under tonic inhibitory control. Cold 
block at the thoracic level of the spinal cord enhanced the responses of spinothalamic 
tract (STT) cells to peripheral stimuli (Brown, 1971). Cervera (1977) found that 
during cold block of the cord, the majority of STT cells respond to excitation or 
inhibition. Tonic descending inhibitory controls affect nociceptive transmission in 
Lamina I cells and Lamina IV-V (Besson et al., 1975; Brown, 1971; Duggan et al., 
1981), yet cells in lamina II are not subject to tonic descending inhibition (Cervera et 
al., 1979). The precise origin of tonic descending inhibition is unclear, although it is 
becoming increasingly evident that pathways originating in the medial part of the 
medulla and pons are likely to contribute to the descending inhibitory (and 
excitatory) control of spinal neurones. Labelling studies have identified that cells of 
the nucleus raphe magnus, pallidus and obscurus and nuclear reticularis 
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gigantocellularis, magnocellularis and pontis caudalis contribute to descending 
modulation (Willis, 1988). Cells of the lateral reticular nucleus also appear to 
conttibute, as bilateral lesions in these areas appear to prevent such an inhibition 
(Foong and Duggan 1986; Morton et al., 1983). 
1.8.3 Stimulus-Evoked Modulation from Supraspinal Sites 
Potent descending inhibitory influences that can be elicited from the brain stem have 
been implicated in the modulation of pain. Several studies have highlighted that 
stimulation of areas of the periaquaductal grey matter (PAO) (Oliveras et al., 1974), 
nucleus raphe (NRM) (Guilbaud et al., 1977), and the caudal lateral reticular nucleur 
(LRN) (Morton et al., 1983) provide analgesia. Interestingly, stimulation of these 
regions of the brainstem results primarily, (but not exclusively), in the inhibition of 
activity evoked by noxious rather than innocuous stimuli applied to the periphery 
(Duggan and Griersmith, 1979; Willis et al. , 1977). 
1.8.4 Segmental Controls 
As proposed by Melzack and Wall (1965) in the "gate control" theory, the 
transmission of messages at the spinal relays is under both segmental and supraspinal 
controls. Segmental controls are characteristically inhibitory effects produced by 
large-diameter fibres on the responses of spinal neurones to nociceptive stimulation 
(Besson and Chaouch, 1987). This has been clearly established by several groups 
(Brown 1971; Cervero et al. , 1976). The inhibition can be produced on both 
nocispecific non-nociceptive neurones and can also be achieved by dorsal column 
stimuation (Besson and Chaouch, 1987). The "gate control" theory proposed that 
cells in the superficial dorsal horn operate to control the transmission of afferent 
volleys. This control is mediated in part, by pre-synaptic inhibition of the primary 
afferent fibres and is itself influenced by the activity of primary afferents; A~ 
stimulation augments the inhibition, and Ao and C fibres reduce it. Facilitation may 
then be exerted by the activation of fine fibres that reduce the inhibitory controls. In 
contrast, the activation of Aj) fibres excites the inhibitory substantia gelatinosa cells, 
producing an increase in inhibition of transmission. (Besson and Chaouch, 1987). 
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Although there has been intense controversy over this theory, neurones of the 
superficial dorsal horn have been implicated in segmental controls of the 
transmission of nociceptive messages. At least pa1t of this control results from pre-
synaptic mechanisms presumed to be acting via axoaxonic synapses where p1imary 
afferent terminals are post-synaptic (Rethelyi and Szentagothai, 1969). However, 
there is evidence that suggests that dendroaxonic synapses play a role in pre-synaptic 
inhibition (Gobel et al., 1980). From the pharmacological point of view, several 
substances have been implicated, notably y-aminobuty1ic acid (GABA), glycine and 
the endogenous opioids, in the mechanisms of pre-synaptic control. 
1.8.5 y-Aminobutyric Acid (GABA) 
There is considerable evidence that the inhibitory neurotransmi tter GABA is present 
in the dorsal horn of the spinal cord, and is implicated in the control of sensory 
processing at the spinal cord level. Immunohistochemical studies have demonstrated 
the presence of GABA in approximate ly one third of cell bodies and axons in lamina 
I-III (Barber et al. , 1982; Todd and McKenzie, 1989). Ionophoretically applied 
GABA has been shown to reverse the excitatory effect of L-glutamate in lamina II 
dorsal horn neurones (Curtis et al., 1959; Zieglgansberger and Sutor, 1983). Other 
evidence implicating a role for GABA in pre-synaptic inhibition is the depressive 
action on pre-synaptic inhibition of locally or intravenous ly applied GABA 
antagonists picrotoxin and bicuculline (Besson et al., 1971; Repkin et al. , 1976). 
1.8.6 Glycine 
Glycine is an impo1tant neurotransmitter with widespread distribution throughout the 
spinal cord. Glycine is present in high concentrations in the grey matter of the spinal 
cord, particularly in the deeper laminae (III-VI) and the ventral horn (Graham et al., 
1967; Todd, 1990). Ionophoretic application of glycine into the spinal cord results in 
a strychnine-sensitive depression of the activity of single cases in approximately 90% 
of neurones tested (Curtis et al., 1967; Werman et al., 1968; Zieglgansberger and 
Sutor, 1983; Sivilotti and Woolf, 1994). Glycine is thought to be an important 
modulator of SP-evoked responses, as it has been shown to be released following 
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rnicrodialysis of SP in to the spinal cord in vivo (Srnullin et al., 1990) and following 
bath application in vitro (Maehara et al., 1993). In addition glycine inhibits SP 
evoked biting and scratching behaviour (Beyer et al., 1989), while intrathecal 
application of the glycine antagonist strychnine facilitates the nociceptive flexor 
reflex (Si lvilotti and Woolf, 1994). However, it is now commonly understood that 
glycine may have two opposing functions in nociceptive processing, not only its well 
established inhibitory action via the strychnine-sensitive glycine receptor (Pullen and 
Powel, 1992), but also an excitatory action via the glycine co-agonist binding site on 
the NMDA (N-methyl-D-aspartate) receptor (Gly NMDA), It has been shown for 
example that the NK-1 receptor facilitation of the NMDA receptor can be blocked by 
ionophoretic application of GIYNMDA site antagonists, whereas glycine acting via the 
strychnine site has inhibitory effects (Heppenstall and Fleetwood-Walker, 1997a; 
1997b). The modulatory influences of glycine therefore are quite complicated, and 
can be exerted through several different pathways. 
1.8. 7 Endogenous Opioids 
Various techniques have demonstrated the presence of opioid receptors on the 
terminals of ptimary afferent fibres (Wamsley, 1983, Gouarderes et al. , 1999 
Abbadie et al., 2001) projecting into the superficial laminae of the dorsal horn, 
suggesting a role for endogenous opioids in pre-synaptic control in the transmission 
of nociceptive information. Opioid receptors ofµ, o and K subtypes have all been 
localised in the superficial dorsal horn of the spinal cord (Atweh and Kuhar, 1977; 
Calza et al., 2000; Dun et al., 2000; Aicher et al., 2000; Zhang et al., 2000). Opioids 
can act directly on the spinal cord, and ionophoretic injection of opioids inhibits 
spinal nociceptive processing (Duggan and North, 1983; Fleetwood-Walker et al., 
1988). This inhibitory action may be pre-synaptic or may be an indirect action in 
response to activation of opioid-containing intemeurones. Electrophysiological and 
behavioural experiments have shown that the powerful analgesic effects of opioids 
result from actions at both spinal and supraspinal sites (Ossipov et al., 2000). It has 
been suggested that these endogenous opioids are released in dorsal horn from opioid 
spinal intemeurones (Basbaum and Fields, 1978; Glazer and Basbaum, 1981) and 
recent evidence has demonstrated that opioids may coexist with other neuropeptides 
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in dorsal horn interneurones (Kemp et al., 1996; Todd and Spike, 1992, Todd and 
Johnston, 1992). 
Enkephalin, dynorphin and nociceptin are families of opioid peptides which are 
present in the dorsal horn. Each may play a role in modulation of nociceptive inputs 
in acute and inflammatory pain states (Lipp et al. , 1991; Caudal and Mannes, 2000; 
Terenius et al., 2000). However, because opioid drugs appear to be poorly effective 
in neuropathic pain states (Amer and Meyerson.1988) this thesis will not deal 
extensively with spinal opioids. 
1.9 Primary Afferent Inputs in the Regulation of Dorsal Horn Neurones 
The afferent connectivity and anatomical organisation of the peiipheral and central 
systems is an important issue since it defines the projection of primary afferent 
nociceptors into the dorsal horn and ascending tracts, and therefore predicts the site 
of release of afferent transmitters. Activation of p1imary afferent nociceptors 
requires an .intense mechanical, thermal or chemical stimulus at the peripheral 
terminal, and results in the release of chemical substances from nerve terminals in 
the dorsal horn to mediate the transmission of nociceptive information centrally. 
Synaptic transfer of information is governed by the nature and amount of the 
transmitter released by different primary afferents, the density and identity of post-
synaptic receptors, the kinetics of receptor activation and ion channel opening and 
closing, and the factors responsible for the removal or breakdown of transmitter. 
Each of these factors is also subject to pre- and post-synaptic modulatory influences. 
This section will consider the pharmacology of the systems that transmit nociceptive 
information and the chemicals and transmitters involved in thi s transmission and/or 
modulation of information. 
Afferent transmitters can be characterised by their ability to evoke excitatory post-
synaptic potentials (EPSPs) on second order neurones. Single unit recording of 
primary afferent fibres has indicated that stimulation of different primary afferent 
fibres will result in two distinct populations of EPSPs which are believed to be 
mono-synaptic . Activation of rapidly conducting primary afferent fibres will result 
22 
in an excitation of dorsal horn neurones and the generation of a rapid and brief EPSP 
(Gerber and Randic, 1989a,b,). In contrast the activation of small slowly conducting 
primary afferent fibres results in the generation of a delayed or extended duration 
EPSP (Urban and Randic, 1984; King et al., 1988; Schneider and Perl, 1988; Gerber 
and Randic, 1989a,b; Yoshimura and Jessel, 1990). These two distinct populations 
of EPSPs generated by primary afferent activation may reflect the presence of 
different classes of afferent neurotransmitters acting on the dorsal horn neurones, and 
these include the excitatory amino acids and peptides respectively. 
1.10 Excitatory Amino Acids (Glutamate and Aspartate) 
Glutamate and aspartate are the major excitatory transmitters in the CNS and mediate 
fast excitatory synaptic responses (Watkins and Evans, 1981). Ionophoretic 
application of glutamate causes excitation of dorsal horn neurones (Curtis et al., 
1959) and evidence has shown that glutamate is released from primary afferent fibres 
fo llowing electrical stimulation (Robe1ts, 1974). Glutamate and aspartate are 
observed in approximately 50% of dorsal root ganglion (DRG) cells (Battaglia and 
Rustioni , 1988; Tracey et al., 1991), and are localised in both unmyelinated dorsal 
root axons and A~ fibres (Westlund et al., 1989). Glutamate is associated with 
synaptic vesicles throughout neurones and primary afferent terminals of the 
superficial dorsal horn (DeBiasi and Rustioni, 1988; Miller et al., 1988; Maxwell et 
al., 1990 a,b ). 
Several lines of evidence suggest that glutamate is involved in the transmission of 
nociceptive information in the dorsal horn. There are higher levels of glutamate in 
dorsal rather than ventral roots (Graham et al., 1967; Duggan and Johnston, 1970), 
and glutamate is localised in the small DRG cells associated with nociception (Salt 
and Hill, 1983; Battaglia and Rustioni , 1988). Glutamate is also released in the 
dorsal horn following noxious stimulation or peripheral inflammation (Skilling et al., 
1988; Sorkin et al., 1992) and immunocytochemistry has identified glutamate in A~, 
A8 and C fibres (DeBiasi and Rustioni, 1988). The majo1ity of units in the dorsal 
horn which respond to extracellular glutamate have been identified in the superficial 
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laminae and are activated by C fibre volleys (Schneider and Perl, 1985; 1988). In 
addition, intrathecal glutamate also produces behavioural hyperalgesia and 
spontaneous nociceptive behaviour (Aanonsen and Wilcox, 1986; 1987). 
There are several receptor subtypes through which glutamate may mediate cellular 
effects. The ionotropic group of receptor-linked ion channels, consists of (i) a-
amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), (ii) Kainate and (iii) N-
methyl- D-aspartate (NMDA) receptors. The metabotropic glutamate receptors 
(mGluRs) are coupled through OTP-binding proteins to various second messenger 
systems. 
1.10.1 AMPA Receptors 
AMPA receptors are prevalent throughout the CNS (Monaghan et al., 1984) and in 
the spinal cord are concentrated in the superficial laminae (LI-III) where they are 
believed to be located on neurones post-synaptic to the primary afferent in the dorsal 
horn (See figure 1.3). AMPA receptors can be composed of one or any two of the 
GluR 1-4 subuni ts (Boulter et al., 1990; Nakanishi et al. , 1990). Their activation 
leads to a potent depolmisation of dorsal horn neurones, conversely a blockade of 
AMPA receptors attenuates synaptic activation of dorsal horn neurones by noxious 
and non-noxious stimuli (Dougherty et al., 1992). 
AMP A receptors are believed to mediate the fast synaptic transmfasion brought about 
by glutamate release (Jahr and Jessell, 1985; Jahr and Yoshioka, 1986; Gerber and 
Randic, 1989). Peripheral administration of AMPA into the glabrous skin of the rat 
hindpaw results in pain behaviours in rats, which can be reversed by local application 
of the inhibitor 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) at concentrations 
selective for AMPA receptors (Zhou et al., 1996). AMPA is believed to increase the 
response of spinal neurones to noxious mechanical stimulation (Aanonsen et al., 
1990), and administration of the inhibitor (CNQX) can decrease dorsal horn neurone 
responses to both innocuous and noxious mechanical stimuli (Dougherty et al., 1992; 
Neugebauer et al., 1993), noxious thermal stimuli and A~ and Ao strength electrical 
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stimuli (Dougherty et al., 1992). Electrically evoked C fibre inputs can also be 
inhibited by CNQX (Blake et al., 1988; Alford and Grillner, 1990). 
1.10.2 NMDA Receptors 
NMDA receptors are located throughout the brain and spinal cord (particularly in the 
superficial dorsal horn) (Greenamyre et al., 1984; Monaghan and Cotman, 1985) 
where they play a key role in excitatory changes such as long term potentiation 
(LTP) (Collingridge et al., 1983) as well as the generation of hyperalgesia 
(Doughe11y et al., 1992; Zhou et al., 1996). Distributional studies have shown that 
NMDA receptors are present on both the nerve terminals of the primary afferents as 
well as on membranes that are post-synaptic to the primary afferent (Liu et al., 1994). 
NMDA receptors are highly permeable to Ca2+ when activated but are readily 
blocked by Mg2+ ions in a basal state. Channel opening requires glycine, glutamate 
as well as the release of the magnesium block resulting from partial depolaiisation of 
the membrane (Johnson and Ascher, 1987; Thompson et al., 1992). 
Electrophysiologically, NMDA results in the potent excitation of dorsal horn 
nociceptors (Aanonsen et al., 1990; Dougherty and Willis, 1992; Doughe1ty et al., 
1992). Intrathecal administration of NMDA has been shown to produce thermal 
hyperalgesia in the rat (Kolhekar et al., 1994). As the NMDA receptor is readi ly 
blocked by Mg2+ ions in a basal state, it is believed that the role of NMDA receptors 
in brief "physiological pain" is limited and that the NMDA receptor may play a more 
integral role in the development of intense or chronic pain states, where other inputs 
may exert the depolarisation required to release Mg2+ block of the channel (see 
section 1.13). 
1.10.3 Metabotropic Glutamate Receptors (mGluRs) 
The metabotropic glutamate receptors comprise eight receptors and are sub-divided 
into three groups, according to their amino acid homology, pharmacology and signal 
transduction profiles: group I (mGluRs 115), group II (mGluRs 213) and group III 
(mGiuRs 4t6m&) (Masu et al., 1991; Abe et al., 1992; Nakanishi, 1992; Pin and 
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Duvoisin, 1995). The mGluRs, which couple via G proteins to several signal 
transduction pathways, regulate neuronal excitability in the CNS by indirectly 
modulating a variety of ion channels (for review, see Saugstad et al., 1995). Many of 
the mGluRs have been shown to be located in the spinal cord, where they appear to 
play a role in mediating nociceptive inputs in the dorsal horn of the spinal cord 
(Neugerbauer et al., 1994a,b; Young et al., 1994; 1995; 1997; 1998). In particular 
(but not exclusively) group I mGluR 115 receptors have been implicated in 
nociceptive responses (Young et al., 1994; 1995; 1997; 1998; Fisher and Coderre, 
1996 a, b; Fundytus et al., 1998), and their actions may be mediated in part by 
protein kinase C (PKC) (Young et al., 1995), protein kinase A (PKA), and the nitric 
oxide activated cGMP protein kinase family (PKG) (Woolf and Costigan, 1999; 
Sluka, 1997; Wu et al., 1998). (see figure 1.3). Post-synaptic group I mGluRs can 
also modulate both AMPA and NMDA receptor-mediated currents in various 
neuronal populations (Neugebauer et al. , 1999) and in the spinal cord (Bleakman et 
al., 1992; Cerne and Randic, 1992) in vitro. Similarly, activation of mGluRs can 
potentiate the responses of dorsal horn neurones to NMDA and AMPA receptor 
activation in vivo (Neugebauer et al. , 1994 a, b; 1999), an effect which is mediated 
through group I mGluRs (Bond and Logdge, 1995; Jones and Headley, 1995). 
Behavioural studies suggest that group I agonists can facilitate the effects of NMDA 
and/or non-NMDA receptors to produce enhanced nociceptive responses and 
hyperalgesia (Coderre and Melzack, 1992; Fisher and Coderre 1996 a, b; Meller et 
al., 1993; 1996 a, b). Metabotropic glutamate receptors undoubtedly have a role in 
the transmission of nociceptive information, and thfa role may be more substantial in 
a sensitised state. However, mGluRs are only one of a large number of receptors that 
contribute to nociceptive processing, and several other receptors have been 
implicated in nociception and sensitisation. 
1.11 Neuropeptides 
Irnmunohistochemical studies have demonstrated the presence of a number of 
neuropeptides in the primary afferent fibres and some of the key candidates for a role 
of somatosensory processing are listed below: 
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1.11 .1 Substance P 
The importance of substance P and NK-1 receptors in pain processing is well 
established (Cao et al., 1998; De Felipe et al., 1998). Substance P (SP) is a member 
of a family of related peptides, the tachykinins, and is considered to be an excitatory 
transmitter released by primary afferent neurones terminating in the dorsal horn of 
the spinal cord (Pernow, 1983). The anatomical distribution of SP in the rat central 
nervous system highlights its potential role as an impo11ant sensory 
neurotransmitter/neuromodulator (Quirion et al., 1983). 50% of all C fibres and 20% 
of Ao fibres contain SP, and SP is present in approximately 20% of all DRG 
neurones specifically the small diameter neurones (Ju et al., 1987; Hokfelt et al., 
1976). SP is also abundant in the spinal cord, and SP immunoreactivity is located in 
all laminae, particularly in LI-III, the central canal and ventral horn (Hokfelt et al., 
1980; Gibson et al., 1981). About 50% of the SP in the dorsal horn is of primary 
afferent origin, and is located predominantly in unmyelinated primary afferent fibres 
(Nagy et al., 1981). It has been demonstrated that SP may be released from both the 
central and peripheral terminals of these neurones (Hokfelt et al., 1976). SP exerts 
its effects by binding to the NK-1 receptor which is densely expressed in the 
superficial dorsal horn of the spinal cord and to a lesser extent the deeper dorsal horn 
(Stucky et al., 1993; Helke et al., 1986; Naastrom et al. , 1992). The tachykinin 
receptors are G protein coupled, and increase intracellular ca2+ levels. 
Direct evidence of a neurotransmitter role for SP has been revealed in a number of 
behavioural and electrophysiological studies. Behavioural studies have demonstrated 
that intrathecal injection of SP in mice elicits a dose-related biting and scratching 
response, which are considered to reflect painful sensations (Hayes and Tyers, 1979; 
Hylden and Wi lcox, 1981; Yashpal et al., 1982), although this analogy has been 
questioned (Frenk et al., 1988). Ionophoretic application of SP increases the 
excitability of dorsal horn neurones (Henry, 1976; Zieglgansberger and Tulloch, 
1979) and selectively activates high threshold multireceptive Lamina I and II 
neurones (Randic and Miletic, 1977). In addition, SP enhances the responses of 
rnultireceptive and nocispecific neurones to C fibre strength stimulation (Kellstein et 
al., 1990). There is also evidence that the excitatory effect of SP and noxious 
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stimulus-evoked pain behaviour can be blocked by selective antagonists of the NK-1 
receptor (Laird et al., 2001). There is now a large body of evidence implicating SP 
and NK-1 receptors in sensory processing in the dorsal horn. 
1.11.2 Calcitonin Gene-Related Peptide (CGRP) 
Among the many peptides that are located in DRG, CGRP provides one of the best 
examples of a neuromodulator (Levine et al., 1993) in the sense that the peptide does 
not exert marked excitatory effects itself on nociceptive responses, and yet 
dramatically potentiates the effects of other compounds, particularly SP. 
CGRP like immunoreactivity has been demonstrated in many dorsal root ganglion 
cells including some large primary sensory neurones and particularly those with 
unmyelinated or small diameter myelinated primary afferent fibres (Rosenfeld et al., 
1983). CGRP cells constitute about 50% of all and 70% of the small/medium sized 
neurones and have been shown to terminate in the dorsal horn LI, II and V (Carlton 
et al. , 1988). CORP is one of the most abundant and frequently occuring peptides so 
far encountered in sensory neurones and CORP containing terminals in the dorsal 
horn appear to derive exclusively from DRO cells as dorsal rhizotomy virtuaJiy 
eliminates CORP in the cord (Carlton et al., 1988). A population of CORP 
containing primary afferent neurones is identical to previously described SP 
neurones (Gibson et al., 1984; Wiesenfeld-Hallin et al., 1984). Up to 80% of SP 
containing DRG neurones co-contain CGRP (Garry et al., 1989; Wiesenfeld-Hallin 
et al. , 1984). 
During nociceptive transmission CGRP is released into the superficial dorsal horn 
(Morton and Hutchison, 1989) implicating this peptide as a possible mediator of 
nociceptive transmission. Noxious thermal, mechanical or electrical stimulation has 
been demonstrated to evoke the release of CORP in the superficial dorsal horn 
(Morton and Hutchison, 1990). Ionophoretically applied CORP produces a slowly 
developing modest, but long lasting excitation of nociceptive dorsal horn neurones in 
vivo (Miletic and Tan, 1988), and the application of antisera to CGRP has been 
demonstrated to exert antinociceptive action (Kuraishi et al., 1988). Concomitant in 
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vitro studies have demonstrated that CORP produces a slow depolarisation by a 
direct action on nociceptive dorsal horn cells (Ryu et al., 1988). 
The pronocicepti ve role of CORP and substance P are considered to be mediated by 
their respective receptors located post-synaptically at the level of the superficial 
dorsal horn (OaITy et al., 1991; Yashpal et al., 1991 a, b, c; Levine et al., 1993). 
However, it is of interest to note that CORP, in addition to its direct actions on dorsal 
horn neurones, may potentiate the exci tatory effects of substance P through 
attenuating its breakdown by saturating degrading endopeptidases (Le Oreves et al., 
1985). 
1.11 .3 Somatostatin 
Somatostatin has also been implicated as a neurotransmitter within the dorsal spinal 
cord. Somatostatin is a tetradecapeptide that in general exerts an inhibitory action 
(Hokfelt et al., 1975), although in electrophysiological expe,iments excitatory 
actions have been reported (Salt et al., 1982). Somatostatin is present in small 
neuronal cell bodies and in spinal ganglia in primary afferent fibres (Hokfelt et al. , 
1976) and it is generally associated with C afferent activation, possibly C-
thermosensitive afferents (Wiesenfeld-Hallin, 1986). In the dorsal horn the highest 
concentration of somatostatin is in lamina II (Hokfelt et al., 1976) where it has been 
shown that somatostatin and substance P generally do not coexist (Tuchscherer and 
Seybold, 1985), although a smal l population (26%) of primary afferents do contain 
somatostatin and SP (Hokfelt et al., 1976; Dodd et al. , 1984). 
Somatostatin inhibits the fi ring of nocicepti ve specific spinal cord neurones (Randic 
and Miletic, 1978; Sandkuhler et al. , 1990), and in vitro studies indicate that the 
somatostatin-induced inhibition of dorsal horn cells is associated with a 
hyperpolarisation of these neurones (Murase et al. , 1982). The functional role for 
this peptide as a neurotransmitter is not very clear and it has been suggested that 
somatostatin may affect the release of other transmitters (MacDonald and Nowak, 
1981). In addition, multiple receptor subtypes for somatostatin have now been 
identified. This may explain the discrepancies in the electrophysiological studies and 
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would suggest that the primary role for this peptide may be as a modulator rather 
than a transmitter. 
1.11 .4 Vasoactive Intestinal Polypeptide (VIP) 
VIP is a neuropeptide thought to behave as an excitatory neurotransmitter within the 
CNS and is widely distributed in the peripheral and central nervous system (Hokfelt 
et al. , 1980; 1982). The spinal cord contains relatively small amounts of VIP relative 
to other parts of the CNS. VIP is found in the dorsal horn in LI, II and V and the 
area around the central canal, regions where A8 and C afferents te1minate. VIP 
levels are generally undetectable in normal animals and there are few or no 
immunoreactive cell bodies found in the DRG of these animals. Sciatic nerve 
stimulation in the cat at intensities that activate small diameter myelinated A8 and C 
afferents causes the release of VIP (Yaksh et al., 1982) and intrathecal (i.t.) VIP 
causes an increase in spinal cord excitability primarily to cutaneous thermal stimuli 
in decerebrate animals. The levels of VIP dramatically increase following peripheral 
axotomy (Noguchi et al., 1989) and CCI (Nahin et al., 1994) and so it is possible that 
its transmitter role becomes more important following nerve injury (section 1.18.5). 
VIP and the related peptide Pituitary Adenylate Cyclase Activating Polypeptide 
(PACAP) exert their effects through the VPAC and PAC receptor family which will 
be discussed in great detail in chapter 3. 
1.11 .5 Neuropeptide Y (NPY) 
NPY is a peptide with 36 amino acids, which is widely distributed in the mammalian 
central and peripheral nervous systems (Tatemoto et al., 1982; Hokfelt et a l. , 1983 a, 
b). NPY is found in all levels of the spinal cord particularly in the dorsal horn 
(Gibson et al., 1984) and is most abundant in the lumbosacral regions. Rhizotomy, 
or application of capsaicin do not result in changes in the levels of NPY and so the 
source of NPY containing fibres in the normal dorsal horn is thought to be the CNS, 
with immunoreactivity not normally detectable in the DRG (Gibson et al. , 1984). 
NPY imrnunoreactive fibres are concentrated in LI and II and NPY binding sites in 
lamina I and II are reduced in numbers after depletion of primary afferent fibres by 
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rhizotomy or capsaicin treatment. This suggests that NPY is present on NPY 
sensitive unmyelinated fibres. The overall distribution of NPY is similar to VIP and 
CCK and NPY has been shown to co-exist with somatostatin in primary afferent 
fibres and nerve terminals (Gibson et al., 1984). 
NPY is an inhibitory neuropeptide, although a variety of receptors have now been 
identified which may serve to mediate distinct actions. Microinjection of NPY in the 
dorsal horn has been shown to evoke a stimulus induced decrease in SP release from 
primary afferents (Duggan et al., 1991), suggesting that NPY could cause pre-
synaptic inhibition of primary afferent transmitter release. In addition, NPY 
administered intrathecally can produce analgesia in conscious rats (Holets et al., 
1988). The maj01ity of NPY containing neurones in the dorsal horn have been 
shown to be GABAergic (Rowan et al. , 1993), and NPY may therefore be acting in 
conjunction with GABA in order to produce pre-synaptic inhibition. Fol lowing 
neuropathic injury NPY expression in DRG cells, especially those with large 
diameter axons is markedly increased (McMahon and Priestley, 1995), so the role of 
NPY may become considerably more significant in nerve injury. 
1.11.6 Cholecystokinin (CCK) 
The neuropeptide CCK is found within the CNS in a number of different mammalian 
species (Yaksh et al. , 1988). CCK is expressed primarily in the small diameter DRG, 
as well as in pe1i.pheral nerves and the supe1ficial layers of the dorsal horn (Fuji et 
al., 1983; 1985). However like VIP, the levels of CCK are relatively low in the 
dorsal horn of normal animals (Noguchi et al. , 1993) and its role is believed to be 
more important following nerve injury when it is substantially upregulated (Hokfelt 
et al. , 1994; Noguchi et al., 1989). 
1.11 .7 Galanin 
Galanin receptors are widely distributed throughout the CNS particularly in the 
supe1ficial dorsal horn (Wiesenfeld-Hallin et al., 1992; Zhang et al., 1995). It is 
normally present in around 23% of small to medium diameter DRG neurones, where 
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it co-exists with several other neuropeptide transmitters including CORP and SP (Ju 
et al., 1987; Zhang et al., 1993; 1995). Galanin levels have been shown to decrease 
in the superficial laminae (LI-II) by neonatal capsaicin treatment (Skofitsch and 
Jacobowitz, 1985), suggesting that spinal galan in arises substantially from primary 
afferent C fibres. The role of galanin within the CNS is not very clear, as functional 
studies have provided variable results depending on the preparation and dose used, 
and the effect studied. In rats with an intact nerve, intrathecal galanin produces brief 
facilitatory effects at low doses, which become inhibitory as the dose increases, such 
that at very high doses galanin exerts a purely inhibitory effect (Wiesenfeld-Hallin et 
al., 1988; 1989). Again, multiple receptor subtypes probably contribute to the 
complex profile of effects. Galanin may be an impot1ant modulator of excitatory 
neuropeptide action, as pre-administration of galanin intrathecally has been shown to 
antagonise the excitatory effects of SP and CORP on the flexor reflex (Wiesenfeld-
Hallin et al. ; 1990, 1991; Xu et al., 1989). 
1.12 Central Integration of Afferent Signals in Prolonged / Repetitive 
Inputs 
A vast number of different neurotransmitters/ neuromodulators thus appear to be 
able to influence the nociceptive processing systems within the spinal dorsal horn, 
and it seems likely that there is no sole mediator of nociceptive transmission. Instead 
it seems more Jikely that a variety of neurotransmitters interact within the CNS to 
mediate I regulate the transmission of nociceptive (and non-nociceptive) information. 
It seems almost inevitable that the influences of these agents will be superimposed on 
those of the excitatory amino acids released from afferents (Figure 1.3). The 
excitatory amino acids act at NMDA, AMPA, kainate and mGluR receptors (Price et 
al., 1994). It appears that the AMPA receptor may be substantially involved in 
mediating responses in the acute "physiological" processing of sensory information. 
However, with prolonged release of glutamate or activation of neurokfoin receptors, 
a secondary process occurs which appears to be crucial in the development of 
abnormal responses to further sensory stimuli. Glutamate and aspartate stimulate the 
influx of Ca2+ through NMDA receptor-operated channels (MacDermott et al. , 1986), 
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as well as increasing Ca2+ influx through voltage gated Ca2+ channels associated with 
AMPA/kainate receptors (Murphy and Miller, 1989), and causing the mobilisation of 
Ca2+ from internal stores after the activation of metabotropic glutamate receptors 
(Berridge and Galione, 1988). A sustained activation of AMPA (or alternatively 
perhaps neurokinin or metabotropic glutamate) receptors may cause the partial 
depolarisation necessary to "prime" NMDA receptors and the concomitant elevation 
of Ca2+ may further enhance phosphorylation-dependent modifications of NMDA 
receptors as well as of voltage-dependent ion channels (Dray et al., 1994). Together, 
these prolonged changes can result in the development of NMDA receptor-dependent 
central sensitisation, as for example in "wind up" (a facilitation of dorsal horn 
neurone responses caused by repetitive afferent stimulation), and expansion of the 
peripheral receptive fields (Davies and Lodge, 1987), and it appears that the NMDA 
receptor is needed for these responses (Dickenson and Sullivan, 1987). This 
supports the idea that NMDA receptors become more involved in the transmission of 
nociceptive information, particularly if the system has undergone some form of 
sensitisation. In the highly sensitised state resulting from peripheral nerve injury 
NMDA appears to play a major facilitatory role. 
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Figure 1.3. Post-Synaptic Integration of Signals in Gating the Role of 
NMDA Receptors 
Afferent transmitters/ neuromodulators act on receptors and ion channels in the 
dorsal horn to elicit Na2+ / Ca2+ entry and/ or activate protein kinases that 
phosphorylate membrane bound NMDA and AMP A receptors and alter their 
functional propetties. These processes then act to prime the NMDA receptor by 
removal of the Mg2+ channel block and allow further Na+ and Ca2+ influx to enhance 
membrane excitability and Ca2+-dependent intracellular responses, which are likely 
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1.13 "Wind-Up" and Central Sensitisation 
A continued barrage of nociceptive inputs to the CNS results in changes to the 
response properties of dorsal horn neurones (Chi et al., 1993). It has been 
demonstrated that repetitive stimulation of C-afferent fibres not only activates dorsal 
horn neurones, but neuronal activity also progressively increases throughout the 
duration of the stimulus (Mendell, 1966). Wind up is frequency dependent and relies 
essentially only on the features of the C fibre afferent inputs and not the post-
synaptic cell (Davies and Lodge, 1987). Activation of AMPA, mGluR and NK-1 
receptors on dorsal horn neurones will produce slow synaptic potentials in response 
to C fibre primary afferent activity and result in the progressive depolarisation, which 
results in the removal of the Mg2+ block from the NMDA receptor. Wind-up is 
dependent on activation of the NMDA receptor (Dickenson and Sullivan, 1987; 
Woolf and Thompson, 1991), and studies have demonstrated that wind-up can be 
mimicked by the application of L-glutamate or NMDA (Gerber and Randic, 1989 a, 
b; King et al., 1985. These studies, together with electrophysiological studies, using 
the electrically evoked wind-up model have consistently observed the ability of the 
NMDA receptor antagonists to decrease or abolish ongoing C fibre activity (Davies 
and Lodge, 1987; Dickenson and Sullivan, 1987; 1990; Thompson et al., 1990). 
Experiments in which electrically-evoked synaptic responses have been broken down 
into separate (early and late) components (Gerber and Randic 1989 a, 1989b; 
Dickenson and Sullivan, 1990) have therefore suggested that NMDA receptors play a 
selective role in high threshold C fibre inputs to the dorsal horn. 
The activity-dependent alterations in dorsal horn neurone responsiveness brought 
about during wind-up are thought to be part of the phenomenon of "central 
sensitisation". Low frequency repetitive nociceptor input or peripheral tissue 
damage leads to functional changes in the processing of nociceptive information in 
the dorsal horn (Woolf, 1984). These changes include: increased responsiveness to 
suprathreshold inputs, expansion of receptive field size so that neurones are activated 
by stimuli normally outside the receptive field area, reduction in thresholds for 
activation such as an innocuous Af3 fibre input resulting in an exaggerated response 
("allodynia"), and prolonged afterdischarge (Woolf, I 983; Woolf and Wall, 1986; 
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Dickenson and Sullivan 1987; Simone et al., 1989; Haley et al., 1990; Woolf and 
King, 1990; Coderre and Melzac, 1992; Dougherty and Willis, 1992; Woolf and 
Doubell , 1994). These modifications collectively comprise central sensitisation. An 
additional manifestation of central sensitisation is secondary hyperalgesia, whereby 
an area outside the si te of injury experiences increased sensitivity to noxious stimuli. 
Evidence for a central component includes a demonstration that local anaesthetic 
administration in the p1imary area prevents capsaicin-induced secondary 
hyperalgesia to mechanical stimuli only if administered before the capsaicin injection 
(LaMotte et al., 1991). NMDA is key in the development of central sensitisation, 
and in behavioural studies, secondary hyperalgesia, due to noxious thermal injury 
can be prevented by pre-treatment with an NMDA antagonist (Coderre and Melzack, 
1991). The central sensitisation and consequently altered sensory processing 
following nerve injury may additionally lead to structural changes (see section 1.20). 
1.14 Post-synaptic Effects of Neurotransmitters/Neuromodulators 
Excitatory amino acids and neuropeptides appear to contribute to nociception by 
direct neurotransmitter actions or neuromodulatory mechanisms on post-synaptic ion 
channels/ receptors. However, the prolonged changes occuring due to a sustained 
noxious input cannot be fully attributed to such rapid effects. Instead, they are likely 
to be mediated by the subsequent intracellular events triggered by the activation of 
these receptors. 
1.14.1 Intracellular Second Messengers Involved in Nociception 
Evidence suggests that there is a contribution of intracellular Ca2+, second messenger 
systems and protein kinases that phosphorylate membrane bound proteins (Nestler 
and Greengard, 1983), leading to the development of noxious stimulus-induced 
neuroplasticity. In addition to increases in intracellular Ca2+, excitatory amino acid 
and neuropeptide receptor activation results in activation of various intracellular 
second messengers. The influx of Ca2+ through NMDA receptor channels activates 
nitric oxide synthase (NOS) which generates NO from free L-arginine (Garthwaite et 
al., 1988), which in tum activates soluble guanylate cyclase and increases cGMP 
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(Southam et al., 1991). The Ca2+ influx also activates neuronal phospholipase A2 
(PLA2), which triggers the production of arachidonic acid (Dumuis et al., 1988; 
1990), which is metabolised into va1ious eicosanoids. Activity of metabotropic 
glutamate receptors triggers an increase in phosphoinositide metabolism, resulting in 
the production of inositol triphosphates (Sladeczek et al., 1985). This leads to a 
release of Ca2+ from intracellular stores (Murphy and Miller, 1988), as well as 
production of diacylglycerol which stimulates the translocation and activation of 
PKC (Manzoni et al., 1990). Activation of calmodulin / Ca2+-dependent kinase II 
(CamKII) by Ca2+ and calmodulin downstream of inositol-1,4,5-triphosphate (IP3) 
metabolism (Erondu and Kennedy, 1985) is widely believed to be involved in the 
downstream influences and regulation of glutamate transmission (Wu et al., 1986; 
McGlade-McCulloh et al., 1993; Watanabe and Onozuka, 1994). In addition, 
activation of the G protein coupled neuropeptide receptors (such as the CGRP, VIP 
and PACAP receptors) results in the activation of adenylate cyclase and an increase 
in cAMP production, which in tum triggers the activation of cAMP-dependent 
protein kinase (PK.A) (Menikoth et al., 1993) (as described in chapter 4). 
Persistent nociception as a result of tissue injury for example, may result in the 
repetitive afferent barrage that bring about altered pe1ipheral and central sensory 
processing. However, once the injury is healed, the central sensitisation will abate 
and the abnormal nociceptive sensations will resolve. In contrast, pain resulting 
from nerve injury can lead to Jong term structural and functional changes in both the 
peripheral and central nervous system that bring about a state of altered sensory 
processing and the establishment of a chronic pain state. 
1.15 Neuropathic Pain 
Damage to a somatic sensory nerve can be expected to cause somatic sensory loss. 
In many patients, however, negative symptoms such as numbness are joined by 
positive sensations, involving in almost all cases some sort of false sensation of pain. 
The experience can range from mild dysesthesia (an unpleasant and abnormal pain 
sensation) (Merskey and Watson, 1979) to unbearable pain. Indeed, some patients 
are unable to work, walk, or sleep, and the contact of clothing with the skin is 
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expetienced as an unbearable burning. Neuropathic pain usually develops into a 
chronic state and fai ls to respond to standard analgesic interventions. Morphine can 
give a degree of relief, but only at doses impractical for what may be a lifelong 
regime. 
Neuropathic pain may develop whenever nerves are damaged by trauma, diseases 
such as diabetes, herpes zoster, cancer or chemical injury. It may also develop after 
amputation. The resultant nerve damage leads to pathological changes both 
peiipherally and centrally and leads to painful neuropathic symptoms which are 
characterised by several different types of pain sensation: 
• Spontaneous pain: this may be a continuous superficial burning pain and/ or 
deep aching pain, or episodic attacks. 
• Hyperalgesia: increased sensitivity to noxious stimulation. 
• Allodynia: pain in response to a normally innocuous stimulus. 
The duration of these abnormal pain states can range from months to decades 
(Scadding, 1984), as the pathological conditions often persist long after healing of 
the damaged peripheral tissue or nerve. 
1.16 Changes in Primary Afferent Responsiveness Following Nerve 
Injury 
It is possible that the spontaneous activity of injured primary afferents may 
contribute to the induction and maintenance of the allodynic and hyperalgesic states 
which follow nerve injury, as well as contributing to the abnormal behaviours 
thought to be indicative of spontaneous pain. When a peripheral nerve is sectioned, 
resources are mobilised for regenerative growth and the axons in the central end may 
undergo sprouting (Devor and Wall , 1976). Successful regeneration restores 
functional contact between the afferent and its target tissue and ideally re-establishes 
normal sensation. However, if local conditions prevent regenerative growth and the 
sprouts fail to reach the distal part of the cut nerve they form a tangled mass called a 
neuroma (Cajal, 1928). Electrophysiological recordings from neuromas have shown 
that many trapped afferent endings fire spontaneously. Moreover, they become 
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directly sensitive to mechanical, thermal and chemical stimulation (Wall and 
Gutnick, 1974; Devor et al., 1989). The resulting abnormal filing patterns have been 
termed ectopic discharges and chemicals that increase ectopic discharges (for 
example; catecholamines and inflammatory mediators) from neurornas have been 
shown to increase spontaneous pain in humans (Chabal et al., 1989). This abnormal 
activity appears to be principally mediated by Al3 and Ao fibres (Kajander and 
Bennett, 1992; Kajander et al., 1992). Following CCI, ectopic activity continues for 
several weeks post-injury and ectopic discharges from C fibres begin slightly later 
than A fibres, from approximately day 10 onwards (Xie and Xiao, 1990), which 
coITesponds with the maximal behavioural changes observed in the CCI model (Attal 
et al. , 1990; Bennett and Xie, 1988). These findings suggest that alterations in the 
firing prope11ies of peripheral nerves following nerve injury can contribute to the 
altered processing of nociception and ultimately an increase in the sensitivity of 
pe1ipheral nerves, particularly the large diameter myelinated Al3 fibres. However, it 
is apparent that altered central nervous system processing also plays a key role. 
1.17 Altered Central Nervous System Processing Following Peripheral 
Nerve Injury 
The abnormal pain-related behaviours result in part from (peripheral sensitisation). 
And this phenomenon probably makes an important contribution to causing altered 
central nervous system processing (central sensitisation) and this central sensitisation 
likely is maintained both by ongoing peripheral inputs as well as mechanisms within 
the spinal dorsal horn itself. Persistent activation of spinal NMDA receptors can 
induce a local state of facilitated processing secondary to small afferent stimulation 
that leads to a increased receptive field size and a increased responsiveness to low 
and high threshold stimulation ("Wind-up"), (Mendell and Wall, 1965) (section 
1.13). NMDA antagonists have also been shown to inhibit the responses of dorsal 
horn neurones induced by prolonged chemical nociception (Haley et al., 1990) and 
joint inflammation (Neugebauer et al., 1993). So it appears that the activation of 
NMDA receptors contribute greatly to prolonged states of nociception, even when 
these arise from different origins. 
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In addition to the depolarisation-induced relief of Mg2+ block, further facil itation of 
NMDA receptor function may arise from phosphorylation-dependent modification of 
the NMDA receptor itself (Chen et al., 1995). Maintenance of the sensitised state 
may be importantly through the persistence of these post-translational modifications 
of the NMDA receptor. This has important clinical implications as NMDA and NK-
1 antagonists may prevent the establishment of central sensitisation but only NMDA 
antagonists can reverse established central sensitisation (Woolf and Thompson 1991; 
Ma and Woolf, 1995; Traub 1996). 
The past decade has seen great progress both in understanding the causes of 
neuropathic pain and in finding new drugs that promise great benefit. The work has 
been advanced by a series of discoveries, beginning with a number of animal models 
that closely mimic neuropathic pain, as seen clinically. These models provide the 
means with which to investigate some of the mechanisms behind the hyperalgesia 
and allodynia induced by nerve injury, and therefore have greatly improved the 
understanding of the neural mechanisms underlying neuropathic pain states. Several 
models now exist using a partial nerve injury, which allows some correlation of the 
central changes which occur following nerve injury, with the severity of pain-related 
behaviour. A variety of tests can be performed on the affected, ipsilateral hind limb, 
which measure alterations in the characteristic reflex withdrawal responses from 
thermal, mechanical and chemical stimuli. The model of choice for this study is the 
chronic const1iction injury (CCI) model first described by Bennett and Xie (1988). 
1.18 The Chronic Constriction Injury Model (CCI) 
This injury is produced by tying four chromic catgut ligatures loosely around the 
sciatic nerve. These ligatures are tied so as to retard, but not stop, blood flow in the 
epineural vessels. The resultant inflammatory response causes constriction of the 
sciatic nerve and within one week post-operatively rats exhibit altered spontaneous 
behaviours indicative of neuropathic pain. Ipsilateral to nerve injury, the affected 
hindpaw exhibits heat hyperalgesia, cold and mechanical allodynia (Bennett and Xie, 
1988; Attal et al., 1990). In addition, Attal et al., (1990) reported that rats with CCI 
held the injured hindpaw in va1ious abnormal positions, exhibited guarding 
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behaviour with the paw generally raised and the toes ventroflexed, which, they 
suggested indicated the presence of spontaneous pain. These behavioural changes 
have been shown to manifest around 36 hours post-operatively and the severity of 
these changes peak at around 2 weeks post-operatively, lasting for up to 3 months 
(Bennett and Xie, 1988). An important feature of the CCI model is that the ligatures 
do not completely sever the nerve so that the continuity of many of the axons within 
the sciatic nerve is maintained. 
Many CCI rats exhibit additional abnormalities, reminiscent of phenomena seen in 
human causalgia (burning pain after nerve injury) and reflex sympathetic dystrophy 
(RSD; post-injury pain accompanied by sympathetic manifestations such as sweating 
pallor or redness). Skin temperature variability between ipsi lateral and contralateraJ 
paws is common following CCI (Wakisaka et al., 1991). Also, the claws on the 
ipsilateral hindpaw grow abnormally thick, long and curved (Wakisaka et al., 1991). 
Equivalent changes are also seen in human causalgia and RSD patients. 
This model has greatly facilitated experiments probing the pathophysiology of 
neuropathic pain, and is the model of choice for this study as it is well established 
and allows the comparison of present results with previous findings. In addition , the 
model is relatively simple and safe to set up and the incidence of autotomy and 
morbidity is low and the affective hindlimb is easily accessed. 
1.18.1 Plasticity Following Nerve Injury 
Following CCI, characteristic and abnormal behavioural manifestations develop: 
namely, hyperalgesia, cold and mechanical allodynia as well as behavioural signs of 
spontaneous pain (Bennett and Xie, 1988; Attal et al., 1990). There is evidence that 
several aspects of the nerve injury may contribute to the development of these 
abnormal pain states. Clatworthy et al., (1995) demonstrated that the local 
inflammatory response that follows CCI may contribute in part to the development of 
hyperalges.ia and guarding behaviour in rats. Injection of the anti-inflammatory 
agent dexamethasone, decreased the inflammatory response induced by ligation of 
the sciatic nerve with chromic ligatures and subsequently blocked the guarding 
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behaviour and thermal hyperalgesia (Clatworthy et al., 1995). Concomitant data 
demonstrated that application of the pro-inflammatory agent Complete Freund's 
Adjuvant (CFA) to the site of injury resulted in the augmentation of these abnormal 
behaviours (Clatworthy et al., 1995). In addition, decreased bloodflow at the site of 
injury caused by the ligatures and accentuated by the resultant inflammation and 
constriction of the sciatic nerve is evident and is believed to contribute to thermal 
hyperalgesia (Myers et a l. , 1993). 
Recent work by Kajander et al., (1996) has demonstrated that the suture material 
used to constrict the sciatic nerve itself is important in the development of abnormal 
behavioural responses. Comparison of chromic cat gut, plain gut, and polyglactin 
sutures revealed significant vmiation in the position in which the rats held there 
affected hind paws with the effects on paw position much greater in rats with 
chromic gut ligatures (Kajander et al., 1996). Since all types of suture succeeded in 
producing a degree of abnormal behavioural responses, the physical constriction of 
the nerve is likely to play an important part in thei r development. However, these 
results also suggest that the chemical constituents of the chromic gut sutures may 
also have an effect, and fm1her evidence by Maves et al., (1995) demonstrated that 
providing an acidic environment around the sciatic nerve for 7 days will result in the 
development of thermal hyperalgesia. 
1.18.2 Morphological Changes Following CCI 
The rat sciatic nerve is associated with spinal segments L4-L6 and contains fibres of 
sensory, motor and sympathetic origin. At the mid-thigh level (site of ligation), the 
sciatic nerve comprises approximately 27, 000 axons of which 6% are motor axons, 
23% are myelinated sensory axons, 48% are unmyelinated sensory axons while 23% 
represent unmyelinated sympathetic axons (Schmalbruch, 1986). 
There are many morphological changes in the fibre composition of the sciatic nerve 
that occur following CCI, and since many axons within the nerve are left in 
continuity, the rat's responses to stimulating the partial denervated limb can be 
tested. 
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There are two main stages involved in the pathological changes of the sciatic nerve 
following CCI (Coggeshall et al., 1993). The first is an early degenerative stage, 
which is thought to be a direct result of the inflammation which occurs following 
nerve ligation, and constricts the axons. Light microscopic analysis has indicated 
that the ligatures predominantly affect large myelinated A~ fibres distal to the injury 
(Gautron et al., 1990). These changes were confirmed in electrophysiological studies 
of single fibres in the distal segment of the ligated sciatic nerve. Almost no rapidly 
conducting fibres could be detected and a complete loss of large myelinated fibres 
distal to the site of nerve ligation was observed at the peak of neuropathy. Based on 
these studies it was suggested that the loss of large fibres underlies the sensory 
changes observed in this model, possibly via a loss of central inhibitory control of 
spinal cord nociresponsive neurones (Gautron et al., 1990; Coggeshall et al., 1993). 
It has also been demonstrated that large rnyelinated fibres are affected proximal to 
the site of the ligature, albeit much less so, and abno1malities have been detected in 
the A8 range (Gautron et al., 1990). Basbaum et al. (1991) demonstrated 
considerable changes in the unmyelinated fibre spectrum following CCI, and there 
was a 34% and 71 % decrease observed in the distal compared to proximal nerve at 
the peak of neuropathy. Large clusters of unmyelinated axons which usually occur 
in the sciatic nerve were absent distally at day 14 post-operatively and generally they 
appeared singly or in loose abnormal bundles. 
The second stage of pathological change is the regenerative phase. This generally 
occurs from day 28 post-operatively onwards, when the sutures have been 
reabsorbed and the swelling has subsided (Coggeshall et al., 1993). This coincides 
with fibre regeneration and the recovery of axonal numbers, and probably accounts 
for the eventual recovery of normal sensation within the affected limb (Guilbaud et 
al., 1993). 
Behavioural studies investigating the time course of degeneration in relation to 
behavioural abnormalities have revealed that the hyperalgesia following CCI is 
generally maximal at day 10-14 post-operatively (Bennett and Xie, 1988; Attal et al., 
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1990). This parallels the onset of fibre loss of large diameter myelinated fibres 
(Gautron et al., 1990; Coggeshall et al., 1993). 
The damage to nerve fibres following CCI does appear to be important as the 
development of abnormal behaviours appears to coincide with the degeneration and 
regeneration of A-fibres. However, there does not appear to be a strong and direct 
link between the development and subsequent recovery of abnormal behaviours 
following nerve injury and the time course of fibre loss. At week 15 post-operatively 
when behavioural signs have generally dissipated, large diameter myelinated fibres 
are still absent (Guilbaud et al., 1993). It does appear likely that the degeneration of 
nerve fibres observed following CCI is important but there are additional factors 
contributing to the overall development of neuropathic behaviours. 
1.18.3 Afferent Neuropeptide Plasticity Following Nerve Injury. 
Following nerve injury, long-lasting changes in the expression of neuropeptides and 
their receptors in pJimary afferent neurones are observed (Figure 1.4). In addition, 
changes in the peripheral and central transport of these substances results in marked 
plasticity within the spinal cord and the changes observed are assumed to represent 
adaptive responses to limit the consequences of the inflicted damage. The two main 
excitatory peptides SP and CGRP and the inhibitory neuropeptide SOM appear to be 
downregulated in response to the nerve injury. 
1.18.4 Substance P, CGRP and SOM 
Following axotomy there is a dramatic decrease in SP mRNA in the small to medium 
diameter DRG cells accompanied by a parallel decrease in SP immunoreactivity in 
the dorsal horn (Barbur et al., 1981; Jessel et al., 1979; Noguchi et al., 1993; Shehab 
et.al, 1986). A similar decrease in the production of SP in primary afferent fibres is 
also observed following CCI (Cameron et al., 1991; 1997; Nahin et al., 1994) with a 
significant decrease in the density of SP immunoreactive fibres in the ipsilateral 
spinal cord (Kajander and Xu, 1995). Concomitantly CGRP immunoreactivity is 
decreased following CCI (Nahin et al., 1994) and CGRP mRNAs have been shown 
45 
to fall to half their normally abundant levels in the DRG. Peripheral axotomy results 
in a marked decrease in the expression of CGRP in p1imary afferent neurone somata, 
which is maximal at day 7-14 post-operatively (Noguchi et al., 1989; 1990; 1993; 
Shehab et al., 1986). A similar finding has been observed following CCI (Nahin et 
al., 1994). However, decreases in the immunoreactivity of this peptide in the dorsal 
horn are not observed until about day 60 after nerve injury (Kajander and Xu, 1995). 
Sciatic nerve section is associated with a decrease in the levels of somatostatin 
mRNA in DRG neurones (Noguchi et al., 1989) and a corresponding decrease in the 
levels of peptide immunoreactivity in tem1inals in the dorsal horn (Barbut et al., 
1981; Shehab et al., 1986; Villar et al., 1989; Zhang et al., 1993). 
1.18.5 VIP, Galanin, NPY and CCK 
In contrast to SP, CGRP and SOM, a different response pattern has been observed 
for a group of peptides almost undetectable under normal circumstances. Thus, 
fo llowing nerve injury there is a marked increase in the levels of the neuropeptides 
VIP, galanin, NPY and CCK (Figure 1.4). The levels of VIP dramatically increase 
following peripheral axotomy (Noguchi et al., 1989) and CCI (Nahin et al. , 1994) 
from apparently undetectable levels in the dorsal horn (Knyihar-Csillik et al., 1993) 
and primary afferent neurones (Fuji et al., 1985) of normal animals. In double 
labelling studies, it was demonstrated that VIP expression only occurs in cells whose 
axons are cut (Shehab et al., 1986). This suggests that sensory neurones may express 
VIP as a direct consequence of nerve injury. VIP has a predominantly excitatory role 
(section 1.11.4), and it has been suggested that VIP takes over the role of SP as a 
piimary neurotransmitter within the CNS of nerve injured animals. Peripheral nerve 
injury also leads to an increase in the neuropeptide galanin. Galanin mRNA 
increases within DRG cells within 24 hours, as well as in the ipsi lateral dorsal horn 
(Ma and Bisby, 1997; Nahin et al., 1994; Rornualdi et al., 1990; Zhang et al., 1995). 
The inhibitory role of galanin is more pronounced following nerve injury 
(Wiesenfeld-Hallin and Xu, 1996), and correspondingly the effect of the galanin 
antagonist M-35 on CS-induced reflex facilitation is more pronounced following 
nerve injury. This suggests that galanin's functional role becomes more important 
following nerve injury. The increase in VIP and galanin seem to occur mainly in 
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small and medium sized neurones, often in the same neurones and especially in those 
that normally contain SP and CORP (Hokfelt et al., 1994). The level of NPY is 
dramatically upregulated following axotomy, mostly in large DRG neurones, that is, 
a population of neurones bel ieved to be almost totally devoid of these neuropeptides 
(Hokfelt et al., 1994). In normal animals NPY positive fibres are present in the 
superficial laminae of the dorsal horn, and all evidence indicates that these fibres 
solely a1ise from local cell populations in the dorsal horn. However, following 
axotomy there is also a dense innervation into Lill and IV suggesting an upregulation 
and a presence in large calibre fibres thought to be of afferent origin (Wakisaka et al., 
1991, 1992; Zhang et al., 1993). CCK, which js normally present in low amounts in 
DRG (Fuji et al., 1985; Ju et al. , 1987) is dramatically upregulated following 
peripheral nerve injury at the mRNA level in primary afferent neurones (Vi llar et al., 
1989). The role of CCK in neuropathy is not clear (See Wiesenfeld-Hallin and Xu, 
1996) but the analgesic effect of morphine and P-endorphin appear to decrease as a 
result of its presence (Fa1is et al. , 1983). In addition, antagonists of the CCK-B 
receptor (which is the prevalent form of CCK receptor within the rat spinal cord) 
potentiate opioid analgesia and attenuate the development of morphine tolerance 
(Baber et al., 1989; Dourish et al., 1990; Wiesenfeld-Hallin et al., 1990). The 
upregulation of CCK following nerve injury may in part help to explain the 
decreased efficacy of opioid analgesia prevalent in neuropathic patients. 
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Figure 1.4 Schematic of the Principal Changes at the Spinal Level 
Following Peripheral Nerve Injury 
Small and large primary sensory neurone in a DRG send a central branch to the 
dorsal horn of the spinal cord and with a peripheral branch that has been sectioned 
(axotomy). The changes occurring in levels of peptides and of both peptide and 
peptide receptor mRNAs are indicated by aiTows. Thus in small diameter, 
unmyelinated DRG neurones CORP, SP and SOM are decreased as well as NPY 
receptor mRNA. In contrast, levels of VIP, GAL are markedly increased, with 
modest increases in CCK and NPY. In large diameter DRG cells there is a 
prominent increase in the levels of NPY and the NPY receptor, along with smaller 
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1.19 Intracellular Mechanisms in Spinal Nociceptive Processing 
1.19.1 Downstream Signal Transduction 
Several studies have aimed to elucidate the intracellular mechanism(s) by which 
nociceptive information is transmitted in dorsal horn neurones. There are 
undoubtedly multiple second messenger pathways involved in this process, many of 
which are beyond the scope of this study. The second messenger pathway that 
involves the activation of the neuropeptide receptor VPAC2 and the associated signal 
transduction cascade involving the formation of adenylate cyclase and subsequent 
activation of PKA was investigated in the cun-ent experiments and so will be 
addressed in detai l in chapters 3 and 4 
1.19.2 Molecular Mechanisms of Nociception 
Beyond the initial effects of second messenger activation, many longer-term 
consequences may also be initiated. For example, in addition to alteiing membrane 
permeability, a number of signalling events, including increases in intracellular Ca2+ 
and the activation of downstream signal transduction enzymes such as PKA, 
converge on the phosphorylation of Ser-133 residue in the cAMP response element-
binding protein (CREB). CREB is an imp01tant downstream effector of the cAMP 
dependent signalling pathway and positively regulates gene expression in response to 
changes in cAMP and Ca2+ dependent signalling pathways (Meyer and Habener, 
1993; Ghosh and Greenberg, 1995) via a conserved cAMP response element (CRE) 
(Montiminy et al., 1986; Comb et al., 1986). The increased expression of 
immediate-early genes (IEG) such as c-fos (Morgan and Cun-an, 1991) generates 
protein products (e.g. Fos) which act as third messengers that are believed to be 
involved in the transc1iptional control of further genes that encode, for example , a 
va1iety of neuropeptides including tachykinins. Regulation of IEG function (both by 
increased expression and phosphorylation) is brought about by a variety of second 
messenger pathways, and is a ciitical factor in controlling expression of many 
cellular changes. There are many IEG products which may be involved in 
nociception, and some of the long term molecular changes observed can be linked 
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with states of central sensitisation and persistent nociception (Coderre et al., 1993). 
The downstream targets of IEG mediated regulation are likely to include many genes 
with signalling or structural functions. One of these potential targets ubiquitin 
Carboxyl-te1minal hydrolase-Ll UCH-Ll) is discussed in Chapter 5. 
1.20 Structural Reorganisation of the Dorsal Horn 
In addition to alterations in biochemicaJ processes there is evidence that the 
microanatomy of the dorsal horn can be modified following afferent nerve injury. 
Partial denervation, as a result of nerve injury, results in a substantial reduction in the 
synaptic contacts made by p1imary afferents with neurones in LII, and the subsequent 
rea1Tangement of the highly ordered laminar termination of primary afferents within 
somatotopically approp1iate regions of the dorsal horn (Castro-Lopes et al., 1990; 
Woolf et al., 1992; Mannion et al. , 1996). It has recently become apparent that 
regenerative changes occur following nerve injury. The discovery by Woolf et al. 
(1992) that large myelinated fibres sprout from LIII into LII in the dorsal horn 
following sciatic transection is of particular interest as thi s provides AB fibre input to 
a region of the dorsal horn normally involved in nociceptive processing by 
nociceptive C fibres. If the low-threshold rnechanoreceptive afferent terminals that 
sprout into LII establish functional contacts with cells that normally would have a 
monosynaptic C-nociceptor input, this could lead to inappropriate responses to 
innocuous peripheral stimuli, perhaps an anatomical correlate of mechanical 
allodynia. This therefore suggests that the sprouting and reorganisation of primary 
afferent input could be related to the symptoms that sometimes fol low nerve lesions 
(Woolf et al., 1992). Therefore, the already well demonstrated peripheral 
regenerative capacity of primary afferent neurones might be accompanied by an 
equally impo11ant central regenerative capacity, or plasticity, that in certain 
circumstances could be maladaptive (Woolf et al., 1992). Peripheral neuropathic 
pain may therefore be an expression in part, of an aJteration in the circuitry of the 
spinal cord. However, it should be noted that the extent of sprouting that occurs 
following nerve injury is difficult to fully evaluate as there appears to be an increase 
in the uptake of the marker of myelinated fibres (Cholera toxin B-subunit (CTB)) 
following nerve injury (Tong et al., 1999). 
1.21 Aims of the Study 
This study had three main lines of investigation (a, band c below) which correspond 
to chapters 3, 4 and 5 respectively. 
(a) The role of the VPAC2 receptor in the development and maintenance of the 
abnormal behavioural responses which occur following CCI in normal and mice 
lacking the VPAC2 receptor (VPAC2R<·'-l). 
(b) The role of cAMP-dependent protein kinase (PKA) in central neuropathic 
sensitisation in rats following CCI. 
(c) The role of targeted protein degradation (via the ubiquitin-proteasome system) in 
central neuropathic sensitisation in rats following CCI. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Suppliers 
Affiniti Research Products Ltd. 
Mamhead Castle, Mamhead, Exeter, Devon, EX6 8HP, UK. 
Amersham Life Sciences 
Amersham Place, Little Chalfont, Buckinghamshire, HP7 9NA, UK. 
Astra-Zeneca 
Alderley Park, Macclesfield, Cheshire, SKlO 4TG, UK. 
BDH Chemical Company 
Merck House, Poole, Dorset, BHl l TD, UK. 
Beckton Dickenson UK Ltd (Transduction Labs) 
Between Towns Road, Cowley, Oxford, OX4 3LY, UK. 
Bio log. Lif esciences Institute 
Forschung Labor und Biochemica-Vertrieb GmbH, PO Box 107125, D-28071, 
Bremen, Gennany. 
Biomol GmbH 
Waldmannster, 35, D-22769, Hamburg, Germany. 
Bio-Rad 
Bio-Rad House, Marylands Avenue, Herne! Hempstead, UK. 
Boehringer Mannheim Ltd. 
Bell Lane, Lewes, East Sussex, BN7 110, UK. 
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CellPath Ltd. 
PO Box 101, Herne] Hempsted, Herts, HP3 8QE, UK. 
Charles River 
Manston Road, Margate, Kent, CT9 4LT, UK. 
Chemicon International Ltd. 
2 Admiral House, Cardinal Way, Harrow, HA3 SUT, UK. 
Clark Electromedical Instruments Ltd. (Harvard Apparatus Ltd.) 
Fircroft Way, Edenbridge, Kent, TN8 6HE, UK. 
Fisher Scientific 
Bishop Meadow Road, Loughborough, Leicestershire, LEl 1 SRE, UK. 
Genus Xpress (Ethicon) 
10 Castings Court, Falkirk, KK2 9HJ, UK. 
Gibco Life Technologies Ltd. 
3 Fountain Drive, lnchinnan Business Park, Paisley, PA4 9RF, UK. 
Goodfellow Metals 
Ermine Business Park, H untingdon, PE29 6WR, UK. 
HA West X-Ray Ltd. 
41 Watson Crescent, Edinburgh, EHl 1 l ES, UK. 
Hayman Ltd. 
Eastways Park, Witham, Essex, CM8 3YE, UK. 
Linton Instrumentation 
No. 1 Forge Business Centre, Norfolk, IP22 lAD, UK. 
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Medical Instruments 
Yale University, USA. 
Merck Ltd. 
Merck House, Poole, Dorset, BH15 lTD , UK. 
NENDupont 
Dupont NEN Research Products, S49 Albany Street, Boston, MA 021 18, USA. 
New England Biolabs 
New England Biolabs, Know! Piece, Wilbury Way, Hitchin, Herts, SG4 0TY, UK. 
Oswel DNA Service 
Institute of Biomolecular Sciences, University of Southampton, Southampton, UK. 
Promega UK Ltd. 
Delta House, Chilworth Research Centre, Southampton SO 16 7NS, UK. 
Rhone Merieux 
Harlow, Essex, CM19 5TS, UK. 
Roche Diagnostics 
Bell Lane, Lewes, East Sussex., BN7 1L6, UK. 
Santa Cruz Biotech Inc., (Autogen Bioclear, UK, Ltd.) 
Holly Ditch Farm, Mile Elm, Caine, Wiltshire, SNI l 0P Y, UK. 
Sigma-Aldrich Company Ltd 
Fancy Road, Poole, Dorset, BH12 4QH, UK. 
Stoel ting 
620 Wheat Lane, Wood Dale, IL60191, USA. 
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Thornton and Ross Ltd. 
Linthwaite, Huddersfield, HD7 5QH, UK. 
Unipath Ltd. 
P1iory Park, Bedford, MK44 3UP, UK. 
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2.2 Materials and Chemicals 
2.2.1 Anaesthetics 
Sodium pentobarbital (Sagatal, Rhone Merieux) 




Adult male Wistar rats (Charles River) 
Adult male C57 / Bl6 wild-type and VPAC2R(-l-l mice (kind gift donated by 
Professor Tony Harrnar, Department of Neuroscience, University of Edinburgh). 
2.2.3 Antibodies 
The name and source of antibodies and their appropriate di lutions for Western 
blotting are shown in Table 2.1 
Table 2.1 Table of Antibodies, Dilution and Source used in Western Blot 
Analysis 
Antibody Type Dilution Source 
UCH-Ll Rabbit polyclonal 1:5000 Affiniti 
GAPDH Mouse monoclonal 1:750 Chernicon 
PKARI Mouse monoclonal 1:250 Transduction Labs 
PKA Rlla Mouse monoclonal 1:100 Transduction Labs 
PKA RII~ Mouse monoclonal 1:1000 Transduction Labs 
PKA ~-CAT Rabbit polyclonal 1:500 Santa Cruz 
Anti Mouse IgG HRP-conjugated l :2000 NEB 
Anti Rabbit lgG HRP-conjugated 1:2000 NEB 
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2.2.4 Drugs 
The name and source of drugs used for ionophoresis and intrathecal administration 
are shown in Table 2.2 
Table 2.2 Drugs used for lonophoresis and lntrathecal Administration 
Drug Supplier Application(s) Action 
Affiniti Ionophoresis Reversible 
MG-132 i.t Injection Proteasome Inhibitor 
Topical Application 
Epoxomicin Affiniti i.t Injection Reversible 
Topical Application Proteasome Inhibitor 
Lactacystin Affiniti Ionophoresis Irreversible 
i.t Injection Proteasome Inhibitor 
Parthenolide Biolog i.t Injection NF-KB Inhibitor 
H-89 Biolog i.t Injection PKA Inhibitor 
Myr-PKJ (5-24) R.Clegg* i.t Injection PKA Inhibitor 
Control Myr- R.Clegg* i.t Injection No Known Activity 
nonsense peptide 
Rp-8-CPT-cAMPS Biolog i.t Injection Competitive 
Inhibitor of PKA 
Activation by cAMP 
Sp-5,6-DCl-cBIMPS Biolog i. t Injection cAMP Analogue 
Des(l-4)Arg 10-Ro P.Robberecht i.t Injection VPAC2 antagonist 
251553 ♦ 
Ro 251553 P .Robberecht i.t. Injection VPAC2 Agonist 
♦ 
* Kind gift donated by Roger Clegg, Hannah Research Institute, Ayr, Ayrshire, UK. 
♦ Kind gift donated by Pattick Robberecht University of Brussels, Belgium. 
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2.2.5 Electrophysiology 
Glass capillaries (Clark Electromedical Ltd) 
Platinum wire (Goodfellow Metals) 
Ally! isothiocyanate (mustard oil , Aldrich) 
Liquid paraffin (Thornton and Ross) 
Agar (Unipath) 
2.2.6 Histological 
OCT embedding matrix (CeIIPath) 
Polysine®-coated microscope slides (BDH). 
Mayer' s haematoxylin (0.1 % haematoxylin with stabilisers, Sigma) 
Eosin (1 % aqueous, Merck) 
DEPX mounting medium (BDH) 
Xylene (BDH) 
Pontamine Sky Blue (BDH) 
Bromophenol blue (BDH) 
Coomassie blue R-250 (BDH) 
Perfex mounting medium (CellPath) 
2.2.7 Oligonucleotides 
Oligonucleotide probes were synthesised and HPLC purified by Oswel Chemicals. 
Each probe was dissolved in approximately 1ml of sterile water, at a given 
concentration (µg/ml). The specificity of each probe was confirmed by data base 
screening of Genobase/EMBL sequences from which no significantly homologous 
alternative target sequences were recognised. 
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PKA Ria (48Mer) Accession number M17086 
360 5'CGGTGGTGAAGGGCCGTCGGCGCCGCGGTGCTATCAGCGCTGAGG 
3· C \GCl ·c,CC1l ,CCiCC.\CC,t\ TAt1 l C< iCGAC TCC 
TTT ACACTGAGGAAGATGCTGCGTCCTACGTI AGAAAGG 3 '444 
,\.\i\ TCTG.\CTCCTI Cl .\C 5' 
PKA RI(3 (48Mer) Accession number 321332 
205'ATGGCCTCCCCATCATGCTICCACTCAGAGGACGAGGACTCTCTGA 
J" rn. I C,.\G.\Ci \CT 
AAGGATGCGAGATGTACGTGCAGAAACATGGTATCCAGCAGGTGCTCAA 
I rt 'CT-\C (iC f CL\C \ J'Ci<".\( '( ,TCl TT(, I. \t C Xl ,\( ,< i 5· 
AGAATGC 3' 122 
PKA Rlla (48Mer) Accession number J02934 
11105' TAGATGTGATGAATCTCGGAGCCTICTCAGTGTGATACCTAATCC 
3 C(i(i,\,\li,\Uf'C\C:\( l.\lti<1T1T,\G(} 
TICCAGTCAGCCACAAGAACACACCCAGAAAACAGACACGACAG 3' 1199 
r\AGG rCJ\GTCCG l'(iTTC I rGTCi s · 
PKA RII(3 (SOMer) Accession numbers M12492; M21194 
1250 5' AGCAAAAGTGTGGGGAAGAAAGCGCGTT AGTGAAGCAGTT ACA 
3· CGC(,CA,\lCACI IC(il< A \lCiT 
TAGCAGTGGTI AGTCCACCGAGGATGTGTTCGTGTAGATCAAGCA 3' 1338 
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A TCGTC t\CCAA TC.\GGTGGCTCCTAC AC 5' 
PKA Ca (48Mer) Accession number X57986 
5605'ACCTTCTCATCGACCAGCAGGGCTATATTCAGGTGACAGACTTC 
3-CCCG \ TA Ti\ \GTCC!\CTG1CTGr\AG 
GGTTTTGCCAAGCGTGTGAAAGG 3' 627 
CCAAAACGGTTCGCAC.\C'TTTCC s· 
PKA C~ (48Mer) Accession numbers D10770 D01144 
405'CGGACTCCCGGGTCATGGGGAACACGGCGATCGCCAAGAAAGGC 
j TTCiTC,CC(iCTACiC(;GT rCTTTCCG 
AGCGAAGTGGAGAGCGTGAAAGAA3 ' 108 
1 C(iC"I IC \C'CTC rCCC\CTrl CIT_.:;· 
UCH-Ll (46Mer) Accession number NM_017237 
290 5' 
CGGGAACTCCTGTGGTACCATTGGGCTGATGCACGCAGTGGCCAAT 
J'CiG.\CACCA fGGT 1\1\CCCCir\CTACG'I (jCGTCAC 'CGGTT\ 





LMl Hypercoat nuclear emulsion (Amersham). 
Kodak D-19 developer powder (HA West) 
Ilford Hypam K5 Rapid fixer (Ilford) 
Enhanced chemiluminescence (ECL) Western blotting detection reagents 
(Amersham) 
Hyperfilm (ECL) autoradiography film (Amersham) 
2.2.9 Sterile Surgery 
Chromic catgut ligatures (4/0 Ethicon) 
Coated vicryl sutures (4/0 Ethicon) 
250 needle microsyringe (Beckton Dickenson) 
Hibitane (chlorhexidine acetate, Zeneca) 
Isopentane (BDH, Poole, UK) 
Ste1ile gowns, biogel gloves, hats, face masks and drapes (Hospital Management and 
Supplies) 
2.2.10 Western Blot Apparatus 
10% Precast Tris-HCI ready gels (10% resolving gel , 4% stacking gel)(Bio-Rad) 
Immuno-blot PVDF m~mbrane (Bio-Rad) 
Methanol (Hayman) 
Blot absorbent filter paper (thick) (Bio-Rad) 
Glacial acetic acid (Sigma) 
Polyoxyethylenesorbitan monolaurate (Tween-20, Sigma) 
Marvel dried skimmed milk 
Laury! sulphate (SDS, Sigma) 
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2.2.11 In situ Hybridisation Histochemistry Materials 
Oligodeoxyribonucleotide probes (Oswel) 
Deoxyadenosine [a-35S]-triphosphate (specific activity <1250 Ci/mol, NEN Dupont) 
Recombinant terminal deoxynucleotidyl transferase (Tdt) enzyme and tailing buffer 
(Promega) 
Nu-Clean D25 disposable spin column (Scientific Imaging Systems) 
Optiphase "Supermix" liquid scintillation cocktail (Fischer) 
Absolute alcohol ANALAR grade (Hayman) 
Acetic anhydride (0.25%) (BDH) 
RNAsin ribonuclease inhibitor (Promega) 
RNase ZAP (Sigma) 
RNAse A (1 mg/ml) (Sigma) 
Diethyl pyrocarbonate (DEPC) (Sigma) 
Parafmmaldehyde (Sigma) 
Ethanolamine (10%, BDH) 
Sx Denhardt's solution (S igma) 
10% dextran sulphate (Sigma) 
NaCl (Sigma) 
Tris-HCI (10 mM, Sigma) 
EDTA (1 mM, Sigma) 
Salmon sperm DNA (Sigma) 
Yeast tRNA (Sigma) 
Glycogen (Gibco) 
Ammonium acetate (Sigma) 
Triethanolamine (TEA, Merck) 
Sodium phosphate NaH2 (PO4)3 (Monobasic, Sigma) 
Sodium phosphate Na2H (PO4)3 (Dibasic, Sigma) 
Formamide (Sigma) 
Mixed bed resin (Sigma) 
20xSSC (Gibco) 
Dithiothreitol (DTT, Sigma) 
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2.2.12 Miscellaneous 
ART pipette tips (RNase free, Promega) 
2ml eppendorf tubes (Merck) 
IM sodium chloride solution (Sigma) 
0.5% aqueous dimethylformamide (Biomol). 
2.2.13 Stock Solutions for In Situ Hybridisation and Western Blotting 
RNase-free ddH20 
DEPC 1 % (v/v) in ddH2O, autoclave 
Phosphate-buffered saline (PBS) 
50mM NaHCO3, pH 7.5; 150mM NaCL 
4% paraformaldehyde (PFA) in PBS 
0. l M PBS, 4% (w/v) (fresh) paraformaldehyde 
Triethanolamine (TEA) 
lOM stock TEA diluted to 0.lM with DEPC H20 pH8 
2X Hybridisation buffer 
Dextran sulphate 10% (w/v), NaCl (600mM), Tri s pH 7.6 (lOmM), EDTA (lmM), 
Denhardt' s solution (1 % solution of bovine serum albumin (BSA), Ficoll and 
polyvinyl pyrrolidone (PVP)) 0.1 % (w/v), salmon sperm DNA 0.01 % (w/v), Bakers 
yeast tRNA 0.005% (w/v), glycogen 0.0005% (w/v) and RNAsin ribonuclease 
inhi bitor (Promega) 
De-ionised formamide 
Formamide was de-ionised using mixed bed ion exchange resin 
SOS lysis buff er (SX Stock) 
0.625M Tris-CI, pH 6.8; 2% (w/v) SDS, 0.1 % (w/v) bromophenol blue, 50% (v/v) 
glycerol 
Electrophoresis buff er 
IM Tris base, 0. IM glycine ( +SDS) 
Coomassie staining reagent 




10% (v/v) acetic acid, 5% (v/v) isopropanol 
Protein transfer buffer 
0.lM Ttis base, 0.5M glycine, 0.01 % (w/v) SDS 
Blocking buffer 
IX PBS, 4% (w/v) non-fat milk (Marvel) 
Wash buffer 
lX PBS, 0.1 % (v/v) Tween 20 
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2.3 Methods 
2.3.1 Chronic Constriction Injury (CCI) to the Sciatic Nerve 
All experiments were carried out in accordance with the U.K. Animals (Scientific 
Procedures) Act 1986. Adult male Wistar rats (200-350g) were anaesthetised with 
sodium pentobarbital (Sagatal 0.06ml / 100g, i.p.) and supplemented with halothane / 
0 2 (2-3%). Under aseptic conditions, the right sciatic nerve was exposed proximal to 
the trifurcation, at a mid-thigh level, and 4 (4 / 0, Ethicon) chromic cat gut ligatures 
were tied to loosely constrict the nerve (chronic constriction injury (CCI)), as viewed 
under x40 magnification (Bennett and Xie, 1988). The overlying muscle and skin 
were closed with sutures (4 / 0, Ethicon) and the animals were allowed to recover for 
72 hours before reflex testing recommenced. CCI surgery was also canied out in 
mice for some experiments (Chapter 3). Adult male C57 / Bl6 mice were 
anaesthetised with Sagatal (0.01ml / 100g, i.p.) and supplemented with halothane / 
0 2 (0.5-1.5%). Under aseptic conditions, the right sciatic nerve was exposed 
proximal to trifurcation, at the mid-thigh level, and 3 (5 / 0, Ethicon) chromic cat gut 
ligatures were tied to loosly constrict the nerve (CCI), as viewed under x40 
magnification. The overlying muscle and skin were closed with sutures (5 I 0, 
Eth icon) and the animals allowed to recover for 72 hours before reflex testing 
recommenced. Sham-operated rats and mice underwent the same surgical procedure, 
but no ligatures were placed around the nerve. 
2.3.2 Behavioural Tests 
Behavioural signs representing three different components of neuropathic pain were 
investigated: thermal hyperalgesia, mechanical allodynia and cold allodynia. 
Behavioural testing was carried out prior to surgery to establish a baseline for 
comparison to post surgical values. Only nerve-injured animals that showed clear 
signs of thermal hyperalgesia, cold and mechanical allodynia were used for further 
study. In practise only 1 in 25-30 animals failed to develop sensitisation and 
whenever these cases were further investigated, technical problems with the nerve 
ligation were identified. 
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2.3.2.1 General Observations 
Inspections were regularly made for signs of autotomy, which was rarely observed. 
General observation of the animals posture and condition of the affected limb were 
also made. 
2.3.2.2 Thermal Hyperalgesia 
Thermal hyperalgesia was monitored using noxious radiant heat (30-55°C) applied to 
the mid-plantar glabrous surface of the hind paw using Hargreaves' thermal device, 
(Linton). The withdrawal response latency was characterised as a brief paw flick 
recorded to the nearest 0 . l s, and a standard cut-off latency of 20s was employed to 
prevent tissue damage. Testing was repeated a minimum of 5 times with not less 
than 5 min between trials to avoid any sensitisation of the paw. 
2.3.2.3 Mechanical Allodynia 
Mechanical allodynia was measured as the threshold for paw withdrawal in response 
to normally innocuous graded mechanical stimuli applied to the mid-plantar glabrous 
surface of the hind paw using Semmes-Weinstein calibrated von Frey filaments 
(Stoelting). Each filament was applied perpendicularly to the mid-plantar surface of 
the foot until it started to bend. This was repeated 10 times at a frequency of 
approx imately lHz. The filaments were applied in ascending order and a response 
characterised as a robust paw flick. Threshold was defined as the force that caused 
foot withdrawal 5 times in every 10 appl ications. 
2.3.2.4 Cold Allodynia 
To detect the presence of cold allodynia, rats were placed in a perspex box with an 
elevated aluminium floor covered with iced water, sufficient to immerse both 
glabrous and hairy skin of the hind paw (3-4°C; Bennett and Xie, 1988). Rats were 
allowed 10s to acclimatise once placed in the box. The number of seconds the 
animal raised its hind paw above the water over a 20s period was recorded. This was 
repeated 4 times at 10 min intervals to establish a mean suspended paw elevation 
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time (SPET) for each rat. Animals determined as being at the peak of neuropathy, 
12-15 days following CCI surgery, were then used in further study. 
2.3.3 Nerve Preparation for Analysis 
2.3.3.1 Dissection and Sampling 
To excise the nerve, mice were deeply anaesthetised with sodium pentobarbita] and 
perfused transcardially with 0.lM PBS (containing 3mM sodium nitrite and lO00u 
heparin, pH 7.4) before being perfused with 2.5% glutaraldehyde and 2% 
parafo1maldehyde in 0.1 % sodium cacodylate buffer (pH 7.3). The sciatic nerve was 
then removed and fixed for 2h in the same fixative and post-fixed in l % osmium 
tetroxide in O.lM sodium cacodylate buffer and embedded in araldite. 
2.3.3.2 Myelinated Fibres 
lµm transverse sections of sciatic nerve (tibial branch) stained with toluidine blue 
were examined using 'Image 1.44' software (NIH). The cross sectional area of the 
tibial nerve was measured at xl00 magnification and 5 randomly generated regions 
on each nerve section were chosen using a 4x4 gtid. For analysis, 30 myelinated 
fibres closest to the centre of the screen were selected and the axon areas, external 
areas, and G ratios (axon diameter/ external diameter) were measured to quantify 
myelin thickness. 
2.3.3.3 Unmyelinated Fibres 
80nm transverse sections of the sciatic nerve were mounted onto copper slot grids 
and examined in a transmission electron microscope. 25 random areas were 
photographed at 2300x magnification and then printed at a final magnification of 
x5750, which was used to count all the myelinated and unmyelinated fibres. For 
analysis, 5 negatives were chosen at random and scanned using a flat bed scanner for 
computer analysis using 'Image 1.44'. The axon diameters/ areas of 30 
unmyelinated fibres were measured from each of the micrographs, the fibres being 
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selected from clusters consisting solely of unmyelinated fibres. The frequency of 
myelinated fibres was scored at 1 µm intervals from 1-10 µm and that of 
unmyelinated fibres at 0.1 µm intervals from 0.1 - 2.7 µm. 
2.3.4 lntrathecal Drug Administration 
Prior to intrathecal injection, baseline measurements were made in rats that had 
undergone CCI surgery as previously described (section 2.3.1). Rats at the peak of 
neuropathy showing behavioural alterations indicative of neuropathic pain were 
selected for i.t. administration experiments. Following induction of brief anaesthesia 
(halothane / 0 2 1 %) the space between the lumbar ve1tebrae (L5-6) was identified 
and a 250 needle microsyringe orientated between the vertebrae and into the 
intrathecal space. A 50 µI (rats) or a 30 µI (mice) bolus was injected and the needle 
slowly removed. Testing began 15 minutes post-injection, and was carried out as 
described previously (sections 2.3.2.2, 2.3.2.3 and 2.3.2.4). Testing continued for a 
minimum of 90 minutes and until recovery to pre-injection values. 
2.3.4.1 Control Experiments 
50 µI injections of Pontamine Sky Blue were canied out and a laminectomy was 
canied out post-mortem to identify the location of the dye. Drug injections were 
performed blind to eliminate bias and saline injections were carried out in parallel 
with drug injections as a further control (data not shown). 
2.3.5 Surgical Procedure for Electrophysiological Preparation 
Details of all reagents can be found in section 2.2. Rats used for electrophysiological 
recordings underwent CCI surgery as outlined in section 2.3.1. Only nerve injured 
animals which showed strong signs of thermal hyperalgesia, mechanical and cold 
allodynia (sections 2.3.2.2, 2.3.2.3 and 2.3.2.4) were used for electrophysiological 
recordings. Normal unoperated rats were also used routinely for control purposes. 
Rats were anaesthetised with intravenous a.-chloralose (60mg I kg) and urethane 
(1.2mg I kg) folJowing induction with halothane to allow jugular vein cannulations. 
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Supplementary doses of a-chloralose were given as required. A tracheotomy was 
performed to maintain an unobstructed airway, and the rat was allowed to breath 
freely, although oxygen (0.1 1 / min) was passed over the end of the cannula to 
enrich the inspired air. Core temperature measured by a rectal probe was maintained 
at 37-38°C by means of a thermostatically controlled heated blanket. The animal 
was mounted in a rigid stereotaxic frame and spinal segment L2 was identified by 
locating the floating rib and the thoraco-lumbar spinal column was supported using 3 
pairs of swan-necked clamps on alternate segments, with the middle clamp 
supporting L2. A pool was made with skin flaps around the area of interest and a 
dorsal laminectomy performed under x 12.5 magnification to expose segments Ll-
L4. To improve the stability of the preparation for extracellular recording, agar 
solution (2% in 0.9% saline solution) at 39°C was injected under the most rostral 
vertebrae and then poured over the entire pool, including the spinal cord. Once 
cooled, a core of agar was removed to expose the area of cord from which the 
recordings would be made, the dura was carefully cut and a pool of 37°C liquid 
paraffin applied to the exposed area to prevent dehydration. 
2.3.6 Extracellular Recording 
Extracellular recordings were made from single dorsal horn neurones using the 
central barrel (4M NaCl, pH 4.0-4.5) of a 7 barrelled glass microelectrode, with tip 
sizes 4.0-5.5µm. One side barrel contained IM NaCl (pH 4.5) for automatic current 
balancing using a Neurophore BH2 ionophoresis system (Medical Systems 
Corporation). A second side barrel contained 2% Pontamine Sky Blue in 0 .5M 
sodium acetate for histological marking of recording sites (section 2.3.6.1). The 
remaining barrels contained the drugs for ionophoresis. Recordings were made at 
depths of 0-lO00µm from the spinal cord surface (as monitored by the microdrive), 
and cellular activity was observed on the oscilloscope screen (Tektronix). The 
output activity from the oscilloscope was continually monitored using a Dl30 
digitimer spike processor, with the spike discriminator adjusted so that the activity of 
one neurone was isolated (as viewed by markers on the oscilloscope) for counting. 
Neuronal firing rate was continuously plotted on-line via a customised analysis 
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program (Scap 90; Dr M Dutia, Department of Physiology, University of Edinburgh) 
on a Dell PIII 500 workstation. 
2.3.6.1 Identification of Neuronal Receptive Fields 
Neuronal receptive fields were identified by manually brushing the ipsilateral hind 
limb, whilst lowering the electrode into the spinal cord using a rnicrodrive. Neurones 
were further examined using noxious pinch and heat (48°C for 10s). The heat 
stimulus was applied using a ramp driven Peltier device (Medical Instruments) with a 
contact area of l cm2. The Peltier probe, while in contact with the animals skin, was 
raised from a resting temperature of 32°C to 48°C (ramp rate 5°C / s) to be held at 
48°C for 10s. The neurones were then classified according to their sensory input and 
those neurones classified as being multireceptive (i.e those that responded to noxious 
heat, pinch and innocuous brush) were used for this study. Extracellular recordings 
were made from single, multireceptive neurones (LIIl-V), ipsilateral to the nerve 
injury, in neuropathic animals and bilaterally in unoperated control rats. 
2.3.6.2 Quantification of Neuronal Responses to Cutaneous Stimuli 
The effects of inhibitors were examined on evoked responses of neurones to sensory 
stimulation in both normal and neuropathic animals. Sustained activation of 
neurones was obtained by the following stimuli : (i) rotating motorised innocuous 
brush for low threshold mechanical stimulation, (ii) intense cold stimulus provided 
by a Peltier device (5°C for 10s, from 32°C (ramp rate 5°C / s), over a surface area of 
1 cm2 repeated every 1-2 min to give reproducible peaks of activity, (iii) topical 
application of the C-fibre selective chemical algogen, mustard oil (ally! 
isothiocyanate, Aldrich), 7.5% solution in paraffin oil, applied up to 7 times at 5 min 
intervals), until a steady state elevated firing (3-45Hz) was maintained. The specific 
proteasome inhibitors Jactacystin and MG-132 (both in 0.5% dimethylfo1mamide at 
concentrations of 500 µMand 200 µM respectively) were ejected using positive 
currents of 5-60 nA and a retention current of -12 nA was applied to each side barrel 
when not in use, to minimise drug leakage. The resistance of the side barrels was 
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monitored regularly and electrodes with resistance values in excess of 45 MQ were 
rejected. Drugs were ejected ionophoretically in a step-wise manner (usually by 10 
nA, over a range of 5-60nA), every 1 to 2 min, until clear effects on the neuronal 
firing rate were observed, or if none was observed by 60 nA after 2 min duration, the 
drug application was terminated. For the majo1ity of neurones, drugs were tested on 
responses to all three sensory stimuli. 
2.3.6.3 Analysis of Electrophysiological Results 
Action potential discrimination enabled data to be digitised and downloaded onto a 
computer to give a record of cell filing rate against time (spikes/ s). After 
subtraction of the ' background' activity, the firing rate following drug application 
was expressed as the percentage change from control responses of the neurone prior 
to drug application. The change in activity was expressed as a percentage of the 
control value for each cell , and then pooled to find the mean± SEM. 
2.3.7 In situ Hybridisation Histochemistry 
2.3.7.1 Preparation of RNase-free ddH2O, Buffers and Apparatus 
Buffers used for RNA analysis are generally treated with diethyl pyrocarbonate 
(DEPC) to inactivate ribonuclease (RNase) enzymes before being autoclaved. 
RNase-free ddH20 was prepared by adding DEPC to 1 % (v / v) in ddH20, mixing 
vigorously and incubating overnight at room temperature before autoclaving. Pipette 
tips an<l 2ml eppendorf tubes were autoclaved to eliminate RNase contamination. 
All apparatus used during in situ hybridisation experiments were treated with RNase 
ZAP and rinsed with DEPC-treated ddH20 prior to use. 
2.3.7.2 Spinal Cord Dissection Prior to lnsitu Hybridisation 
Histochemistry and Western Blot Analysis. 
Neuropathic, sham operated and age-matched control rats were deeply anaesthetised 
with halothane / 0 2 (4% for induction and maintenance). Under aseptic conditions a 
laminectomy (L3-L6) was performed for spinal cord removal as described previously 
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(section 2.4.4). Tissue was removed intact for in situ mounted on a cryostat chuck 
with OCT embedding matrix , and snap frozen in isopentane at -40 to -45°C. For 
Western blot analysis spinal cord samples were hemisected down the midline. To 
split the spinal cord medially a scalpel blade was used to slice from L3-L5 and each 
hemisected section removed separately and placed immediately in a sterile eppendorf 
on ice. 
2.3.7.3 3' Labelling of Oligonucleotides with Deoxyadenosine [35S]-
Triphosphate 
The oligonucleotides were 3' end-labelled with deoxyadenosine [35S]-triphosphate 
(specific acti vity <1250 Ci / mol; NEN Dupont) using terminal deoxynucleotidyl 
transferase (Tdt) (Promega), and potassium cacodylate tailing buffer (Tdt buffer) 
(Promega) and DEPC H20 (1hr, 37°C). The labelled oligonucleotide was then 
separated from unincorporated oligonucleotide using a Nu-Clean D25 disposable 
spin column (Scientific Imaging Systems). Samples were taken before and after this 
purification stage for scintillation counting. This allowed the percentage 
incorporation of oligonucleotide / radiolabel to be calculated (oligonucleotides were 
selected that showed 40-60% incorporation). 
2.3.7.4 Tissue Preparation Prior to In situ Hybridisation Histochemistry 
For details on tissue dissection refer to section 2.3.7.2. Frozen transverse sections of 
spinal cord (10 µm) were taken at -19°C in a cryostat and thaw-mounted onto 
Polysine®-coated microscope slides. T issue sections were equilibrated to room 
temperature and then post-fixed for 10 min in 4% PFA / 0.1 M phosphate-buffered 
saline (pH 7.4). They were then pre-hybridised in ethanolamine (10%) (0. l M TEA 
and 0.025M acetic anhydride for 10 min at room temperature), before being 
dehydrated in ascending concentrations of ethanol (50, 60, 70, 90, 95 and 100%), 
each buffered with ammonium acetate, and air dried. 
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2.3.7.5 Hybridisation 
Previously prepared stock solutions of hyb1idisation buffer and deionised formarnide 
(section 2.2.13) were combined (l x hybridisation buffer/ 40% deionised 
formamide). The radiolabelled oligonucleotides were added in a relative volume to 
give a final count number of 2xl06 cpm / 100µ1 hybridisation buffer (optimised to 
establish clearest signal:background ratio). The resulting hyb1idisation mix was 
heated to 60-70°C (10 min) to eradicate dimer formation, cooled on ice (1 rnin) 
before adding the reducing agent DTT (lOmM). Sections were then covered with 
this solution and placed in sealed containers at 50°C (15-20 h) which were kept 
humid with equal volumes of 4x SSC and deionised formamide. 
2.3.7.6 Post-Hybridisation Washes 
After hybridisation the sections were washed in 2 x SSC, 1 x SSC and 0.5 x SSC (all 
2 h each at 40°C), to remove any excess hybridisation buffer or non-specifically 
bound oligonucleotides. The slides were then dehydrated in ascending ethanol 
concentrations, after which they were air dried. 
2.3.7.7 Photographic Development of Sections 
The sections were then apposed to Hyperfilm-f3-Max to provide an estimate for 
subsequent exposure time after dipping in photographic emulsion. After 3 - 7 weeks 
they were developed at 15°C using Kodak D19 developer (4 min) and Ilford Hypam 
rapid fixer (5 min), then counterstained in 0.1 % Mayer' s haematoxylin, and 0.1 % 
eosin, mounted using DEPX mounting medium, and coverslipped. 
2.3.7.8 Stringency Controls for In Situ Hybridisation Histochemistry 
Controls used to demonstrate specificity of the respective oligonucleotide consisted 
of (i) pretreating sections with RNAse A (1 mg/ ml) for l h prior to hybridisation, 
(ii) co-incubation of the 35S-labelled oligonucleotide in the hyb1idisation medium 
with a 100-fold excess of unlabelled oligonucleotide. 
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2.3.7.9 Image Analysis 
Cell Counts 
The number of cells positively hybridised within lateral and medio-lateral locations 
of laminae I - V was calculated at x40 magnification (total grid area 175 x 175 µm). 
Cells were considered to be positively-labelled if the silver grains showed a dense 
pattern around the nucleus and were 5-fold denser than a typical non-expressing cell 
wi thin the same field area or background levels. The total number of positively 
hybridised cells was determined for each spinal cord section, and these values used 
to calculate the mean number of positively hybridised cells per unit area, in the 
lumbar sp.inal segments L3-6. 
Silver Grain Counting 
To assess any changes in the relative expression of mRNA following chronic 
constriction injury, the mean silver grain density per positively labelled cell was 
measured using 'Image 1.44' software (Improvision) with video input from a CCD 
camera (Sony, Japan) mounted on a Zeiss Axioscope microscope (x40 
magnification). For each section, counts were made both ipsilateral and contralateral 
to the nerve injury in lateral and medial zones. A minimum of 5 positively 
hybridised cells were counted in each region. A pixel count was obtained, which 
was converted to silver grain number via a pre-determined calibration procedure. 
The mean number of silver grains per cell was calculated for each section, to allow 
calculation of the mean number of silver grains per cell. In total, 500 positively 
hybridised <.:ells were counted within one side of the spinal dorsal horn for each 
animal. 
2.3.8 Tissue Preparation Prior to Western Blotting 
For details on tissue dissection refer to section 2.2.13 and section 2.2 for solutions 
and buffers. Immediately following tissue extraction, samples were individually 
weighed and transfetTed to a 1ml homogeniser containing ten volumes of ice cold 2x 
sample buffer. Once homogenised, samples were heated to 100°C for 5 min. 
Genomic DNA I RNA was sheared by passing the lysate several times through a 
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narrow gauge hypodermic needle and syringe prior to centrifugation at 13,000 x g for 
10 min at room temperature. The supernatant was transfeJTed to a fresh 
microcentrifuge tube and either analysed by gel electrophoresis, or stored at -40°C. 
2.3.8.1 SOS Polyacrylamide Gel Electrophoresis (SOS-PAGE) 
Polyacrylamide gel electrophoresis was performed using the Tris-glycine 
discontinuous buffer system described by Laemmli et al, (1970), for protein 
separation. 10-15 well 10% pre-cast gels were used for the experiments shown. The 
gel tank was filled with electrophoresis running buffer (lx). Samples and molecular 
weight marker proteins were loaded into the wells of the stacking gel and 
electrophoresed at a constant voltage of lO0V, until the samples passed into the 
resolving gel. At this point the voltage was raised to 150V, and run for 
approximately 70 minutes until the dye front had run off the end of the resolving gel. 
Following electrophoresis the protein was either visualised by Coomassie staining 
(section 2.3.8.2) or transferred to PVDF membrane (section 2.3.8.3). 
2.3.8.2 Coomassie Staining 
Polyacrylamide gel slabs were transferred into an excess volume of Coomassie 
staining solution and agitated on an orbital mixer for lh at room temperature. 
Protein bands were visualised following several changes of excess Coomassie 
destaining solution. 
2.3.8.3 Electrotransfer of Protein from SOS-PAGE Gels to PVOF 
PVDF membranes were soaked in methanol for 1 minute. Following SDS-PAGE, 
the gel, PVDF, pre-cut filter paper, and fibre pads were soaked in SDS buffer for 2 
minutes. The Bio-Rad Protein II gel transfer apparatus was assembled, ensuring no 
air bubbles were present. 
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2.3.8.4 Electro-Transfer to PVDF 
The gel, membrane and filter paper sandwich was then placed in the electrophoresis 
buffer chamber, along with an ice pack, and filled with transfer buffer. A constant 
voltage of 100V was applied for 45 min. 
2.3.8.5 Western Blotting 
Following electrophoretic transfer, the PVDF membrane was rinsed briefly in PBS 
tween (PBS-T). Blocking was performed in 4% Marvel dtied skimmed milk in PBS-
T for either 60 minutes at room temperature or overnight at 4°C on a rocking 
platform. Following blocking the membrane was briefly rinsed with PBS-T and 
incubated with the primary antibody at the required dilution (Table 2.1), in PBS-T 
with 4% Marvel at room temperature for 90 mjnutes. After six X 5 minute washes in 
PBS-T at room temperature, the PVDF was incubated with the Horseradish 
peroxidase (HRP)-conjugated secondary antibody (Table 2.1) in PBS-T with 4% 
Marvel for 40 minutes. Finally the PVDF was washed as above with the addition of 
a final rinse in PBS only. 
2.3.8.6 Enhanced Chemiluminescence Detection 
To detect bound antibody, membranes were incubated with a minimal volume of 
enhanced chemjluminescence (ECL) detection reagent for l minute at room 
temperature as described in the manufacturers protocol. PVDF was placed between 
two transparency sheets before exposure to Hyperfilm ECL autoradiography film. 
Several exposures were carried out to ensure linear exposure for direct comparison 
between bands. 
2.3.9 Ex vivo PKA Activity Assays 
Following lumbar L3-6 laminectomy under anaesthesia, rats, (normal; n=3, 
neuropathic; n=3,) were treated by topical application of agents to the dorsal suiface 
of the spinal cord. Epoxorrucin (15 µM), MG-132 (100 µM) or vehicle (0.5% 
dimethylformarrude in saline) was applied in a volume of 500µ1 for l hour before 
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rapid removal to cold buffer on ice. cAMP-evoked PKA enzymic activity and 
constitutive activity, (thought to reflect PKA previously activated in situ) were 
measured by the following procedure; a modification of those of Roskoski (1983) 
and Corbin (1983). Hemisected spinal cord samples were rapidly homogenised on 
ice in 20 mM Na HEPES pH 7.5 with 5% glycerol, 0.25% BSA, lmM EGTA, lmM 
dithiothreitol, lmM AEBSF (4-(2-aminoethyl) benzene sulphonyl fluoride), (Alexis 
Corporation), 2 µg.mr' aprotinin, 10 µg.mr' leupeptin, 2 µg.mi-1 pepstatin, 50 
µg.mr1 soybean trypsin inhibitor, 25 mM Na a-glycerophosphate, lmM Na 
orthovanadate, lmM NaF, 1 µM calyculin A, 1 µM cypermethrin (Calbiochem, 
Nottingham, UK) and 500 µM isobutyl methylxanthine. All reagents were from 
Sigma unless otherwise indicated. Aliquots of homogenate were incubated for 10 
min at 30°C (linear range of assay) with 100 µM kemptide as substrate, 100 µM ATP 
(with [33P] a-ATP to 0.2 µCi / tube; NEN-DuPont, Dreiech, Germany), 10 mM 
MgCI2 and 10 µM cAMP and/ or l µM PK! 6.22 amide (Calbiochem) as appropriate. 
Assays were terminated with cold TCA (to 10%), centiifugation and spotting of the 
supernatant onto P81 phospho-cellulose paper. Samples were washed extensively in 
75 mM H3PO4 and dtied before scintillation counting. Positive controls were canied 
out with purified bovine heart PKA catalytic subunit and each homogenate was 
assayed in parallel for cAMP-evoked activity (in the absence or presence of PKJ 6.22 
amide), constitutive activity (in the absence or presence of PK! 6•22 amide) and zero 
time incubation blanks. Authentic (PK! 6.22 amide-sensitive) PKA-activity was 
always 86-97% of the recorded activity for constitutive and cAMP-evoked 
conditions and zero time blanks were always <2% of total activity. 
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CHAPTER 3: THE ROLE OF THE VPAC2 RECEPTOR IN 
NEUROPATHIC PAIN 
3.1 VIP and PACAP 
The 28 amino-acid peptide Vasoactive Intestinal Polypeptide (VIP) was isolated 
from porcine small intestine (Said and Mutt, 1970; Mutt and Said, 1974). 
Radioimmunochemical studies have revealed a widespread distribution of VIP 
throughout the peripheral and central nervous system (Gibson et a l. , 1981; Larsson et 
al., 1976; Yaksh et al., 1988), suggesting that it may also play an impo11ant role as a 
neurotransmitter. 
Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) was isolated from 
ovine hypothalamus (Miyata et al., 1989). There are two variants, PACAP-38 (a 38 
amino-acid polypeptide) and the C-tenninally truncated PACAP-27 (Miyata et al., 
1990). PACAP is a member of the VIP/secretin/glucagon family of structurally 
related peptides, and PACAP shows 68% homology with VIP at its N-terminal 
(Arimura, 1992). PACAP is widely distributed throughout the PNS and CNS where 
it may act as a neurotransmitter/neurornodulator (Atimura, 1992; Arimura and 
Shioda, 1995; Ghatei et al., 1993; Moller et al. , 1993). The distinct anatomical 
distribution of VIP and PA CAP within the CNS has lead to the suggestion that these 
peptides may serve as sensory transmitters and so may play an important role in the 
modulation of somatosensory processing. (Arimura and Shioda, 1995; Ghatei et al., 
1993; Gibson et al., 1981; Lamotte and de Lanerolle, 1986; Larsson et al. , 1976; 
Yaksh et al., 1988). 
The close sequence homology between VIP and PACAP means that they share the 
same receptor binding sites (Harmar and Lutz, 1994). VIP and the 2 forms of 
PACAP are recognised by a family of three receptors, namely the VPAC1 (Ishihara 
et al., 1992), VPAC2 (Lutz et al., 1993) and PACAP (Hosoya et al., 1993) receptors. 
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3.2 VPAC1 and VP AC2 Receptors 
VPAC1 and VPAC2 receptors are seven trans-membrane domain G-protein coupled 
receptors. They are positively coupled to the a-subunit of the adenylate cyclase 
stimulating G protein (Gs), and so upon activation stimulate the activity of adenylate 
cyclase (Figure 3.1) (Ishihara et al., 1992; Lutz et al., 1993). Both receptors bind 
VIP and PACAP with similar high affinity, although they are differentially 
distributed (Cauvin et al., 1991; Usdin et al., 1994). The VPAC1 receptor is located 
predominantly in liver, small intestine and certain areas of the brain (co1tex, 
hippocampus and olfactory bulb). The VPAC2 receptor however, is primarily 
located in the thalamus, hippocampus suprachiasmatic nucleus (SCN) and 
hypothalamus, but is also present in superficial dorsal horn (Sheward et al., 1995; 
Lutz et al. , 1993). 
3.3 PACAP Receptor 
The PACAP receptor displays much greater affinity for the 2 forms of PA CAP than 
VIP (Hashimoto et al., 1993; Shivers et al., 1991), and has a widespread distribution 
including the CNS (Cauvin et al., 1991; Masuo et al., 1991). The PACAP receptor is 
coupled to dual signalling cascades involving the Gs and Gq proteins (Figure 3.1) 
and so upon activation can stimulate both adenylate cyclase and phospholipase C 
(PLC) signal transduction cascades. 
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Figure 3.1 VIP/PACAP Receptor Activation of Second Messenger 
Pathways 
Schematic representation of the VIP/PACAP receptors and the signal transduction 
pathways associated with their activation. The VPAC1 and VPAC2 receptors are 
both positively-coupled to the a-subunit of the adenylate cyclase stimulating G 
protein (Gs) which activates adenylate cyclase (AC) following the agonist-induced 
exchange of guanosine tri-phosphate (OTP) into guanosine di phosphate (GDP). 
Adenylate cyclase subsequently converts adenosine triphosphate (ATP) into cAMP, 
which in tum activates PKA, to result in the phosphorylation of a number of proteins 
and receptors within the cell. Both VIP and PACAP can activate the VPAC1 and 
VPAC2 receptors with similar binding affinity. The PACAP receptor is coupled to 
dual signalling cascades involving the Gs protein which activates AC as above, and 
the Gq protein, which activates the phospholipase C (PLC) pathway converting 
phosphatidyl inositol 4,5-diphosphate (PIP2) into inositol 1,4,5-triphosphate (IP3). 
This causes the intracellular release of Ca2+ ions from intracellular ca2+ stores, and 
diacyl glycerol (DAG) which induces phosphorylation of intracellular proteins 
through activation of PKC. Increases in the intracellular levels of ca2+ ions have 
been linked with a number of physiological effects, including the activation of 
immediate early genes and subsequently changes in receptor and gene expression 















► Physiological effects 
3.4 VIP/PACAP Mediated Spinal Somatosensory Transmission 
The tachykinins SP and CORP appear to lose their excitatory role following nerve 
transection and it is believed that VIP could adopt the excitatory role of SP following 
nerve injury (Wiesenfeld-Hallin et al. , 1990). Intrathecal admjnistration of VIP leads 
to a facilitation of nociceptive flexor reflexes, and when applied ionophoretically 
VIP causes a marked excitation of both the rat trigeminal nucleus caudalis neurones 
as well as neurones of the rat and cat spinal cord (Dickinson et al., 1999; Salt and 
Hill, 1981; Dickinson et al., 1997; Jeftinija et al. , 1982). VIP appears not to play a 
role in C-fibre induced spinal sensitisation (wind up), in normal animals. However, 
intrathecal administration of the VIP antagonist (Ac-Tyr, D-Phe2)-GRF(l-29)-NH2 
significantly inhibits C-fibre facilitation of the flexor reflex following CCI (Xu and 
Wiesenfeld-Hallin, 1991; Wiesenfeld-Hallin et al., 1990). Therefore it appears that 
VIP adopts a more important role in spinal somatosensory processing following 
nerve injury. 
PACAP displays a general ly excitatory effect and ionophoretically applied PACAP 
displays an excitatory effect on single dorsal horn neurones (Dickinson et al., 1999). 
However, the behavioural effects of PA CAP are not as obvious as VIP. Some 
evidence demonstrates an antinociceptive effect at the spinal level as intrathecal 
administration of PACAP-27 suppresses wind up in normal rats (Zhang et al., 1993). 
Concomitant data has demonstrated that pre-treatment of rats with intrathecal 
PACAP decreased formalin induced flinching behaviour (Yamamoto and Tatsuno, 
1995). In contrast, flexor reflex studies in decerebrate spinalised rats revealed that 
intrathecal PACAP-27 produced dose dependent facilitation of the flexor reflex (Xu 
and Wiesenfeld-Hallin, 1996). In agreement with these findings, another study has 
since shown that low doses of intrathecal PACAP-38 produces a dose dependent 
decrease in tail flick latency to noxious heat in mjce whereas higher doses produced 
a dose dependent increase in biting and scratching behaviours indicative of pain 
behaviours (Narita et al., 1996). 
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3.5 Roles of VPAC1, VPAC2 and PAC1 Receptors in Spinal Sensory 
Processing 
VPAC1, VPAC2 and PAC1 receptors appear to play an important regulatory role in 
the transmission of sensory information at the spinal cord level (Dickinson and 
Fleetwood-Walker, 1999). lonophoretically applied inhibitors of both VPAC1 and 
PAC1 receptors exert a generalised modulation of dorsal horn neurones in normal, 
anaesthetised rats, inhibiting both innocuous brush evoked activity and sustained C-
fibre evoked activity (Dickinson et al., 1999). In contrast, ionophoretic application 
of the VPAC2 receptor inhibitor (Des-l-4-Arg
16-Ro25-1553) inhibited only the 
noxious C-fibre evoked activity induced by topical application of mustard oil 
(Dickinson et al., 1999). 
Following CCI, all three receptor inhibitors have negligible effects on innocuous 
brush evoked activity of dorsal horn neurones (Dickinson et al., 1999). VPAC1 and 
PAC1 receptor antagonists have been shown to attenuate cold-induced neuronal 
firing, implicating them in the development and/or maintenance of cold allodynia 
following nerve injury (Dickinson and Fleetwood-Walker, 1999). Antagonists of all 
three receptor subtypes inhibited mustard oil-induced activity, particularly 
antagonists of the VPAC2 receptor subtype (Dickinson et al., 1999). The altered 
involvement of these receptors following CCI is likely to result, in part, from their 
altered expression in the dorsal horn as revealed by in situ hybridisation 
histochemistry. In fact VPAC2 receptor mRNA is increased in the dorsal horn 
following CCI (Dickinson et al. , 1999). In addition, ionophoretically applied Ro25-
1553, a VPAC2 receptor agonist greatly increases neuronal excitation following CCI 
(Dickinson et al., 1999) thus highlighting the potential importance of the VPAC2 
receptor in the development and/or maintenance of neuropathic pain following CCI. 
3.6 Aims of The Experiments 
From the most recent functional studies carried out, using novel selective 
antagonists, it appears that the VPAC2 receptor antagonists could serve as selective 
analgesics, strongly reducing polymodal C-fibre mediated pain in normal and 
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neuropathic pain states. These experiments sought to further characterise the 
possible contribution made by the VPAC2 receptor to the development and 
maintenance of the abnormal pain behaviours indicative of neuropathic pain 
following CCI in normal and VPAC2R<-t-J mice, and also sham-operated mice. 
Sciatic nerve morphology was assessed for control purposes, to ensure that any 
behavioural differences between wild-type and VPAC2R(-t-J mice were not caused by 
developmental abnormalities in pe1ipheral nerve morphology. In unoperated wild-
type and VPAC2R(-t-J mice, the tibial branch of the sciatic nerves were compared at 
the light and electron microscopic level to examine myelin thickness and total 
numbers of myelinated and unmyelinated fibres jn normal and VPAC2R(-t-J mice. 
The effects of selective antagonists and agonists of the VPAC2 receptor were 
examined on reflex withdrawal responses to noxious heat and innocuous mechanical 
stimulation. 
Baseline reflex withdrawal responses to noxious heat and innocuous mechanical 
stimulation were measured in nmmal and VPAC2R(-t-J mice and measurements were 
made until day 21 post surgery. An antagonist of the VPAC2 receptor (Des- l -4-
Arg16-Ro25-1553) was administered intrathecally in conscious mice 2-3 weeks 
following CCI surgery in normal and VPAC2R<-t-J mice and reflex withdrawal 
responses to heat and mechanical stimuli were recorded. An agonist of the VPAC2 
receptor (Ro25-1553) was also administered intrathecally in normal and VPAC2R(-t-) 
mke 2-3 weeks following CCI and reflex withdrawal responses to heat and 
mechanical stimuli were recorded. Injections were carried out in wild-type litter 
mate VPAC2R (+t+J mice for control purposes. The general methods are described in 
detail in chapter 2. 
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3.7 Results 
3.7.1 Behavioural Analysis of Sensory Responses in Wild-Type and 
VPAC2 Receptor<·!-) Mice Following CCI 
These results were obtained from a total of 38 mice (n=28 CCI and n= lO sham-
operated). Throughout these experiments the experimenter was blinded to the 
genotype of the subject to eliminate bias and an independent third party was 
responsible for identification of mice after the experiments were terminated on 
completion. Reflex withdrawal responses to noxious heat (Hargreaves test) and 
normally innocuous mechanical stimuli (von Frey filaments) were measured. 
Several days of pre-operative baseline testing was carried out in order to establish a 
stable baseline for comparison to post-operative values, and following CCI surgery 
the behavioural testing recommenced at day 3 post-operatively. Behavioural testing 
continued daily for a minimum period of four weeks and/ or until reflex withdrawal 
response values had returned to baseline values. 
Following CCI surgery in wi ld-type mice, there was a characteri stic and significant 
decrease in the ipsilateral paw withdrawal latency to noxious heat (Figure 3.2A). 
There was also a similar decrease in the paw withdrawal threshold to previously 
innocuous mechanical stimulation using von Frey filaments and these abnormal 
behavioural responses peaked at around 10-14 days post-operatively (Figure 3.3A). 
In contrast, the characteristic development of abnormal behavioural reflex responses 
to noxious heat and innocuous mechanical stimuli following CCI were delayed and 
attenuated in VPAC2R (-/-) mice. Although there was still a significant decrease in the 
paw withdrawal latency/threshold to noxious heat and previously innocuous 
mechanical stimuli as in wild-type littermates (Figure 3.2B and 3.3B), both the 
magnitude and duration of the changes were dramatically attenuated. Sham surgery 
in wild-type mice was carried out in parallel with CCI surgery to demonstrate that 
the effects were not simply due to any of the surgical procedures. Following sham-
surgery there were no characteristic decreases in the reflex withdrawal responses to 
noxious heat or mechanical stimuli (Figure 3.2 C and 3.3 C) respectively. 
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Figure 3.2 Analysis of Paw Withdrawal Latency to Noxious Heat in Wild-
Type and VPAC2 Receptor<·
1·> Mice Following CCI or Sham Surgery 
Data are presented as mean paw withdrawal latency (s) from noxious heat stimuli for 
ipsilateral and contralateral paws plotted against days pre- and post-surgery. 
(A) In wild-type littermates of the mutant mice, paw withdrawal latency to noxious 
heat ipsilateral to nerve injury was significantly reduced following CCI, when 
compared to pre-operative baseline values (t p::::; 0.05; one way ANOV A followed 
by Neuman-Keuls post-hoe test) and from postoperative contralateral va lues(* p::::; 
0.05; Student's paired t-test). 
(B) In VPAC2 receptor(-/-) mice, paw withdrawal latency to noxious heat ipsilateral 
to nerve injury was significantly reduced following CCI when compared to baseline 
values (t p::::; 0.05; one way ANOV A fo llowed by Neuman-Keuls post-hoe test) and 
from post-operative contralateral values(* p::::; 0.05; Student's paired t-test). 
However, the duration and extent was markedly diminished when compared to wild-
type mice. 
(C) In wild-type littermates of the mutant mice, paw withdrawal latency to noxious 
heat was unaffected (one way ANOVA) following sham surgery, which was carried 
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Figure 3.3 Analysis of Reflex Withdrawal Responses to Innocuous 
Mechanical Stimuli in Wild-Type and VPAC2 Receptor(·/-) Mice Following 
CCI or Sham Surgery 
Data are presented as mean paw withdrawal threshold (rnN/mm2) to innocuous 
mechanical stimuli for ipsilateral and contralateral paws plotted against time (days) 
pre- and post-surgery. 
(A) In wild-type littermates of the mutant mice, paw withdrawal threshold to 
normally innocuous mechanical stimuli ipsilateral to nerve injury was significantly 
decreased following CCI, when compared to pre-operative values (t p::; 0.05; 
Kruskal-Wallis ANOVA followed by Dunn's post-hoe test) and from post-operative 
contralateral values(* p::; 0.05; Mann-Whitney U test). 
(B) In VPAC2 receptor<·'·> mice, paw withdrawal threshold to normally innocuous 
mechanical stimuli ipsilateral to nerve injury was significantly decreased fo11owing 
CCI when compared to pre-operative values (t p::; 0.05; Kruskal -Wallis ANOVA 
followed by a Dunn's post-hoe test) and from post-operative contralateral values(* p 
$ 0.05; Mann-Whitney U test). However, the duration and extent was markedly 
diminished when compared to wild-type mice. 
(C) In wild-type littermate mice, paw withdrawal threshold to normally innocuous 
mechanical stimuli was unaffected (Kruskal-Wallis ANOVA) following sham 
surgery, which was earned out for control purposes. 
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3. 7 .2 Sciatic Nerve Morphology 
To exclude the possibility that any behavioural changes were associated with 
developmental abnormalities in the pattern of myelination in sciatic afferents, axon 
diameter and myelin thickness profiles were examined by light and electron 
microscopy. In unoperated VPAC2R <-t -J mice and wild-type mice the sciatic nerves 
were examined by light microscopy to determine if the myelin sheath was affected. 
In all experiments the expe1imenter was blinded to the genotype to eliminate bias and 
in all mice tested there was no overt alteration in the gross appearance of peripheral 
nerves of VPAC2R (-/-) mice when compared to wild-type. Myelin thickness was 
measured by measuring axon diameter/ external diameter and plotting G-ratios 
(Figure 3.4). There was no statistically significant alteration between VPAC2R (-t-) 
mice and wild-type littermates, and the myelinated fibres of VPAC2R (-t-) mice 
appeared structurally normal. Electron microscopy was canied out to assess axon 
diameter of unmyelinated fibres and to count total numbers of myelinated and 
unmyelinated fibres in wild-type and VPAC2R (-t-) mice. In all samples both axon 
diameter and myelin thickness profiles for myelinated (A8 and A0) fibres and the 
diameters of unmyelinated (C) fibres were similar between unoperated wild-type and 
VPAC2R (-t-) mice (Figure 3.5, 3.6). Values were in accordance with previous reports 
(Guilbaud et al., 1993; Sommer et al., 1995). 
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Figure 3.4 Morphological Analysis of Myelin Sheath Thickness of 
Myelinated Fibres Located in the Tibial Branch of the Sciatic Nerve of 
Normal Wild-Type and VPAC2 Receptor<·1·> Mice 
(A) Myelin sheath thickness of myelinated fibres in terms of G-ratio (internal/ 
external diameter) as a function of the external diameter in normal wild-type mice 
(]ittermates to the mutant animals, n=3). In each nerve 500 fibres were used for 
measurement of myelin thickness. 
(B) Myelin sheath thickness of myelinated fibres in terms of G-ratio (internal/ 
external diameter) as a function of the external diameter in VPAC2R (-t-) mice (n=3). 
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Figure 3.5 Morphological Analysis of Axon Diameters of Myelinated 
Fibres Located in the Tibial Branch of the Sciatic Nerve of Normal Wild-
Type and VPAC2 Receptor<·'·) Mice 
(A) Frequency distribution of the axon diameters of myelinated fibres in the A8/Af3 
diameter range from the tibia] branch of the sciatic nerve in unoperated wild-type 
mice (littermates of the mutant animals, n=3). In each nerve 750 fibres were used for 
diameter measurement. 
(B) Frequency distribution of the axon diameters of myelinated fibres in the AcS/Af3 
diameter range from the tibia! branch of the sciatic nerve in unoperated VPAC2R(-t-) 
mice. In each nerve 750 fibres were used for diameter measurement. 
No significance differences were observed (x2 test) at the light microscopy level for 
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Figure 3.6 Morphological Analysis of Axon Diameters of Unmyelinated 
Fibres in the Tibial Branch of the Sciatic Nerve of Normal Wild-Type and 
VPAC2 Receptor<·
1·> Mice 
(A) Frequency distribution of the axon diameters of unmyelinated C-fibres from the 
tibia! branch of the sciatic nerve in wild-type mice (littermates of the mutant mice, 
n=2). In each nerve 250 fibres were used for diameter measurement. 
(B) Frequency distribution of the axon diameters of unmyelinated C-fibres from the 
tibia! branch of the sciatic nerve in VPAC2R (-t-) mice. In each nerve 250 fibres were 
used for diameter measurement. 
No significance differences were observed Cx2 test) at the electron mkroscopy level 
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3.7.3 Effects of lntrathecal Administration of the Highly Selective 
VPAC2R Antagonist des (1-4) Arg16-Ro 25-1553 on Reflex 
Withdrawal Responses to Noxious Heat and Innocuous 
Mechanical Stimuli in Wild-Type and VPAC2 Receptor(·/·) Mice 
Following CCI 
Results were obtained from a total of 28 mice, (n=l4 wild-type littermates of the 
mutant animals and n=l4 VPAC2 receptor<-
1
-\ lntrathecal administration of the 
selective VPAC2R antagonist des (1-4) Arg
16-Ro 25-1553 was canied out as 
described previously (Chapter 2 section 2.3.4). 
In wild-type mice exhibiting peak behavioural changes following CCI, des-(l-4)-
Arg16-Ro 25-1553 significantly reversed the increased reflex withdrawal responses to 
noxious heat and mechanical stimulation (Figure 3.7 A and B). This inhibition was 
monitored over a 90 minute testing period. In VPAC2R(-/-) mice exhibiting peak 
behavioural changes fo llowing CCI, des-( l-4)-Arg16-Ro 25-1553 had no significant 
effect on the increased reflex withdrawal responses to noxious heat and mechanical 
stimulation (Figure 3.8 A and B). Control intrathecal administration of vehicle in 
wild-type CCI mice had no significant effect on reflex withdrawal responses to 
noxious heat and normally .innocuous mechanical stimuli (Figure 3.11). 
98 
Figure 3.7 Effects of lntrathecal Administration of the VPAC2 Receptor 
Antagonist des-(1-4) Arg16-Ro 25-1553 on Reflex Withdrawal Responses 
to Noxious Heat and Innocuous Mechanical Stimuli in Wild-Type Mice 
Following CCI 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN/mm2) to innocuous mechanical stimuli (B) for 
ipsilateral and contralateral paws plotted against time (min) pre-and post-injection 
(n=7). Arrows mark intrathecal drug administration. 
(A) In wild-type mice (littermates to mutant animals) exhibiting peak behavioural 
changes following CCI, paw withdrawal latency to noxious heat stimuli ipsilateral 
(but not contralateral) showed significant differences between pre- and post-drug 
administration values (t p S 0.05; one way ANOVA followed by Neuman-Keuls 
post-hoe test). Significant djfferences between ipsilateral and contralateral paw 
withdrawal latencies are indicated(* p ~ 0.05; Student's paired t-test). des-(1-4)-
Arg16-Ro 25-1553 was administered at a dose of [200pmol in 20µ1]. 
(B) In wild-type mice exhibiting peak behavioural changes following CCI, paw 
withdrawal threshold to innocuous mechanical stimuli ipsilateral (but not 
contralateral) to nerve injury showed significant differences between pre-and post-
drug administration values (t p ~ 0.05; Kruskal-Wallis ANOVA followed by Dunn's 
post-hoe test). Significant differences between ipsilateral and contralateral 
withdrawal thresholds are indicated(* p S 0.05; Mann-Whitney U test). des-(1-4)-
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Figure 3.8 Effects of lntrathecal Administration of the VPAC2R 
Antagonist des-(1 -4) Arg16-Ro 25-1553 on Reflex Withdrawal Responses 
to Noxious Heat and Innocuous Mechanical Stimuli in VPAC2 Receptor<· 
'·) Mice Following CCI 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN/mm2) to innocuous mechanical stimuli (B) for 
ipsilateral and contralateral paws plotted against time (min) pre-and post-injection 
(n=7). Arrow marks intrathecal drug administration. 
(A) In VPAC2R<-J-) mice exhibiting peak behavioural changes following CCI, paw 
withdrawal latency to noxious heat ipsilateral (but not contralateral) to nerve injury 
showed significant differences between pre-and post-drug administration values (t p 
~ 0.05; one way ANOV A followed by Neuman-Keuls post-hoe test). Significant 
differences between contralateral and ipsilateral values are indicated(* p ~ 0.05; 
Student's paired t-test). des-(l-4)-Arg16-Ro 25-1553 was administered at a dose of 
[200pmol in 20µ1]. 
(B) In VPAC2R(-t-) mice exhibiting peak behavioural changes following CCI, paw 
withdrawal threshold to innocuous mechanical stimuli ipsilateral (but not 
contralateral) to nerve injury showed significant differences between pre- and post-
drug administration values values (t p ~ 0.05; Kruskal-Wallis ANOVA followed by 
Dunn's post-hoe test). Significant differences between contralateral and ipsilateral 
values are indicated(* p ~ 0.05; Mann-Whitney U test). des-(1-4)-Arg16-Ro 25-1553 
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3.7.4 Effects of lntrathecal Administration of the Selective VPAC2 
Receptor Agonist Ro 25-1553 on Sensory Reflex Withdrawal 
Responses in Wild-Type and VPAC2R<·1·> Mice 
Results were obtained from a total of 16 mice, (n=8 wild-type litte1mates of the 
mutant animals and n=8 VPAC2 receptor<-
1->). Intrathecal administration of the 
selective VPAC2R agonist Ro 25-1553 was canied out as described previously 
(chapter 2 section 2.3.4). In unoperated wild-type mice, the VPAC2R agonist Ro 25-
1553 significantly decreased the latency and threshold respectively of reflex 
withdrawal responses to noxious heat and mechanical stimulation compared to pre-
injection values (Figure 3.9 A and B). Following drug administration, responses 
were monitored over a 90 minute testing period during which recovery was observed. 
In VPAC2R(-J-) mice the VPAC2R agonist Ro 25-1553 had no significant effect on the 
reflex withdrawal responses to noxious heat and innocuous mechanical stimulation 
(Figure 3.10 A and B). Testing continued for 90 minutes. Control intrathecal 
administration of saline in wild-type CCI mice had no significant effect on reflex 
withdrawal responses to noxious heat and innocuous mechanical stimuli (Figure 
3.11). 
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Figure 3.9 Effects of lntrathecal Administration of the VPAC2 Receptor 
Agonist Ro 25-1553 on Reflex Withdrawal Responses to Noxious Heat 
and Innocuous Mechanical Stimuli in Normal Wild-Type Mice 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN/mrn2) to innocuous mechanical stimuli (B) 
plotted against time (min) pre-and post-injection (n=8). Arrow marks intrathecal 
drug administration. 
(A) In normal wild-type mice (littermates of mutant mice) mean paw withdrawal 
latency from noxious heat stimuli showed significant differences between pre-and 
post-drug administration values (* p::::; 0.05; one way ANOV A followed by Neuman-
Keuls post-hoe test). Ro 25-1553 was administered at a dose of [200pmol in 20µ1]. 
(B) In normal wild-type mice (littermates of mutant mice) mean paw withdrawal 
threshold to innocuous mechanical stimuli showed significant differences between 
pre-and post- drug administration values(* p::; 0.05; Kruskal-Wallis ANOVA 
followed by Dunn's post-hoe test). Ro 25-1553 was administered at a dose of 
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Figure 3.10 Effects of lntrathecal Administration of the VPAC2 Receptor 
Agonist Ro 25-1553 on Reflex Withdrawal Responses to Noxious Heat 
and Innocuous Mechanical Stimuli in VPAC2 Receptor<·
1·> 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN/mm2) to innocuous mechanical stimuli (B) 
plotted against time (min) pre- and post-injection (n=8). Arrow marks intrathecal 
drug administration. 
(A) In normal VPAC2R(-/-) mean paw withdrawal latency to noxious heat showed no 
significant difference between pre-and post-drug administration values (one way 
ANOVA). Ro 25-1553 was administered at a dose of [200pmol in 20µ1]. 
(B) In VPAC2R (-/-) mice exhibiting peak behavioural changes following CCI, mean 
paw withdrawal threshold to innocuous mechanical stimulation showed no 
significant difference between pre- and post-drug administration values (Kruskal-
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Figure 3.11 Effects of lntrathecal Administration of Vehicle on Reflex 
Withdrawal Responses to Noxious Heat and Innocuous Mechanical 
Stimuli in Wild-Type Mice Following CCI 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN/mm2) to innocuous mechanical stimuli (B) for 
ipsilateral and contralateral paws plotted against time (min) pre- and post-injection 
(n=6). AITow marks intrathecal drug administration. 
(A) In wild-type mice exhibiting peak behavioural changes following CCI, paw 
withdrawal latency to noxious stimuli ipsilateral to nerve injury showed no 
significant difference between pre-and post-vehicle administration values (one way 
ANOV A). Significant differences between contralateral and ipsilateral values are 
indicated(* p s; 0.05, Student's paired t-test). Vehicle was administered at a volume 
of 20µ1. 
(B) In wild-type mice exhibiting peak behavioural changes following CCI, paw 
withdrawal threshold to innocuous mechanical stimuli ipsilateral to nerve injury 
showed no significant difference between pre-and post-vehicle administration values 
(Kruskal-Wallis ANOVA). Significant differences between contralateral and 
ipsilateral values are indicated(* p s; 0.05, Mann-Whitney U test). Vehicle was 
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VIP and the two alternatively processed forms of the PACAP precursor (PACAP-27 
and PACAP-38) are recognised by a family of three G protein coupled receptors 
(Harmer and Lutz, 1994), namely the PACAP receptor (Shivers et al., 1991; 
Hashimoto et al., 1993), the VPAC1 receptor (Ishihara et al., 1992) and the VPAC2 
receptor (Lutz et al., 1993). There is a distinct distribution of the VPAC1, VPAC2 
and PACAP receptors in both the peripheral and central nervous systems of the rat 
(Harmer and Lutz, 1994; Lutz et al., 1993, Shioda et al., 1997, Usdin et al., 1994; 
Vertongen et al., 1997; Dickinson et al., 1999). Binding sites for VIP and PACAP 
ligands have been shown to be present in the rat spinal cord, particularly in the 
lumbar and sacral segments, with the highest concentrations in lamina I and II of the 
dorsal horn (Kar and Qui,ion, 1995; Moller et al., 1993; Yashpal et al., 1991). The 
mRNA for VPAC1 (Ishihara et al., 1992), VPAC2 (Sheward et al., 1995) and PACAP 
receptors (Arimura and Shioda, 1995) is also expressed in the spinal dorsal horn. 
Following pe1ipheral nerve injury, a number of neurochemical changes within DRG 
neurones and the spinal dorsal horn have been well documented including a marked 
up-regulation of the expression of VIP and PACAP (Hokfelt et al., 1994). Previous 
evidence has suggested that these peptides may have neurotransmitter and/ or 
neuromodulatory functions within the CNS (Jeftinija et al., 1982; Phillis et al., 1978; 
Narita et al., 1996; Salt and Hill, 1981; Xu and Weisenfeld-Hallin, 1996). In fact 
fol lowing CCI there is a marked increase in the levels of mRNA for the VPAC2 
receptor rather than VPAC1 or PACAP receptors (Dickinson et al., 1999) and 
concomitant functional data data suggest that the VPAC2 receptor may play an 
important role in the transmission of sensory information within the spinal cord of 
both normal mice and especially in neuropathic mice (Dickinson et al., 1997; 1999). 
CCI was carried out in VPAC2R(-/-l mice to evaluate the contribution of the VPAC2 
receptor to the development and maintenance of the abnormal behavioural responses 
that develop following CCI. CCI was also carried out in wild-type littermate mice 
for comparison. Following surgery, the wild-type mice developed the abnormal 
ipsilateral behavioural responses indicative of neuropathic pain. However, in mice 
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lacking the VPAC2 receptor, the development of mechanical allodynia and thermal 
hyperalgesia was markedly reduced. The magnitude of ipsilateral, injury-induced 
decrease in paw withdrawal latency to noxious heat, also appeared to be diminished 
in mutant compared to wild-type mice. Effects on the magnitude of change in paw 
withdrawal threshold to normally innocuous stimuli were however less. Sham 
surgery was carried out for control purposes and no alteration in reflex withdrawal 
responses from noxious heat or innocuous mechanical stimuli were observed at any 
time point. These results suggest that the VP AC2 receptor may play a key role in the 
mechanisms underlying the development and maintenance of the abnormal 
behavioural responses that follow CCI believed to be indicative of neuropathic pain. 
In support of this is the observation that the levels of immunoreactive VIP are 
markedly increased from almost undetectable levels in the dorsal horn, to high levels 
following nerve injury (Hokfelt et al., 1994), and the increase in the levels of mRNA 
for the VPAC2 receptor in the ipsilateral dorsal horn following CCI (Dickinson et al., 
1999). These results taken together suggest that there may be an increased 
involvement of the VPAC2 receptor in spinal sensory processing following nerve 
injury that may participate in the development and maintenance of neuropathic pain. 
Intrathecal administration of the VPAC2 receptor inhibitor (Des-1-4-Arg
16-Ro 25-
1553) was carried out to further evaluate the contribution of the VPAC2 receptor to 
the maintenance of the abnormal behavioural responses that occur in established CCI 
neuropathy. In wild-type mice at the peak of neuropathic reflex changes, intrathecal 
injection of Des-1-4-Arg16-Ro 25-1553 significantly reversed the injury-induced 
changes in ipsilateral reflex withdrawal responses. This reversal was specific to the 
sensitised responses from the ipsilateral limb and the antagonist showed no effect on 
responses from the contralateral limb. Control intrathecal administration of saline in 
wild-type mice had no effect. Intrathecal administration of Des-l-4-Arg16.Ro 25-
1553 in VPAC2R<-t-) mice was carried out to further confirm both the specificity of 
the drug and the genotype of the VPAC2R(-t-) mice and the antagonist had no effect 
on reflex responses. The antinociceptive effect of the novel VPAC2 receptor 
antagonist following CCI in wi ld-type mice was in agreement with previous 
electrophysiological studies which applied the VPAC2 receptor antagonist in the 
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proximity of single dorsal horn neurones whose activity was evoked by the 
application of mustard-oil. The effects of Des-1-4-Arg16 -Ro 25-1553 were 
selectively antinociceptive, (markedly inhibiting the sustained C-fibre activity 
induced by topical application of the chemical initant mustard oil), (Dickinson et al., 
1997; 1999). The inhibitor also inhibited mustard oil-induced activity in nerve 
injured animals (Dickinson et al., 1999). These results taken together suggest that 
inhibitors of the VPAC2 receptor may serve as selective analgesics, strongly reducing 
polymodal C-fibre mediated pain in normal and neuropathic pain states. In the 
present behavioural studies, the attenuating effects of the VPAC2 receptor antagonist 
and of the VPAC2 receptor knockout were more marked on sensitised responses to 
heat than to mechanical stimuli. This suggests that VPAC2 receptor antagonists 
might be useful to target selectively the hyperalgesia seen in relation to C-fibre 
nociceptor responses in neuropathic pain. 
Previous findings have demonstrated that ionophoretic application of the VPAC2 
receptor agonist Ro 25-1553 in normal rats leads to a state of neuronal excitation 
which is further increased in nerve injured rats (Dickinson et al., 1999). To further 
assess the contribution of the VPAC2 receptor and its potential modulatory rnle 
following nerve injury, parallel studies were carried out using intrathecal 
administration of the VPAC2 receptor agonist Ro 25-1553 in both wild-type and 
VPAC2R<-t-) mice that had undergone CCI. Intrathecal administration of Ro 25-1553 
in wild-type mice dramatically decreased the paw withdrawal latency to noxious heat 
and the paw withdrawal threshold to innocuous mechanical stimuli with no effect in 
VPAC2R(-t-) mice. These results provide further evidence that suggest that the 
VPAC2 receptor may play a modulatory role in the processing of sensory information 
particularly following nerve injury. 
Morphological investigation of the sciatic nerve was canied out in both wild-type 
and VPAC2R<-t-) mice. Myelin thickness in A fibres and the frequency distribution of 
both A and C fibres were assessed to exclude the possibility that the differences 
observed for reflex withdrawal responses in the subsequent investigations were due 
to the presence/ absence of the VPAC2 receptor, and not due to any gross 
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developmental changes in the properties of the sciatic nerve. No structural changes 
in afferent fibres were detected. 
It has been suggested using different experimental paradigms, that VIP and its action 
via the VPAC1, VPAC2 and PACAP receptors may in ce1tain instances suppress or 
even prevent tissue responses to injury and consequent inflammation (reviewed in 
Said, 1998). Such evidence includes: (1) prevention of acute high-permeability 
pulmonary oedema caused by oxidant stress or glutamate; (2) attenuation of 
bronchoconstriction and airway inflammation induced by capsaicin, which releases 
the proinflammatory sensory neuropeptide tachykinins; (3) protection of CNS 
neurones against death induced by a variety of insults (Brenneman et al., 1998); and 
(4) inhibition of the production of tumour necrosis factor a and other inflammatory 
cytokines by lipopolysacchatide-stimulated macrophages (Delgado et al., 1999). 
However, whilst the mechanisms underpinning inflammatory and neuropathic pain 
states share a number of similarities, there are aJso a number of clear differences in 
the underlying mechanisms and it is perfectly reasonable to expect VIP, as a 
neuromodulator, to exert contrasting modulatory effects in the distinct mechanisms 
of inflammatory and neuropathic pain states. In the present study any potential 
influences of spinal VIP/PACAP receptors on inflammatory pain responses have not 
been investigated. In general, the anti-inflammatory actions reported for VIP are at 
peripheral tissue sites and often involve modifying the function of inflammation-
related leukocytes. The facts that we are here assessing central rather than peripheral 
roles of these receptors and that VIP/PACAP expression in afferents is specifically 
up-regulated in the nerve injury model mean that any direct compa1ison between 
those experiments and the current study would not be possible. 
In summary, these results provide further evidence of the modulatory role of 
VIP/PACAP within the dorsal horn of the spinal cord. This investigation also 
provides new insight into the role of the VPAC2 receptor in the mechanisms 
underlying the development and maintenance of abnormal behavioural responses 
indicative of neuropathic pain following CCI. The combined evidence of this and 
recent studies indicates that the VPAC2 receptor plays a key role in the thermal 
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hyperalgesia and mechanical allodynia following nerve injury and that antagonists of 
the VPAC2 receptor may act as selective analgesics, strongly reducing polymodal-C-
fibre-mediated pain in neuropathy. These novel findings also suggest that 
mechanical allodynia may be reversed in conscious mice following intrathecal 
administration of VPAC2 receptor antagonists. The effects on mechanical allodynia 
appear less marked, but further extensive studies with a number of different agents 
would be needed to make a definitive conclusion this. Importantly, these 
experiments when added to previous findings underline the potential importance of 
the VPAC2 receptor antagonists as new analgesics for use in currently intractable 
neuropathic pain states. 
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CHAPTER 4: THE ROLE OF CYCLIC-AMP DEPENDENT 
PROTEIN KINASE IN NEUROPATHIC PAIN 
4.1. cAMP and the cAMP-Dependent Protein Kinase (PKA) Signalling 
System 
Reversible protein phosphorylation is a key regulatory mechanism in eukaryotic 
cells. Protein phosphorylation was first demonstrated to regulate glycogen 
phosphorylase in response to glucagon (Fischer and Krebs, 1955; Sutherland and 
Wosilait, 1955) and the concept of 3', 5' -cyclic adenosine monophosphate (cAMP) 
was developed. The principal route of signal transduction by means of cAMP in 
mammalian cells, (with which the majority of biological effects of cAMP have been 
associated), is cAMP-dependent protein kinase (PK.A) (Walsh et al., 1968). In the 
absence of cAMP, PK.A is an enzymatically inactive tetrameric holoenzyme 
consisting of two homodimeric regulatory (R) subunits (Ria, Rlf3, Rlla or Rllf3) and 
two catalytic (C) subunits (Ca and Cf3) (Krebs and Beavo., 1979; Nairn et al. , 1985) 
(Figure 4.1 ). Activation of PK.A occurs when four molecules of cAMP co-
operatively bind to two sites on each R-subunit (Beebe et al., 1986). When both 
cAMP binding sites (A and B) are occupied, the R-subunit adopts a conformation 
with low affinity for the C-subunit, and the active C-subunits dissociate and 
phosphorylate serine / threonine residues within specific substrate proteins 
(Meinkoth et al. , 1993). There is increasing evidence that an imbalance of the R:C-
subunit equilibrium can lead to PK.A becoming persistently activated at basal cAMP 
levels. This imbalance can be due in pa1t to a degradation of the R-subunits by the 
ubiquitin proteasome pathway (Chain et al., 1999). 
4.2. lsozymes of PKA 
Two major types of PK.A have been identified by DEAE ion exchange 
chromatography (Reimann et al., 1971; Corbin et al., 1975) and named type I and 
type II according to their elution order. The two types of holoenzyme differ in the 
structure of the regulatory subunit incorporated (RI or RU). Recent work has shown 
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that there are two RI subun its tem1ed Rla (Lee et al. , 1983; Sandberg et al. , 1987) 
and RI~ (Clegg et al., 1988; Solberg et al., 1991) and two RII subunits termed RIIa 
and RII~ (Scott et al. , 1987; Oyen et al. , 1989). Furthermore, two distinct C-subunits 
have been initially identified by molecular cloning, and designated Ca (Uhler et al., 
1986) and C~ (Uhler et al., 1986; Showers and M aurer, 1986). Low homology 
screening of Ca and C~-related sequences from human testis has also revealed an 
additional C-subunit designated Cy (Beebe et al. , 1990; Reinton et al. , 1998). Splice 
variants of both Ca and C~ have also been reported (Lange-Carter and Malkinson, 
1991 ; San Agustin et al., 1998). 
4.2.1. Structure of the Regulatory Subunits 
The RI and RII subunits contain an amino-terminal dimerization domain , a region 
responsible for interaction with the C-subunit, and in the carboxy-terminus, two 
tandem cAMP bi nding sites, termed A and B (Corbin et al. , 1978; Doskeland, 1978). 
Of the two cAMP binding si tes that are located in the C-terminal domain, only site B 
is exposed in the inactive tetrameric PKA complex (Doskeland et al. , 1993). Binding 
of cAMP to this site enhances binding of cAMP to the site A in a positively co-
operative fash ion, as a result of a confo1mational change in the molecule. 
4.2.2. Structure of the Catalytic-Subunits 
The C-subunits retain the catalytic core moti f that is common to al l protein kinases 
(Hanks et al., 1988, Taylor et a l. , 1992). The C-subunits are bi-lobed globular 
proteins, with a small amino-terminal and a larger carboxyl-terminal lobe involved in 
peptide binding and cata lysis. Ca and C~ contain a domain that is capable of 
binding the specific peptide inhibitor of PKA, PKI (Wen et al., 1994). PKI, which 
contains a nuclear export signal (NES), appears to have the ability of transporting the 
C-subunit from the nucleus to the cytosol, and may serve as a major regulator of C-
subunit activity in vivo (Wen et al., 1995). 
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4.2.3. Levels and Expression of the Regulatory and Catalytic-Subunits 
Studies by Cadd and McKnight (1989) revealed that in mice, Rla is expressed in the 
heatt and central nervous system (CNS), whereas RI~ expression is more restricted 
to nervous tissues such as the spinal cord and the brain. Furthe,more, Rlla and Ril~ 
show distinct patterns of expression, with Rlla predominantly expressed in the heart 
and RII~ expressed in the li ver and fat tissue, whilst both are expressed in the brain 
(Cummings et al., 1989). It is generally assumed that the C-subunits associate freely 
with dimers of all the R-subunits. However, PKA I holoenzymes are more readily 
dissociated by cAMP in vitro than PKA II holoenzymes (Beebe and Corbin, 1986; 
Dostmann et al., 1990). Furthermore, studies have shown that the C-subunit will 
preferentially bind to RII and leave the RI present as free dimers (Otten and 
McKnight, 1989), which indicates that PKA II holoenzymes are assembled 
preferentially over PKA I under physiological conditions. In addition to their unique 
expression patterns across tissues, the various PKA subunits show preferential 
distribution subcellularly. RU subunits are generally found in the particulate fraction 
of neural homogenates. This is attributable to their high affinity for a group of 
anchoring proteins, A-kinase anchoring proteins (AKAPs) which bind PKA 
(predominantly type II) to various subcellular locations and are now believed to act 
as scaffolds supporting multi-protein signal transduction complexes that can also 
include other kinases and phosphatases (Coghlan et al., 1995; Faux and Scott, 1996). 
Histologica11y, RII subunits have been found to be associated with structures such as 
the nuclear envelope, the golgi apparatus, and the dendritic cytoskeleton (Diviani and 
Scott, 2001; Skalhegg and Tasken, 2000). In contrast Rl subunits tend to be found in 
the cytosolic fraction of cells, although this may be simply due to the low affinity of 
RI subunits for binding proteins (Skalhegg et al., 1994). 
Taken together, this demonstrates the existence of multiple R and C-subunits 
harbouring different biochemical features and activities. When assembled, they may 
give rise to a number of PKA holoenzymes with different biological characteristics 
and activities. A number of different PKA holoenzymes may certainly account for 
some of the specificity seen in the cAMP / PKA pathway. 
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Figure 4.1 The cAMP Signal Transduction Cascade 
cAMP is generated from ATP when a ligand binds to a G protein coupled receptor 
that activates adenylate cyclase (AC). PKA is a holoenzyme consisting of regulatory 
(R) and catalytic (C) subunits. When associated as a holoenzyme the R-subunits 
restrain the C-subunits in a catalytically inactive state. Activation of PKA occurs 
when four molecules of cAMP bind to the R-subunit dimer, two to each subunit. 
When both cAMP binding sites are occupied the R-subunit adopts a confonnation 
with low affinity for the C-subunit and the holoenzyme dissociates. 
The cAMP I PKA pathway is known to be activated by a number of different 
receptors that upon binding of their respective ligands, transduce signals over the cell 
membrane by coupling G proteins. These G proteins interact with adenylate cyclase 
on the inner membrane surface either to activate or inhibit the production of cAMP. 
Receptors that activate PKA, through the generation of cAMP, regulate a vast 
number of ce llular processes, such as metabolism (Krebs and Beavo, 1979), gene 
regulation (Roesler et al. , 1988), cell growth and division (Whitfield et al. , 1979), 
cell differentiation (Liu, 1982; Schwartz and Rubin, 1983) and sperm motility (Tash 
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4.3. cAMP Signal Transduction Cascade and Sensory Transmission 
The results in chapter 3 have suggested the importance of the VPAC2 receptor in 
nociceptive processing following peripheral nerve injury. There is considerable 
evidence suggesting that the underlying mechanisms of persistent pain result from 
long term changes in nociceptive processing of peripheral sensory neurones 
(peripheral sensitisation) and/ or neurones of the CNS (central sensitisation). While 
membrane receptors certainly contribute to the initiation of pe1ipheral and central 
sensitisation, it is likely that second messenger-activated changes in neuronal activity 
account for the maintenance of persistent pain states. 
Pre-synaptic transmitter/ neuromodulator release (glutamate/ substance P) results in 
changes in signal transduction pathways in dorsal horn neurones and the activation of 
ligand-gated ion channels (such as AMPA and NMDA receptors), but also second 
messenger-linked receptors (such as mGluR and NK-1 receptors). Activation of 
these multiple receptors results in an increase in intracellular ca2+, both via Ca2+ 
inflow and release from intracellular stores (Mayer and Miller, 1991). These 
pathways and/ or Ca2+ elevation per se can lead to production of a number of second 
messengers including (IP3, DAG), and cAMP, which is also generated more directly 
via other G protein coupled receptors such as the VPAC / PAC receptors. These 
second messengers and Ca2+ lead to activation of key protein kinases such as CaM 
kinase, PKC and PKA. There is now considerable evidence to suggest that 
intracellular second messenger activated protein kinases are impo11ant for the 
development of increased neuronal exci tabi lity and persistent alterations in 
nociceptive processing. 
After stimulation, the activated protein kinases may phosphorylate various substrate 
proteins, including ion channels, G protein coupled receptors and other enzymes to 
enhance neuronal function and pain signalling (Taiwo et al., 1989; Taiwo and 
Levine, 1991). One of the downstream targets for these kinases are membrane bound 
receptors/ ion-channels, of which the NMDA and AMPA are the best characterised. 
Phosphorylation of the NMDA receptor leads to post-translational modification of 
the receptor resulting in dramatic changes in NMDA-receptor channel kinetics and a 
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reduction in its voltage-dependent Mg2+ block. Both of these changes augment 
subsequent responsiveness to synaptically released glutamate, increasing synaptic 
strength, membrane excitability and thereby eliciting central sensitisation and thus 
enabling previously sub-threshold inputs to dtive the output of the cell. These 
changes can establish a persistent pain state in which there are enhanced responses to 
noxious stimuli (hyperalgesia) and non-noxious stimuli can produce pain (allodynia). 
Many neurotransmitters and hormones transduce their signal into a cell by activating 
G protein coupled receptors that modulate adenylate cyclase activity. These ligands 
include small molecule neurotransmitters, such as acetylcholine, dopamine, 
noradrenaline, serotonin and histamine, as well as peptide transmitters such as VIP, 
SOM and NPY (Brandon et al., 1997). The cAMP transduction cascade is associated 
with several G protein receptors found in the spinal cord such as the prostaglandin 
receptors (Hintgen et al., 1995) CORP (Bushfield et al., 1993) substance P (Satoh et 
al., 1992) opioid (Aantaa et al., 1995) VPAC2 receptors (Lutz et al., 1993) serotonin 
(Hen. , 1993) adrenergic (Aantaa et al. , 1995) and metabotropic glutamate receptors 
(Schoepp and Johnson, 1993). 
Increasing evidence suggests that the cAMP transduction pathway is implicated in 
the establishment of prolonged changes in the excitability of p1imary afferent 
nociceptors and dorsal horn neurones (Taiwo et al. , 1989; Taiwo and Levine, 1991; 
Cerne et al., 1992, 1993; Mao et al., 1993; Palecek et al., 1994; Lin et al., 1996; 
Sluka, I 997; Malmberg et al. , 1997). The sensitisation of p1imary afferent neurones 
that occurs in the setting of inflammation has been shown to involve cAMP and 
PKA-dependent mechanisms (England et al., 1996; Kress et al., 1996). Peripherally 
cAMP acts in nociceptive primary afferents as a second messenger to mediate the 
decrease in mechanical nociceptive threshold produced by a number of inflammatory 
mediators that are thought to act at different receptors on the peripheral terminals of 
primary afferents . In fact all steps of the cAMP second messenger cascade have 
been shown to be necessary for the induction of hyperalgesia by direct acting agents 
(Taiwo et al., 1989). Forskolin, which directly activates adenylate cyclase, results in 
a lowering of nociceptive thresholds, and the duration of this hyperalgesia is 
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prolonged by phosphodiesterase inhibitors (FeJTeira and Nakamura, 1979). The 
lowering of pain threshold produced by paw injection of prostaglandin E2 (PGE2) can 
be reduced by inhibiting PKA (Taiwo et al., 1989; Taiwo and Levine, 1991). Also, 
the increases in the conductance of TIX-resistant Na+ channel by PGE2 
(predominantly expressed on small diameter nociceptive neurones), (Akopian et al., 
1996) are mimkked by cAMP (England et al., 1996; Gold et al., 1996). Activators 
of PKA, including cAMP analogues, have been shown to enhance peptide release 
from cultured sensory neurones (Hintgen et al., 1995; Supowit et al., 1995). 
Furthermore cAMP-dependent phosphorylation of Ca2+ channels has also been 
demonstrated, suggesting that PKA is one essential component of the mechanisms of 
enhanced neurotransmitter release during persistent nociception (Hell et al., 1995). 
The peripheral component of hyperalgesia is independently maintained by PKA and 
inhibitors of PKA can inhibit the catalytic-subunit-induced hyperalgesia at any point 
during its time course. This suggests that hyperalgesia is not maintained by very 
persistent changes in the cell downstream from PKA, such as long lasting 
enhancement of ion-channels (Aley and Levine, 1999). 
Centrally, the role of cAMP in spinal nociceptive processing is less clear. Injection 
of the cAMP analogue 8-Br-cAMP or the catalytic-subunits of PKA enhances the 
responses of dorsal horn neurones to glutamate gated ion channel activation (Cerne 
et al., 1992; 1993). Activation of the cAMP transduction cascade at the spinal cord 
level results in mechanical hyperalgesia and allodynia and it has been demonstrated 
that the secondary mechanical allodynia following intradermal injection of capsaicin 
is mediated by this transduction cascade (Sluka et al., 1997). Also, blockade of PKA 
with H89 by microdialysis infusion in the dorsal horn reduces the sensitisation of 
STT cells to capsaicin injection (S luka et al., 1997b), and capsaicin-induced 
mechanical hyperalgesia in rats (Sluka and Willis, 1997). While selective inhibitors 
of the PKA isoforms are not available, mutant mice that lack one of the subunits 
have been developed to study the function of PKA isoforms. In mice that selectively 
lack the Ril3 subunit (Brandon et al., 1995) the induction of the transcription factor 
C-fos in the spinal dorsal horn by intraplantar formalin injection is significantly 
reduced providing a molecular indicator of the loss of function in these mice 
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(Malmberg et al., 1997). It is believed that RIB is a critical pre-synaptic PKA 
subunit, in this case for nociceptive processing in the terminals of ptimary afferent 
fibres (Malmberg et al., 1997). Thus, it appears that the cAMP transduction cascade 
at a central s ite is involved in maintaining secondary hyperalgesia and allodynia 
(Sluka et al., 1997), and activation of the cAMP pathway must occur in response to 
mechanisms responsible for inducing central sensitisation (Sluka, 1997). These 
studies are consistent with other studies suggesting that PKA plays a role in 
prolonged changes in neuronal synaptic efficacy, which include studies of long term 
potentiation in the hippocampus (Frey et al. , 1993; Huang et al., 1995). 
4.4. Aims of the Present Experiments 
This study aimed to investigate the possible role of PKA in the abnormal behavioural 
responses fo llowing CCI, and to identify any specific alterations in the expression of 
the subunits of PK.A fol lowing CCI. To assess the contribution of PKA in the 
maintenance of thermal hyperalgesia, and mechanical and cold allodynia followi ng 
CCI, intrathecal injection of a number of inhibitors of PKA (H89, myr-PKI (5-24) 
and Rp-8-CPT-cAMPs) was catTied out in neuropathic rats and normal controls. 
Since several isoforms of PKA exist, its involvement in nociception may be related 
to one specific isoform, and/ or alteration in the expression of various isoforms. To 
assess any alterations in the levels of expression of PKA subunits in the lumbar 
dorsal horn following CCI, in situ hyb1idisation histochemistry and Western blot 
analysis of the expression of mRNA and protein for the catalytic (CCX, CB) and 
regulatory (Ricx, RIB, Rllcx and RIIB) subunits of PKA was catTied out. 
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4.5. Results 
4.5.1. Effects of lntrathecal Injection of the Highly Selective PKA 
Inhibitors H89, myr-PKI (5-24) and Rp-8-CPT-cAMPs (Rp-cAMPs) 
on Reflex Withdrawal Responses in Normal and CCI Rats 
These results were obtained from a total of 117 rats (n=99 CCI and n=l8 no,mal). 
Intrathecal injection of the selective PKA inhibitors H89, myr-PKI (5-24) and Rp-8-
CPT-cAMPs was canied out as described in previously (Chapter 2 section 2.3.4). 
Behavioural measurements commenced at 15 min post-injection and continued until 
full recovery was observed or for a minimum testing period of 90 min. In order to 
differentiate between the contribution of PKA catalytic-subunit activity compared to 
activation of PKA by cAMP, several different inhibitors of PKA were administered. 
H89 and myr-PKI (5-24) inhibit the catalytic activity of PKA by inhibiting the 
catalytically active C-subunits. Rp-8-CPT-cAMPS however, is a competitive 
inhibitor of cAMP and sequesters PKA as an inactive holoenzyme. All three 
inhibitors, H89, myr-PKI (5-24) and Rp-8-CPT-cAMPs significantly reversed the 
ipsilaterally enhanced sensory reflex withdrawal responses to noxious heat measures, 
innocuous mechanical stimulation and innocuous cold, believed to be indicative of 
thermal hyperalgesia, mechanical and cold allodynia respectively. No significant 
effects were observed on the reflex responses elicited from the contralateral limb 
(Figures 4.2 - 4.12). 
Injection of increasing concentrations of H89 resulted in a characteristic dose 
dependent inhibition (Figures 4.2, 4 .3 and 4.4). Injection of Myr-PKI (5-22) and Rp-
8-CPT-cAMPs (Figure 4.6, 4.7, 4.8, 4.9 and 4.10) had a similar effect. Intrathecal 
injection of vehicle had no effect on baseline values in all three sensory tests (Figure 
5.5, 5.6, 5.7) and injection of the inhibitors of PKA in normal animals also had no 
effect on baseline values (Figure 4.5). An additional control involved the injection of 
a myristoylated inactive control peptide in CCI rats which had no significant effect 
on reflex withdrawal responses (Figure 4.7). The effects of all three inhibitors 
appeared to be specific to the ipsilateral limb following CCI with no apparent effect 
on either the contralateral limb or baseline values in normal unoperated rats. 
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Figure 4.2 Effects of lntrathecal Injection of the PKA Inhibitor H89 on 
Reflex Withdrawal Responses to Noxious Heat in CCI Rats 
Data are presented as mean paw withdrawal latency for ipsilateral and contralateral 
paws plotted against time (min) pre- and post-injection. Arrow marks intrathecal 
drug injection. In rats exhibiting peak behavioural changes following CCI, paw 
withdrawal latency to noxious heat ipsilateral (but not contralateral) to nerve injury 
showed significant differences between pre- and post-drug injection values (t p ~ 
0.05; one way ANOV A fo llowed by Neuman-Keuls post-hoe test). Significant 
differences between contralateral and ipsilateral paw withdrawal latency are 
indicated(* p ~ 0.05; Student's paired t-test). A dose dependent effect was observed 
following injection of H89 (at atTow) in that the recovery was faster at lower doses. 
(A) Effects of intrathecal injection of H89 ([2nmol in 50µ1], n=9). (B) Effects of 
intrathecal injection of H89 ([6nmol in 50µ1], n=9). (C) Effects of intrathecal 
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Figure 4.3 Effects of lntrathecal Injection of the PKA Inhibitor H89 on 
Reflex Withdrawal Responses to Innocuous Mechanical Stimuli in CCI 
Rats 
Data are presented as mean paw withdrawal threshold to innocuous mechanical 
stimulation for ipsilateral and contralateral paws plotted against time (mjn) pre- and 
post-injection. Arrow marks intrathecal drug injection. In rats exhibiting peak 
behavioural changes following CCI, paw withdrawal threshold to innocuous 
mechanical stimuli ipsilateral (but not contralateral) to nerve injury showed 
significant differences between pre- and post-drug injection values (t p :s; 0 .05; 
Kruskall-Wallis ANOVA followed by a Dunn's post-hoe test). Significant 
differences between contralateral and ipsilateral paw withdrawal threshold are 
indicated(* p:::; 0 .05; Mann-Whitney U test). A dose dependent effect was observed 
following injection of H89. (A) Effects of intrathecal injection of H89 ([2nmol in 
50µ1], n=9). (B) Effects of intrathecal injection of H89 ([6nmol in 50µ1], n=9). (C) 
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Figure 4.4 Effects of lntrathecal Injection of the PKA Inhibitor H89 on 
Reflex Withdrawal Responses to Innocuous Cold Stimuli in CCI Rats 
Data are presented as mean suspended paw elevation time (SPET) (s) for ipsilateral 
and contralateral paws plotted against time (min) pre- and post-injection. A!Tow 
marks intrathecal drug injection. In rats exhibiting peak behavioural changes 
following CCI, suspended paw elevation time (SPET) ipsilateral (but not 
contralateral) to nerve injury showed significant differences between pre- and post-
drug injection values (t p :s; 0.05; one way ANOVA followed by Neuman-Keuls 
post-hoe test). Significant differences between contralateral and ipsilateral paw 
withdrawal duration are indicated(* p :s; 0.05; Student's paired t-test). (A) Effects of 
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Figure 4.5 Effects of lntrathecal Injection of the PKA Inhibitor H89 on 
Reflex Withdrawal Responses to Noxious Heat and Innocuous 
Mechanical Stimuli in Normal Rats 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN / mm2) to innocuous mechanical stimuli (B) for 
left and right paws plotted against time (min) pre- and post-injection. Arrow marks 
intrathecal drug injection. 
In normal unoperated rats, paw withdrawal latency to noxious heat (A) and paw 
withdrawal threshold to innocuous mechanical stimulation (B) was unaltered 
following intrathecal injection of H89 (Neuman-Keuls one way ANOVA and 
Kruskall-Wallis ANOVA respectively). H89 was injected at a dose of [6nmol in 
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Figure 4.6 Effects of lntrathecal Injection of the PKA Inhibitor myr-PKI 
(5-24) on Reflex Withdrawal Responses to Noxious Heat, Innocuous 
Mechanical and Innocuous Cold Stimuli in CCI Rats 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), mean 
paw withdrawal threshold (mN / mm2) to normally innocuous mechanical stimuli (B) 
and mean suspended paw elevation time (s) from normally innocuous cold (C) for 
ipsilateral and contralateral paws plotted against time (min) pre- and post-injection. 
(A) In rats exhibiting peak behavioural changes following CCI, paw withdrawal 
latency to noxious heat ipsi1atera1 (but not contralateral) to nerve injury showed 
significant differences between pre- and post-drug injection values (t p 5 0.05; one 
way ANOV A followed by Neuman-Keul's post-hoe test). Significant differences 
between contralateral and ipsilateral paw withdrawal latency are indicated(* p 5 
0.05; Student's paired t-test). myr-PKI (5-24)was injected at a dose of [2nmol in 
50µ1] , (n=9). 
(B) In rats exhibiting peak behavioural changes following CCI, paw withdrawal 
threshold to innocuous mechanical stimulation ipsilateral (but not contralateral) to 
nerve injury showed significant differences between pre- and post-drug injection 
values (t p 5 0.05; Kruskal-Wallis ANOVA followed by a Dunn's post-hoe test). 
Significant differences between contralateral and ipsilateral paw withdrawal 
threshold are indicated(* p 5 0.05; Mann-Whitney U test). myr-PKI (5-24) was 
injected at a dose of [2nmol in 50µ1] , (n=9). 
(C) In rats exhibiting peak behavioural changes fo llowing CCI, suspended paw 
e levation time (SPET) ipsilateral (but not contralateral) to nerve injury showed 
significant differences between pre- and post-drug injection values (t p 5 0.05; one 
way ANOV A followed by Neuman-Keuls post-hoe test). Significant differences 
between contralateral and ipsilateral paw wi thdrawal duration are indicated(* p 5 
0.05; Student's paired t-test). myr-PKI (5-24) was injected at a dose of [2nmol in 
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Figure 4.7 Effects of lntrathecal Injection of the Myristoylated Control 
Peptide on Reflex Withdrawal Responses to Noxious Heat, Innocuous 
Mechanical and Innocuous Cold Stimuli in CCI Rats 
Data are represented as mean paw withdrawal latency (s) to noxious heat (A) and 
mean paw withdrawal threshold (mN / mm2) to innocuous mechanical stimuli (B), 
for ipsilateral and contralateral paws plotted against time (min) pre- and post-
injection. Arrow marks intrathecal drug injection. 
(A) In rats exhibiting peak behavioural changes following CCI, paw withdrawal 
latency to noxious heat ipsilateral and contralateral to nerve injury was unchanged 
compared to pre- and post-drug injection values (one way ANOV A). Significant 
differences between contralateral and ipsilateral paw withdrawal latency are 
indicated(* p $ 0.05 Student's paired t-test). myr-control peptide was injected at a 
dose of [2nmol in 50µ1], (n=6). 
(B) In rats exhibiting peak behavioural changes following CCI, paw withdrawal 
threshold to mechanical stimulation ipsilateral and contralateral to nerve injury was 
unchanged compared to pre- and post-drug injection values (Kruskal-Wallis 
ANOV A). Significant differences between contralateral and ipsilateral paw 
withdrawal threshold are indicated (* p $ 0.05 Mann-Whitney U test). myr-control 
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Figure 4.8 Effects of lntrathecal Injection of the PKA Inhibitor myr-PKI 
(5-24) on Reflex Withdrawal Response to Noxious Heat and Innocuous 
Mechanical Stimuli in Normal Rats 
Data are presented as mean paw withdrawal latency (s) from noxious heat (A), mean 
paw withdrawal threshold (mN / mm2) to innocuous mechanical stimuli (B) for left 
and right paws plotted against time (min) pre- and post-injection. Arrow marks 
intrathecal drug injection. 
(A) In normal unoperated rats, paw withdrawal latency to noxious heat was 
unchanged compared to pre- and post-drug injection values (one way ANOVA). 
There was no significant difference between left and ri ght paw withdrawal latency 
(Student's paired t-test). Myr-PKI (5-24) was injected at a dose of [2nmol in 50µ1], 
(n=6). 
(B) In normal unoperated rats, paw withdrawal threshold to innocuous mechanical 
stimuli was unchanged compared to pre- and post-drug injection values (Kruskal-
Wallis ANOVA). There was no significant difference between left and right paw 
withdrawal threshold (Mann-Whi tney U test). Myr-PKI (5-24) was injected at a dose 
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Figure 4.9 Effects of lntrathecal Injection of the PKA Inhibitor Rp-8-CPT-
cAMPs on Reflex Withdrawal Responses to Noxious Heat in CCI Rats 
Data are presented as mean paw withdrawal latency for ipsilateral and contralateral 
paws plotted against time (min) pre- and post-injection. Anow marks intrathecal 
drug injection. In rats exhibiting peak behavioural changes following CCI, paw 
withdrawal latency to noxious heat ipsilateral (but not contralateral) to nerve injury 
was showed significant differences between pre- and post-drug injection values (t p 
:::;; 0.05; one way ANOV A followed by Neuman-Keuls post-hoe test). Significant 
differences between contralateral and ipsilateral paw withdrawal latency are 
indicated(* p:::;; 0.05; Student's paired t-test). A dose dependent effect (in that 
recovery was more rapid at lower doses) was observed following injection of Rp-8-
CPT-cAMPs. (A) Effects of intrathecal injection of Rp-8-CPT-cAMPs [lOnmol in 
50µ1], (n=9). (B) Effects of intrathecal injection of Rp-8-CPT-cAMPs [30nmol in 
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Figure 4.10 Effects of lntrathecal Injection of Rp-8-CPT-cAMPS on 
Reflex Withdrawal Responses to Innocuous Mechanical Stimuli in CCI 
Rats 
Data are presented as mean paw withdrawal threshold to innocuous mechanical 
stimulation for ipsi lateral and contralateral paws plotted against time (min) pre- and 
post-injection. AJTow marks intrathecal drug injection. In rats exhibiting peak 
behavioural changes following CCI, paw withdrawal threshold to innocuous 
mechanical stimuli ipsilateral (but not contralateral) to nerve injury showed 
significant differences between pre- and post-drug injection values (t p ~ 0.05; 
Kruskall-Wallis ANOVA fol lowed by a Dunn's post-hoe test). Significant 
differences between contralateral and ipsilateral paw withdrawal threshold are 
indicated(* p ~ 0.05; Mann-Whitney U test). Selective ipsilateral effects were 
observed following injection of Rp-8-CPT-cAMPs. (A) Effects of intrathecal 
injection of Rp-8-CPT-cAMPs [lOnmol in 50µ1] , (n=9). (B) Effects of intrathecal 
injection of Rp-8-CPT-cAMPs [30nmol in 50µ1 ], (n=9). (C) Effects of intrathecal 
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Figure 4.11 Effects of lntrathecal Injection of Rp-8-CPT-cAMPs on 
Reflex Withdrawal Responses to Innocuous Cold Stimuli in CCI Rats 
Data are presented as mean suspended paw elevation time (SPET) (s) for ipsilateral 
and contralateral paws plotted against time (min) pre- and post-injection. Arrow 
marks intrathecal drug injection. In rats exhibiting peak behavioural changes 
following CCI, suspended paw elevation time (SPET) ipsilateral (but not 
contralateral) to nerve injury showed significant differences between pre- and post-
drug injection values (t p :5 0.05; one way ANOV A followed by Neuman-Keuls 
post-hoe test). Significant differences between contralateral and ipsilateral paw 
withdrawal duration are indicated(* p :5 0.05; Student's paired t-test). (A) Effects of 
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Figure 4.12 Effects of lntrathecal Injection of the PKA Inhibitor Rp-8-
CPT-cAMPs on Reflex Withdrawal Responses to Noxious Heat and 
Innocuous Mechanical Stimuli in Normal Rats 
Data are represented as mean paw withdrawal latency (s) from noxious heat (A), 
mean paw withdrawal threshold (mN / mm2) to innocuous mechanical stimuli (B) for 
left and right paws plotted against time (min) pre- and post-injection. AITow marks 
intrathecal drug injection. 
(A) In normal unoperated rats, paw withdrawal latency to noxious heat was 
unchanged compared to pre- and post-drug injection values (one way ANOVA). 
There was no significant difference between left and right paw withdrawal latency 
(Student's paired t-test). Rp-8-CPT-cAMPs was administered at a dose of [6nmol in 
50µ1], (n=6). 
(B) In normal unoperated rats, paw withdrawal threshold to innocuous mechanical 
stimuli was unchanged compared to pre- and post-drug injection values (Kruskal-
Wallis ANOV A). There was no significant difference between left and right paw 
withdrawal threshold (Mann-Whitney U test). Rp-8-CPT-cAMPs was administered 
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4.5.2 Distribution of mRNA for the Catalytic and Regulatory Subunits 
of cAMP Dependent Protein Kinase (PKA) within the Spinal 
Dorsal Horn of CCI Rats 
The mRNAs for all subunits were distributed widely in spinal cord of normal, sham-
operated and CCI rats. The levels of PKA C~ mRNA were particularly abundant. 
4.5.2.1 Catalytic subunits of PKA (Ca and CJ3) 
Following CCI of the rat sciatic nerve, there were marked changes in the expression 
of mRNA for both catalytic-subunits in the dorsal horn ipsilateral to nerve injury, 
with a particularly large change in the relative levels of C~ when compared to 
contralateral values (Figure 4.13). The total number of neurones positively 
expressing mRNA for Ca and CJ3 was significantly increased in the ipsilateral dorsal 
horn both mediolaterally and lateral ly in laminae I, II and III (Tables 4.1 and 4.2). 
Silver grain density was also significantly increased mediolaterally and laterally in 
LI, II and In (Figures 4.14 and 4.16. There was no significant difference in either 
cell counts or silver grain densities between contralateral and control values. Within 
the ventral horn of normal animals, labelling of motoneurones was especially intense 
(Figure 4.15) but showed no significant change following CCI treatment. 
4.5.2.2 Regulatory subunits of PKA (Ria, RIJ3, Rlla, and RIIJ3) 
Following CCI, there were no changes in the relative expression of mRNA for the 
regulatory subunits of PKA in the spinal dorsal horn following CCI (Figures 4.17, 
4.19, 4.21 and 4.23). Both the total number of neurones expressing mRNA for the 
regulatory subunits and the mean si lver grain density were unaltered in all laminae 
investigated (Tables 4.3, 4.4, 4.5 and 4.6; Figures 4.18, 4.20, 4.22 and 4.24). Control 
assessment of R subunit mRNA expression in motoneurones appeared unal tered 
following CCI (data not shown). 
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Figure 4.13 PKA Ca Subunit mRNA Expression in Lamina I, Ill and 
Motoneurones of the Rat Lumbar Spinal Dorsal Horn in CCI (lpsilateral 
and Contralateral), Normal and Sham-Operated Rats 
Highpower lightfield, black and white photomicrographs showing typical levels of 
PK.A Ca mRNA expression in the rnediolateral area of lamina I and III and 
motoneurones of rat lumbar spinal dorsal horn (scale bars lOµm). Photomicrographs 
show typical examples of the expression ipsilateral and contralateral to nerve injury 
and in normal and sham-operated control rats respectively. Positively labelled 
neurones were identified by a dense accumulation of silver grains (approximately> 5 
times background expression) over and around haematoxylin stained nuclei. 
Analysis of quantitative densitometry data demonstrated a significant increase in the 
expression of PKA Ca subunit mRNA ipsilateral to nerve injury when compared to 
contralateral and control tissue in the superficial laminae of the dorsal horn (A). 
However, in motoneurones (B) there was no significant alteration in the expression 
of PKA Ca rnRNA ipsilateral to nerve injury when compared to contralateral as 
revealed by cell counts and silver grain density. There were no significant 
differences between contralateral and control levels of rnRNA expression as revealed 
by cell counts and silver grain density (Table 4.1 , Figure 4.14). 
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Table 4.1 Mean Number of Dorsal Horn Neurones Positively Expressing 
PKA Ccx mRNA 
Summary table showing the average number of dorsal horn neurones within a 
graticule area of 175 x 175 µm2 positive ly expressing PK.A Ccx mRNA in lamina I , 
II, III, IV, and V in mediolateral and lateral locations of the dorsal horn. 
Values ipsi lateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The mean number of cells expressing mRNA for PK.A Ccx was significantly 
increased ipsilateral to nerve injury in laminae I, II and ill with no significant change 
in laminae IV and V when compared to contralateraJ values and to normal and sham-
operated values (* p ~ 0.05 one way AN OVA followed by a Neuman Keul 's post-
hoe test). For all laminae analysed there was no significant alteration in the relative 
expression of Ccx rnRNA when comparing contralateral CCI values to normal and 
sham-operated values (one way ANOVA). 
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Cell Counts per 175 x 175 µm2 
Mediolateral Lateral 
I psi lateral Contralateral Sham Normal I psi lateral Contralateral Sham Normal 
Lamina I 32.5 ± 3.2 * 22.5 ± 2.5 23.4 ± 2.8 21.9 ± 2.1 32.6 ± 2.3 * 23.9 ± 1.9 22.3 ± 2.6 23.1 ± 2.3 
Lamina II 33.2 ± 2.2 * 22.7 ± 2.8 21.2 ± 2.6 24.1 ± 2.2 34.3 ± 2.5 * 23.4 ± 2.3 24.2 ± 2.6 23.8 ± 2.8 
Lamina Ill 37.3 ± 2.9 * 27.3 ± 2.6 26.3 ± 3.4 25.7 ± 2.7 36.5 ± 3.2 * 29.1 ± 2.6 27.3 ± 2.7 27.3 ± 2.9 
Lamina IV 43.2 ± 4.6 44.7 ± 4.1 42.6 ± 3. 1 46.8 ± 4.6 38.3 ± 3.2 37.4 ± 2.4 39.1 ± 3.2 37.4 ± 3.1 
Lamina V 48.1 ± 4.8 45.5 ± 4.2 46.7 ± 4.9 47.7 ± 4.6 39.1 ± 3.1 36.7 ± 3.7 40.1 ± 3.5 38.8 ± 3.8 
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Figure 4.14 Mean Silver Grain Density of Dorsal Horn Neurones 
Positively Expressing PKA Ca mRNA 
Summary histogram showing the mean silver grain density for dorsal horn neurones 
positively expressing PKA Ca mRNA in lamina I, II, III, IV and V in mediolateral 
and lateral locations of the spinal cord. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The relative si lver grain density per positively expressing cell , indicative of the 
expression of PKA Ca mRNA, was significantly increased ipsilateral to ne rve injury 
in lamina I, II and III but was unaltered in laminae IV and V when compared to 
contralateral val ues, normal and sham-operated values (* p ~ 0.05 one way ANOV A, 
followed by a Neuman-Keul 's post-hoe test). For all laminae analysed there was no 
significant alteration in the relative expression of Ca mRNA when compating 
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Figure 4.15 PKA C~ mRNA Expression in Lamina I, Ill and 
Motoneurones of the Rat Lumbar Spinal Dorsal Horn in CCI (lpsilateral 
and Contralateral), Normal and Sham-operated Rats 
Highpower lightfield, black and white photomicrographs showing typical levels of 
PKA cp mRNA expression in the mediolateral area of lamina I and III and 
motoneurones ofrat lumbar spinal dorsal horn (scale bars lOµm). Photomicrographs 
show typical examples of the expression ipsilateral and contralateral to nerve injury 
and in normal and sham-operated control rats respectively. Positively labelled 
neurones were identified by a dense accumulation of silver grains (approximately> 5 
times background expression) over and around haematoxylin stained nuclei . 
Analysis of quantitative densitometry data demonstrated a significant increase in the 
expression of PKA cp subunit mRNA ipsilateral to nerve injury when compared to 
contralateral and control tissue in the superficial laminae of the dorsal horn (A). 
However, in motoneurones (B) there was no significant alteration in the expression 
of PKA cp mRNA ipsilateral to nerve injury when compared to contralateral as 
revealed by cell counts and si lver grain density. There were no significant 
differences between contralateral and control levels of mRNA expression as revealed 
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Table 4.2 Mean Number of Dorsal Horn Neurones Positively Expressing 
PKACl3 mRNA 
Summary table showing the average number of dorsal horn neurones within a 
graticule area of 175 x 175 µm2 positively expressing PKA Cl3 mRNA in lamina I, 
II, III, IV, and V in mediolateral and lateral locations of the dorsal horn. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The mean number of cells expressing mRNA for PKA C~ was significantly 
increased ipsilateral to nerve injury in laminae I, II and III compared to contralateral 
values and to normal and sham-operated values (* p ~ 0.05 one way ANOV A, 
followed by a Neuman-Keul's post-hoe test). For all laminae analysed there was no 
significant alteration in the relative expression of Cl3 mRNA when comparing 
contralateral CCI values to normal and sham-operated values (one way ANOVA). 
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Cell Counts per 175 x 175 µm2 
Mediolateral Lateral 
I psi lateral Contra lateral Sham Normal lpsilateral Contra lateral Sham Normal 
Lamina I 46.3 ± 4.4 * 32.2 ± 1.5 31.4±2.5 28.9 ± 1.8 42.2 ± 2.4 * 34.4 ± 2.1 32.7 ± 2.5 32.5 ± 2.5 
Lamina II 45.2 ± 2.8 * 31.5 ± 2.2 32.4 ± 2.6 35.5 ± 2.4 44.6 ± 2.3 * 34.2 ± 2.4 33.4 ± 2.1 34.1 ± 1.8 
Lamina Ill 47.1 ± 1.9 * 33.5 ± 2.2 31.5 ± 3.2 32.4 ± 1.5 46.2 ± 3.8 * 32.3 ± 2.3 34.3 ± 2.1 35.3 ± 2.7 
Lamina IV 52.2 ± 4.2 48.2 ± 3.2 49.2 ± 3.6 49.8 ± 4.4 50.1 ± 4.1 47.5 ± 3.4 49.7 ± 3.8 46.8 ± 3.7 
Lamina V 58.9 ± 4.4 56.5 ± 3.8 58.5 ± 4.8 57.5 ± 4.2 52.3 ± 4.2 52.1 ± 4.6 50.8 ± 4.1 52.6 ± 4.5 
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Figure 4.16 Mean Silver Grain Density of Dorsal Horn Neurones 
Positively Expressing PKA Cf3 mRNA 
Summary histogram showing the mean silver grain density for dorsal horn neurones 
positively expressing PKA C~ mRNA in lamina I, II, III, IV and V in mediolateral 
and lateral locations of the spinal cord. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The relative silver grain density per positively expressing cell , indicative of the 
expression of PKA C~ mRNA, was significantly increased ipsilateral to nerve injury 
in lamina I, II and III when compared to contralateral and values and to normal and 
sham-operated values (* p $ 0.05 one way ANOV A, followed by a Neuman-Keuls 
post-hoe test). For all laminae analysed there was no significant alteration in the 
relative expression of PKA C~ mRNA when comparing contralateral CCI values to 
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Figure 4.17 PKA Ria mRNA Expression in Lamina I of the Rat Lumbar 
Spinal Dorsal Horn in CCI (lpsilateral and Contralateral), Normal and 
Sham-Operated Rats 
Highpower lightfield, black and white photomicrographs showing typical levels of 
PKA Ria mRNA expression in the mediolateral area of lamina I of rat lumbar spinal 
dorsal horn (scale bar l Oµm). Photomicrographs show typical examples of the 
expression ipsilateral and contralateral to nerve injury and in normal and sham-
operated control rats respectively. Positively labelled neurones were identified by a 
dense accumulation of silver grains (approximately> 5 times background 
expression) over and around haematoxylin stained nuclei. 
Analysis of quantitative densitometry data demonstrated no significant alteration in 
the expression of PKA Rla mRN A ipsilateral to nerve injury when compared to 
contralateral and control tissue in the supe1ficial laminae of the dorsal horn. There 
were also no significant differences between contralateral and control levels of 














Table 4.3 Mean Number of Dorsal Horn Neurones Positively Expressing 
PKA Ria mRNA 
Summary table showing the average number of dorsal horn neurones within a 
graticule area of 175 x 175 µm2 positively expressing PKA Ria mRNA in lamina I, 
II, III, IV, and V in mediolateral and lateral locations of the dorsal horn. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and n01mal control values. 
The mean number of cells expressing mRNA for PK.A Ria appeared unchanged 
ipsilateral to nerve injury in all laminae, compared to contralateral values and to 
normal and sham-operated values (one way ANOVA). For all laminae analysed 
there was no significant alteration in the relative expression of Rla mRNA when 
comparing contralateral CCI values to no1mal and sham-operated values (one way 
ANOVA). 
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Cell Counts per 175 x 175 µm2 
Mediolateral Lateral 
I psi lateral Contra lateral Sham Normal lpsilateral Contra lateral Sham Normal 
Lamina I 8.5 ± 0.6 8.1 ± 0.6 7.9 ± 1.1 8.6 ±0.8 8.6 ± 1.1 8.8 ± 1.0 7.8 ± 0.8 8.4 ± 1.2 
Lamina II 11.4 ± 1.2 11 .8 ± 0.8 12.2 ± 1.8 11 .4 ± 1.0 10.1 ± 1.5 10.4 ± 1.8 11 .2 ± 1.6 10.8 ± 1.8 
Lamina Ill 13.5 ± 1.4 13.2 ± 1.5 14.5 ± 1.9 12.9 ± 1.6 11.6 ± 1.2 12.1 ± 1.4 12.7 ± 1.7 11 .8 ± 1.9 
Lamina IV 15.5 ± 1.9 15.2 ± 2.1 16.7 ± 1.2 15.1 ± 1.6 13.5 ± 1.2 14.4 ± 1.4 14.2 ± 1.9 13.6 ±2.1 
Lamina V 15.1 ± 1.6 15.5 ± 1.2 14.5 ± 2.1 15.3 ± 1.6 13.8 ± 2.1 14.5 ± 2.4 13.9 ± 1.8 14.2 ± 1.4 
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Figure 4.18 Mean Silver Grain Density of Dorsal Horn Neurones 
Positively Expressing PKA Ria mRNA 
Summary histogram showing the mean silver grain density for dorsal horn neurones 
positively expressing PKA Ria mRNA in lamina I, II, 111, IV and V in mediolateral 
and lateral locations of the spinal cord. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The relative si lver grain density per positively expressing cell, indicative of the 
expression of PKA Ria mRNA, was unchanged ipsilateral to nerve injury in all 
laminae when compared to contralateral values and n01mal and sham-operated 
values(* p :5 0.05 one way ANOVA, followed by a Neuman-Keul's post-hoe test). 
For all laminae analysed there was no significant alteration in the relative expression 
of PKA Ria mRNA when comparing contralateral CCI values to normal and sham-






en Cl) 40 
0 0 ........ 
_8 if 30 
E "' 










en Cl) 40 
c50 .... 
.._ Cl) 30 .8 a. 
E "' 








Lamina I Lamina II Lamina Ill Lamina IV Lamina V 
Lateral 
Lamina I Lamina II Lamina Ill Lamina IV Lamina V 
165 
- lpsilateral CCI 
c::::::J Contralateral CCI 
'""""I I\Jormal 
~ lpsilateral Sham 
Figure 4.19 PKA RIS mRNA Expression in Lamina I of the Rat Lumbar 
Spinal Dorsal Horn in CCI (lpsilateral and Contralateral), Normal and 
Sham-Operated Rats 
Highpower lightfield, black and white photomicrographs showing typical levels of 
PKA RIS mRNA expression in the mediolateral area of lamina I of rat lumbar spinal 
dorsal horn (scale bar lOµm). Photomicrographs show typical examples of the 
expression ipsilateral and contralateral to nerve injury and in normal and sham-
operated control rats respectively. Positively labelled neurones were identified by a 
dense accumulation of silver grains (approximately> 5 times background 
expression) over and around haematoxylin stained nuclei. 
Analysis of quantitative densi tometry data demonstrated no significant alteration in 
the expression of PKA RI~ mRNA ipsi lateral to nerve injury when compared to 
contralateral and control tissue in the supe1ficial laminae of the dorsal horn. There 
were also no significant differences between contralateral and control levels of 






















Table 4.4 Mean Number of Dorsal Horn Neurones Positively Expressing 
PKA Rll3 mRNA 
Summary table showing the average number of dorsal horn neurones within a 
graticule area of 175 x 175 µm2 positively expressing PKA RI~ mRNA in lamina I, 
II, III, IV, and V in mediolateral and lateral locations of the dorsal horn. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The mean number of cells expressing mRNA for PKA RI~ appeared unchanged 
ipsilateral to nerve injury in all laminae when compared to contralateral values and to 
normal and sham-operated values (one way ANOVA). For all laminae analysed 
there was no significant alteration in the relative expression of PKA RI~ mRNA 
when comparing contralateral CCI values to normal and sham-operated values (one 
way ANOVA). 
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Cell Counts per 175 x 175 µm2 
Mediolateral I Lateral 
lpsilateral Contra lateral Sham Normal lpsilateral Contra lateral Sham Normal 
Lamina I 8.3 ± 0.8 8.6 ± 0.7 8.9 ± 0.8 8.1 ± 0.7 8.1 ± 0.8 9.1 ± 1.2 8.5 ± 1.2 8.6 ± 1.0 
Lamina II 13.4 ± 1.2 12.8 ± 1.3 13.2 ± 1.4 12.6 ± 1.5 9.9 ± 1.1 10.1 ± 1.2 10.4 ± 1.1 10.2 ± 1.4 
Lamina Ill 16.4 ± 1.6 15.5 ± 1.2 16.5 ± 1.7 15.9 ± 1.5 10.6 ± 1.2 11 .1 ± 1.5 11.5 ± 1.4 11.2 ± 1.3 
Lamina IV 16.5 ± 2.1 15.8 ± 1.7 16.2 ± 1.9 15.8 ±1.7 11 .0 ± 1.1 11.4 ± 1.4 11 .3 ± 1.3 12.5 ± 1.7 
Lamina V 15.5 ± 1.4 15.1 ± 1.7 16.1 ± 1.9 15.8 ± 1.4 11 .2 ± 1.8 12.5 ± 2.1 11 .9 ± 1.6 11 .7 ± 1.7 
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Figure 4.20 Mean Silver Grain Density of Dorsal Horn Neurones 
Positively Expressing PKA Rlj3 mRNA 
Summary histogram showing the mean silver grain density for dorsal horn neurones 
positively expressing PKA Rm mRNA in lamina I, II, III, IV and V in mediolateral 
and lateral locations of the spinal cord. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The relative silver grain density per positively expressing cell, indicative of the 
expression of PKA Ril3 mRNA, was unchanged ipsilateral to nerve injury in all 
laminae when compared to contralateral values and normal and sham-operated 
values (one way ANOVA). For all laminae analysed there was no significant 
alteration in the relative expression of PKA Ril3 mRNA when comparing 
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Figure 4.21 PKA Rlla mRNA Expression in Lamina I of the Rat Lumbar 
Spinal Dorsal Horn in CCI (lpsilateral and Contralateral), Normal and 
Sham-Operated Rats 
Highpower lightfield, black and white photomicrographs showing typical levels of 
PKA RIIa mRNA expression in the mediolateral area of lamina I of rat lumbar 
spinal dorsal horn (scale bar lOµm). Photomicrographs show typical examples of the 
expression ipsilateral and contralateral to nerve injury and in normal and sham-
operated control rats respectively. Positively labelled neurones were identified by a 
dense accumulation of silver grains (approximately> 5 times background 
expression) over and around haematoxylin stained nuclei. 
Analysis of quantitative densitometry data demonstrated no significant alteration in 
the expression of PKA RIIa mRNA ipsilateral to nerve injury when compared to 
contralateral and control tissue in the superficial laminae of the dorsal horn. There 
were also no significant differences between contralateral and control levels of 

















Table 4.5 Mean Number of Dorsal Horn Neurones Positively Expressing 
PKA Rlla. mRNA 
Summary table showing the average number of dorsal horn neurones within a 
graticule area of 175 x 175 µm 2 positively expressing PKA RIIa. mRNA in lamina I, 
II, III, IV, and V in mediolateral and lateral locations of the dorsal horn. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The mean number of cells expressing mRNA for PKA RIIa. appeared unchanged 
ipsilateral to nerve injury in all laminae when compared to contralateral values and 
normal and sham-operated values (one way ANOVA). For all laminae analysed 
there was no significant alteration in the relative expression of PKA RIIa. mRNA 
when comparing contralateral CCI values to normal and sham-operated values (one 
way ANOVA). 
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Cell Counts per 175 x 175 µm2 
Mediolateral I Lateral 
lpsilateral Co ntralatera I Sham Normal lpsilateral Contra latera I Sham Normal 
Lamina I 18.2 ± 1.9 19.5 ± 1.6 18.1 ± 1.8 18.7 ± 1.6 16.5 ± 1.2 15.4 ± 1.8 15.2 ± 1.7 15.7 ± 1.5 
Lamina II 22.4 ± 2.0 23.2 ± 1.8 23.1 ± 2.3 22.1 ± 1.9 21 .5 ± 2.0 22.1 ± 1.9 22.9 ± 1 .4 21.2 ± 1.6 
Lamina Ill 25.2 ± 2.5 24.1 ± 2.6 25.1 ± 1.9 23.9 ± 2.8 24.2 ± 1.4 25.1 ± 2.1 24.7 ± 2.2 24.8 ± 1.7 
Lamina IV 25.5 ± 2.4 24.5 ± 2.1 24.2 ± 2.6 25.1 ± 2.1 24.3 ± 2.2 25.5 ± 1.9 25.8 ± 2.0 24.8 ± 1.9 
Lamina V 25.7 ± 2.3 24.9 ± 2.6 24.8 ± 2.7 24.5 ± 2.4 25.5 ± 2.0 25.9 ± 2.4 25.1 ± 1.9 26.1 ± 2.4 
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Figure 4.22 Mean Silver Grain Density of Dorsal Horn Neurones 
Positively Expressing PKA Alla mRNA 
Summary histogram showing the mean silver grain density for dorsal horn neurones 
positively expressing PKA Rlla mRNA in lamina I, II, Ill, IV and V in mediolateral 
and lateral locations of the spinal cord. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The relative silver grain density per positively expressing cell, indicative of the 
expression of PKA Rlla mRNA, was unchanged ipsilateral to nerve injury in all 
laminae when compared to contralateral values and to normal and sham-operated 
values (one way ANOVA). For all laminae analysed there were no significant 
alteration in the relative expression of PKA Rlla mRNA when compming 
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Figure 4.23 PKA RIIP mRNA Expression in Lamina I, of the Rat Lumbar 
Spinal Dorsal Horn in CCI (lpsilateral and Contralateral), Normal and 
Sham-Operated Rats 
Highpower lightfield, black and white photomicrographs showing typical levels of 
PKA RIIP mRNA expression in the mediolateral area of lamina I of rat lumbar spinal 
dorsal horn (scale bar lOµm). Photomicrographs show typical examples of the 
expression ipsilateral and contralateral to nerve injury and in normal and sham-
operated control rats respectively. Positively labelled neurones were identified by a 
dense accumulation of silver grains (approximately> 5 times background 
expression) over and around haematoxylin stained nuclei . 
Analysis of quantitative densitometry data demonstrated no significant alteration in 
the expression of PKA RIIB mRNA ipsilateral to nerve injury when compared to 
contralateral and control tissue in the superficial laminae of the dorsal horn. There 
was also no significant differences between contralateral and control levels of mRNA 















Table 4.6 Mean Number of Dorsal Horn Neurones Positively Expressing 
PKA RII~ mRNA 
Summary table showing the average number of dorsal horn neurones within a 
graticule area of 175 x 175 µm2 positively expressing PKA RII(3 mRNA in lamina I, 
II, III, IV, and V in mediolateral and lateral locations of the dorsal horn. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and nmmal control values. 
The mean number of cells expressing mRNA for PKA RII(3 appeared unchanged 
ipsilateral to nerve injury in all laminae when compared to contralateral values and to 
normal and sham-operated values (one way ANOVA). For all laminae analysed 
there was no significant alteration in the relative expression of PKA RII(3 mRNA 
when compaiing contralateral CCI values to normal and sham-operated values (one 
way ANOVA). 
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Cell Counts per 175 x 175 µm2 
Mediolateral I Lateral 
lpsilateral Contra lateral Sham Normal lpsilateral Contra lateral Sham Normal 
Lamina I 13.3 ± 1.5 13.5 ± 1.9 14.2 ± 1.8 13.7 ± 1.7 12.2 ± 1.1 12.4 ± 1.6 12.7 ± 1.6 11 .9 ± 1.7 
Lamina II 15.4 ± 1.9 16.2 ± 1.8 15.2 ± 1.9 16.1 ± 1.7 14.6 ± 1.7 14.1 ± 1.4 15.2 ± 1.9 15.2 ± 1.6 
Lamina Ill 16.4 ± 1.9 16.9 ± 1.5 17.4 ± 1.8 16.9 ± 1.6 15.3 ± 1.9 16.1 ± 2.1 16.5 ± 1.9 15.2 ± 1.8 
Lamina IV 18.5 ± 2.4 18.4 ± 1.9 19.2 ± 2.1 18.6 ± 1.8 18.0 ± 1.9 17.5 ± 1.6 17.3 ± 1.4 17.5 ± 1.7 
Lamina V 17.5 ± 1.9 17.1 ± 2.3 17.4 ±1.9 18.2 ± 1.7 17.4 ± 1.4 17.7 ± 2.0 17.9 ± 1.7 16.7 ± 1.8 
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Figure 4.24 Mean Silver Grain Density of Dorsal Horn Neurones 
Positively Expressing PKA RIIJ3 mRNA 
Summary histogram showing the mean silver grain density for dorsal horn neurones 
positively expressing PKA RIIJ3 rnRNA in lamina I, II, III, IV and V in medioJateraJ 
and lateral locations of the spinal cord. 
Values ipsilateral to nerve injury are shown compared to contralateral, sham-
operated and normal control values. 
The relative silver grain density per positively expressing cell, indicative of the 
expression of PKA RIIJ3 mRNA, was unchanged ipsilateral to nerve injury in all 
laminae when compared to contralateral values and to normal and sham-operated 
values (one way ANOVA). For all laminae analysed there was no significant 
alteration in the relative expression of PKA RIIJ3 mRNA when comparing 
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4.5.3 Determination of Protein Levels of Catalytic Subunits and 
Regulatory Subunits of cAMP Dependent Protein Kinase A (PKA) 
Following CCI 
4.5.3.1 Catalytic Subunits of PKA (Ca and CP) 
In order to determine whether the increase in the expression of mRNA for the 
catalytic subunits of PKA leads to increased steady state levels of catalytic subunit 
protein in the lumbar spinal cord following CCI, Western blot analysis was carried 
out using an antibody which recognises both catalytic subunits of PKA (PKA Ccx/~; 
Table 2.1). These results are based on data obtained from a total of 12 rats (n=4 CCI, 
n=4 Sham and n=4 normal). Using materials and methods described in detail in the 
general procedures chapter (Chapter 2 section 2.3.8), western blots were can-ied out 
using the catalytic subunit specific antibody and an antibody specific to the 
established cel lular housekeeping enzyme GAPDH (Table 2.1). Samples were 
normalised in relation to protein leve ls and to GAPDH expression and values for 
Ccx/~ immunoreactivity were expressed as the percentage GAPDH expression 
(Figure 4.25). 
Quantitative densitometry of immunoreactive bands revealed an increase in the 
levels of both Ca and C~ in the spinal cord ipsilateral to nerve injury when 
compared to contralateral, sham-operated and nonnal values (*p :5 0 .05 Student's 
unpaired t-test; Figure 4.25). 
4.5.3.2 Regulatory Subunits of PKA (Ria, Rip, Rlla and RIP) 
In order to determine whether there was any alteration in the levels of protein for the 
regulatory subunits of PKA in the lumbar spinal cord fo llowing CCI, Western blot 
analysis was canied out using several antibodies. An antibody which recognises 
both type I regulatory subunits of PKA (Ria and RIP), (PKA-RI), an antibody which 
specifically recognises RIIP (PKA-RIIP) and an antibody specific to RIIa (PKA 
Rlla) (Table 2.1). These results were obtained from a total of 36 rats (n=l2 CCI, 
n=l2 sham-operated and n=l2 n01mal). Using materials and methods described 
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previously (Chapter2 section 2.3.8) western blots were carried out using the specific 
antibodies and an antibody specific to GAPDH. Samples were normalised in relation 
to GAPDH and values expressed as the percentage GAPDH expression (Figure 
4.26). 
Quantitative densitometry of immunoreactive bands revealed a contralateral decrease 
in the level of RI~ subunit protein when compared to normal and sham-operated 
values (*p:::; 0.05 Student's unpaired t-test; Figure 4.26) and no alterations in the 
levels of protein for Rlla or RII~ in the lumbar spinal cord following CCI surgery 
(Student's unpaired t-test; Figure 4.27 and 4.28). 
185 
Figure 4.25 Western Blot Analysis of PKA Catalytic Subunits (Ca and 
Cf3) and GAPDH Protein Expression in the Rat Lumbar Spinal Cord in 
CCI (lpsilateral and Contralateral), Normal and Sham-Operated Rats 
(A) Western blots of hemisected lumbar spinal cord tissue showing Ca (42kDA) 
and cp (53kDa) protein expression and the housekeeping protein GAPDH (36kDa). 
Scanner print-outs from ECL films show typical examples of Ca, cp and GAPDH 
expression within the same lanes. The positions of the molecular weight markers are 
shown. 
The expression of both Ca and cp protein ipsilateral to nerve injury (I) appeared 
consistently greater than that in contralateral (C), normal (N) and sham-operated (S) 
tissue. 
(B) Table represents Ca and cp expression as a percentage of GAPDH expression 
in terms of relative grey scale values fo llowing quantitative densitometry of ECL 
films. Data are presented as mean ± SEM (n=4) (* p ~ 0.05, compared to 
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Figure 4.26 PKA (Ria and RIP), and GAPDH Protein Expression in the 
Rat Lumbar Spinal Cord in CCI (lpsilateral and Contralateral), Normal 
and Sham-Operated Rats 
(A) Western blots of hemisected lumbar spinal cord tissue showing Ria ( 46kDa), 
RIP (52kDa) protein expression and the housekeeping protein GAPDH (36kDa). 
Scanner print-outs from the ECL films show typical examples of Rla, Rlf3 and 
GAPDH expression within the same lanes. The positions of the molecular weight 
markers are shown. 
The expression of Rlf3 protein in CCI tissue ipsilateral (I) and contralateral (C) to 
nerve injury appeared consistently decreased than that in no,mal (N) and sham-
operated (S) tissue. The expression of Ria protein ipsilateral to nerve injury (I) 
appeared unaltered when compared to that in contralateral (C), normal (N) and sham-
operated (S) tissue. 
(B) Table represents Ria and Rif3 expression as a percentage of GAPDH expression 
in terms of relative grey scale values following quantitative densitometry of ECL 
films. Data are presented as mean± SEM (n=4) (*p $ 0.05 compared to 
contralateral, sham-operated and normal rats Student's unpaired t-test). 
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Figure 4.27 Western Blot Analysis of Alla and GAPDH Protein 
Expression in the Rat Lumbar Spinal Cord in CCI (lpsilateral and 
Contralateral), Normal and Sham-Operated Rats 
(A) Western blots of hemisected lumbar spinal cord tissue showing Rlla (5 l kDa) 
protein expression and the housekeeping protein GAPDH (36kDa). Scanner print-
outs from the ECL films show typical examples of Rila and GAPDH expression 
within the same lanes. The positions of the molecular weight markers are shown. 
The expression of RIIa protein ipsilateral to nerve injury (I) appeared unaltered 
when compared to that in contralateral (C), normal (N) or sham-operated (S) tissue. 
(B) Table represents RIIcx. expression as a percentage of GAPDH expression in 
terms of relative grey scale values following quantitative densitometry of ECL films. 
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Figure 4.28 All~ and GAPDH Protein Expression in the Rat Lumbar 
Spinal Cord in CCI (lpsilateral and Contralateral) Normal and Sham-
Operated Rats 
(A) Western blots of hemisected lumbar spinal cord tissue showing RIIf3 (53kDa) 
protein expression and the housekeeping protein GAPDH (36kDa). Scanner print-
outs from the ECL films show typical examples of RIIf3 and GAPDH expression 
within the same lanes. The positions of the molecular weight markers are shown. 
The expression of RU~ protein ipsilateral to nerve injury (I) appeared unaltered when 
compared to that in contralateral (C), normal (N) or sham-operated (S) tissue. 
(B) Table represents Rllf3 expression as a percentage of GAPDH expression in terms 
of relative grey scale values following quantitative densitometry of ECL films. Data 
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4.6 Discussion 
There is considerable evidence that the underlying mechanisms of persistent pain 
after nerve injury result from long-term changes in nociceptive processing of 
pelipheral sensory neurones (peripheral sensitisation) and/or neurones of the CNS 
(central sensitisation). Many studies have focused on NMDA mediated long-term 
changes in the firing of dorsal horn neurones (eg. Woolf and Thompson, 1991). 
However, while ionotropic receptors may contribute to the initiation of pe1ipheral 
and central sensitisation, it seems likely that second messenger-activated changes in 
neuronal activity account for the maintenance of these conditions. The behaviour of 
all cells is governed by signalling systems that translate external information into a 
repertoire of internal signals (eg. second messenger systems and their downstream 
targets, such as voltage-gated and ligand-gated ion-channels and gene expression). 
Studies have provided evidence for a cont1ibution of specific second messenger 
pathways to the establishment of these prolonged changes in the excitability of dorsal 
horn neurones (Codene et al., 1993). 
Peripheral sensitisation may be evoked by a variety of inflammatory mediators. 
There is substantial evidence that the mechanism of prostaglandin-induced 
sensitisation of sensory neurones involves activation of the cAMP transduction 
casade (Taiwo et al., 1989; Taiwo and Levine, 1991; Hintgen et al., 1995; England et 
al., 1996; Kress et al., 1996; Malmberg et al., 1997). At the spinal cord level , several 
studies have demonstrated that the persistent pain states after nerve injury are 
sensitive to antagonists selective for the NMDA subtype of glutamate receptors 
(Coderre and Melzack, 1992; Nasstrom et al., 1992; Chaplan et al., 1997). The 
NMDA receptor is highly permeable to Ca2+ and several second messenger activated 
pathways have been implicated in NMDA receptor signalling. After stimulation, the 
second messenger-activated protein kinases may phosphorylate various substrate 
proteins such as ion channels, G-protein coupled receptors and other enzymes, to 
enhance neuronal function and pain signalling. Specifically, PKC and PKA have 
been implicated in the establishment of changes in excitability of neurones involved 
in nociceptive transmission (Taiwo et al. , 1989; Taiwo and Levine, 1991; Cerne et 
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al., 1992, 1993; Mao et al., 1993; Palecek et al., 1994; Lin et al. , 1996; Sluka et al., 
1997; Malmberg et al., 1997) 
Intrathecal injection of the PKA inhibitors H89 and myr-PKI (5-24) were caITied out 
to evaluate the contribution of the catalytic subunits of PKA to the maintenance of 
the abnormal behavioural responses that occur following CCI. H89 and myr-PKI (5-
24) specifically inhibit the catalytic subunits of PKA whilst Rp-cAMPs is a 
competitive inhibitor of the activation of PKA by cAMP and allows us to 
identification of the contribution of cAMP to PKA regulation following CCI. In rats 
at the peak of neuropathy intrathecal injection of H89, myr-PKI (5-24) and 
RpcAMPs significantly reversed the abnormal behavioural manifestations that 
develop following CCI and are believed to be indicative of neuropathic pain. This 
inhibition was specific to the ipsilateral limb and the agents showed no effect on the 
contralateral limb or baseline values in normal unoperated rats. Control intrathecal 
injection of vehicle and an inactive myristoylated peptide in CCI rats also had no 
effect. These results highlight the potential contribution of PKA catalytic activity to 
the abnormal behavioural responses that occur following nerve injury. They also 
demonstrate that the activation of PKA by cAMP makes a contribution. Thus 
cAMP-regulated PKA activity and potentially also unregulated PKA catalytic 
activity may contlibute to central sensit isation. The fact that the agents can reverse 
established sensitisation suggests that an active dynamic phosphorylation of key 
target substrates by enzymaticall y active PKA is likely to be an important component 
in maintaining central sensitisation. 
In situ hybridisation histochemistry and Western blot expeliments were canied out to 
investigate the levels of catalytic and regulatory subunits of PKA and dete1mine any 
alterations in the levels of expression of mRNA and protein in the dorsal horn of the 
spinal cord. The levels of expression of mRNA and protein for both PKA catalytic 
subunits (Ca and Cf3) were unilaterally increased in the ipsilateral dorsal horn, 
specifically in the superficial laminae (LI, II and ill). The supeificial laminae are 
regions where primary afferent A8 and C-polymodal nociceptors predominantly 
terminate. The expression of mRNA for the regulatory subunits of PKA (Ria, Rlf3, 
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RIIa and RIIl3) remained unaltered following CCI. However, Western blot analysis 
demonstrated a decrease of Ril3 protein levels following CCI. Interestingly it 
appears from the results that as well as the increase in the catalytic subunits of PKA 
within the superficial dorsal horn, which would presumably lead to an increase in the 
unrestrained catalytic activity of PKA within these dorsal horn neurones, there was 
also a decrease in the protein levels of the neurospecific isoform of a PKA regulatory 
subunit Ril3. Presumably this would lead to a further, and neurospecific imbalance in 
the inhibitory regulatory activity of PKA leading to a further increase in the levels of 
unrestrained catalytic activity following CCI. The altered expression of selective 
genes and protein products of PKA within this region of the dorsal horn suggests that 
prolonged functional changes in PKA activity may occur centrally following CCI. 
This apparent increase in PKA catalytic activity due to an alteration of the R:C ratio 
may contribute to the abnormal behavioural responses following CCI and together 
with the observations that spinally admjnistered inhibitors of PKA can substantially 
reverse these abnormal behavioural responses suggests that the sustained activation 
of PKA may be an integral mechanism underlying central sensitisation following 
CCI. 
These findings are consistent with other studies suggesting that PKA plays a role in 
prolonged changes in neuronal synaptic efficacy, which include studies of long-term 
potentiation (LTP) in the hippocampus (Frey et al., 1993; Huang et al., 1996) and 
long-term facilitat ion (LTF) in Aplysia (Byrne and Kandel , 1996; Kandel and 
Schwartz, 1982). The induction of LTP is presently thought to requi re both 
activation of NMDA receptors by synaptically released glutamate (Collingridge et 
al., 1983) and depolarization of the postsynaptic membrane (Gustafsson and 
Wigstrom, 1986). The biochemical cascades that lead to the associated form of LTP 
appear to be triggered by a surge of free Ca2+ ions in the post synaptic neurone after 
activation of NMDA receptor-gated Ca2+ conductances (Mayer et al. , 1984) and 
voltage dependent Ca2+ channels (Siegelbaum and Kandel, 1991). It is now well 
establ ished that increases in cAMP and the activation of PKA play a critical role in 
the induction of long-term synaptic, cellular and behavioural changes implicated in 
Long term facilitation in Aplysia (Bacskai et al., 1993), Drosophila (Davis et al. , 
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1995), honey bee (Fiala et al., 1999) and mice (Abel et al., 1997), and it has been 
demonstrated that PKA is specifically involved in the switch from short to long-te1m 
memory (Frank and Greenberg, 1994). Despite the differing circumstances in these 
quite distinct fo1ms of synaptic plasticity, PKA is a key factor in common that 
appears to play a crucial role in the sensitisation of responsiveness. 
During acquisition of the long-term process, serotonin, a facilitating neurotransmitter 
induces a persistent increase in cAMP dependent protein phosphorylation in sensory 
neurones (Sweatt and Kandel , 1989) and prolonged application or intracellular 
injection into the sensory neurone of cAMP produces long-te1m increases in synaptic 
strength (Schacher et al., 1988). PKA plays a critical role in the consolidation of 
long-term memory (Abel et al., 1997), and inhibition of PKA completely blocks the 
late phase of LTP (L-LTP) in hippocampal CAI neurones, and activators of PKA 
facilitate the neurones in a similar manner to LTP (Frey et al., 1993). It has been 
demonstrated that the amount of regulatory subunits of PKA is decreased when 
compared with catalytic subuni ts (Greenberg et al., 1987; Bergold et al., 1990), 
which results in an imbalance of the R:C ratio and subsequent persistent activation of 
the kinase. One of the key consequences of PKA activation is the activation of 
CREB which has been implicated in long-term memory formation in Aplysia 
(Bartsch et al., 1995, 1998 Dash et al. , 1990; Alberini et al., 1994) Drosophila (Yin et 
al., 1994; 1995) and rodents (Silva et al. , 1998). 
Studies using mice selectively lacking the gene encoding the neuronal specific 
isofo1m of the type I regulatory subunit (RIB) (Brandon et al., 1995) show normal 
responses in tests of acute nociception (Malmberg et al., 1997). In contrast, PKA 
RI~ mutant mice show a marked reduction of persistent pain after tissue injury (eg. 
second phase of the formalin test). The second phase of the formalin test is known to 
result from both inflammation-evoked p1imary afferent activity and from 
sensitisation of dorsal horn neurones (Dickenson and Sullivan, 1990; Puig and 
Sorkin, 1996). PKA RI~ mice also displayed reduced formalin evoked paw swelling 
suggesting the reduced pain behaviours may be a result of attenuated peripheral 
inflammation in the fo1malin test (Malmberg et al., 1997). However, in contrast to 
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our findings, PKA Rlf3 mutant mice also showed normal development of behavioural 
and anatomical changes in the spinal cord after pe1ipheral nerve injury. This lack of 
effect is difficult to interpret since Rlf3 is only one of several similar isoforms; 
secondly, the unconditional knockout may cause adaptive changes in other subunits 
or invoke alternative mechanisms and finally, the major role of PKA may be fulfilled 
by a constitutitively-active form of the enzyme, de-regulated by degeneration of the 
regulatory subunits. 
In summary, inhibitors of activated PKA can selectively inhibit neuropathic 
sensitisation, which is believed to underlie the development of neuropathic 
sensitisation following CCL Expression of the catalytic subunits of PKA is increased 
in the spinal dorsal horn ipsilateral to nerve injury, which taken together with the 
decrease in the neurospecific type-I regulatory subunit of PKA (Rif3) suggests that 
CCI leads to an imbalance in the R:C ratio and persistent activation of PKA catalytic 
activity. The decrease in Rlf3 protein levels observed following CCI, provides 
further evidence of the importance of Rif3 in nociceptive processing. These novel 
findings when considered with the substantial evidence implicating PKA in long-
term changes associated with memory formation suggest that persistent activation 
PKA following CCI may be important for the development of the increased neuronal 
excitability and persistent nociceptive processing. Parnllel studies examining LTF in 
Aplysia have demonstrated that the degradation of PKA regulatory subunits observed 
in the switch from sho1t to long term memory storage is due to targeted degradation 
by the ubiquitin proteasome system. The role of the ubiquitin proteasome system in 
nociceptive processing following CCI is addressed in chapter 5. 
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CHAPTER 5: THE ROLE OF THE UBIQUITIN-PROTEASOME 
SYSTEM IN NEUROPATHIC PAIN 
5.1 The Ubiquitin-Proteasome System 
The ubiquitin-proteasome system is involved in various cellular functions including 
degradation of obsolete abnormal or damaged proteins (Hershko and Ciechanover, 
1982), regulation of the cell cycle by degradation of cyclin dependent kinases 
(Hershko et al., 1994), and regulation of signal transduction by the degradation of 
pathway components, for example the regulatory subunits of PKA (Chain et al., 
1999). Intracellular protein degradation is a highly selective process. Some proteins 
are degraded within mjnutes, while others are practical ly stable (Coux et al., 1996). 
Usually, regulatory proteins or enzymes have fast turnover rates so that their levels 
can be rapidly changed in response to appropliate stimuli. In some cases, the rates of 
degradation of regulatory proteins are control led with high precision. In the 
ubiquitin-proteasome system, proteins destined for degradation are ligated to the 
polypeptide ubiquitin , and then are degraded by a specific protease complex that acts 
on ubiquitinated proteins. 
Ubiquitination is a three-step process. First, ubiquitin is activated by a ubiquitin 
activating enzyme (El). El is the first enzyme in the ubiquitination process. In the 
presence of ATP and magnesium El forms a high-energy thiol ester bond with 
ubiquitin (Haas et al., 1982; Hershko and Ciechanover, l 992). The activated 
ubiquitin is then transfeJTed to a ubiquitin canier protein (E2). E2 proteins are a 
family of enzymes which shuttle ubiquitin between El and protein substrates or E3 
proteins. More than a dozen E2 enzymes have been identified (Jentsch, 1992). 
Different E2 enzymes may have different functions and different substrate specificity 
(Pickart and Rose, 1985; Pickart and Vella, 1988; Hershko and Ciechanover, 1992; 
Jentsch, 1992; Wing et al., 1992). Finally, ubiquitin is conjugated to a protein 
substrate by forming an isopeptide bond between the C-terminal glycine residue of 
ubiquitin and the amino terminal lysine residue of the protein substrate (Gregori et 
al., 1990). This conjugation step requires a ubiquitin protein ligase enzyme (E3). 
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Multiple molecules of ubiquitin can be ligated to a protein substrate to form poly-
ubiquitin chains (Chau et al., 1989). Polyubiquitinated proteins are targets for 
degradation by the proteasome, a large multi subunit particle found in the nucleus 
and cytoplasm of eukaryote cells known as the 26S proteasome. The 26S 
proteasome is composed of a 20S catalytic core and a 19S regulatory complex (Coux 
et al., 1996). 
5.2 Ubiquitin Carboxyl-Terminal Hydrolases (UCHs) 
Essential to the operation of the ubiquitin system is the recycling of free ubiquitin. 
Ubiquitin carboxyl-tenninal hydrolase (UCB) is required to release ubiquitin from 
linkage with the protein substrate (Figure 5.1). UCHs are a class of smal l 
cytoplasmic thiol proteases with specificity for cleavage of small esters and amides 
of the carboxyl-termina l g lycine of ubiquitin. In addition, UCB isopeptidase activity 
may be expected to disassemble polyubiquitin chains linked to the protein substrate, 
following the degradation of the protein. Several UCHs have been characterised: 
UCH-Ll is among the most abundant prote ins of brain, constituting from 1 to 5 % of 
the soluble protein. It is a cytoplasmic protein of 212 amino acids (Day et al., 1989); 
a neuronal-specific protein strongly expressed in neuronal, neuroendocrine, and 
perhaps some feta! cells. Isozyme L3 is present mainly in haemopoietic cells and 
many tissues and cells contain isozyme L2, which appears to be a "housekeeping" 
isozyme (Wilkinson et al., 1992). The expression ofUCHs appear to be highly tissue 
specific, suggesting the role of ubiquitination may vary with tissue type or 
differentiation. 
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Figure 5.1 The Ubiquitin-Proteasome System 
Conjugation of ubiquitin to the target protein 
1) Activation of ubiquitin by El. 
2) Transfer of the activated ubiquitin moiety to a member of the E2 family of 
enzymes. 
3) Formation of a binary complex between E3 and the protein substrate. 
4) Formation of a ternary E2-E3-protein substrate complex and transfer of the 
activated ubiquitin moiety from E2 to E3. 
5) Synthesis of protein substrate-anchored polyubiquitin chain. 
6) Recycling of E2 and E3. 
Degradation of the polyubiquitin-conjugated substrate by the proteasome 
7) Transfer of the protein substrate-ubiquitin adduct to the ubiquitin proteasome, 
and subsequent proteolysis of the protein substrate into constituent amino acids. 
8) Recycling of ubiquitin by ubiquitin C-terminal hydrolases (isopeptidases). 
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Modified from Ciechanover and Schwartz, 1998 
202 
5.3 The Ubiquitin-Proteasome System in Sensory Transmission 
The results in chapter 4 highlighted a potential role for PKA in neuropathic pain 
following peripheral nerve injury. Activation of PKA also plays an important role in 
producing long term facilitation (LTF) in Aplysia sensory neurones. In the LTF 
model, pre-synaptic facilitation of sensory to motor synapses is thought to underlie 
behavioural sensitisation, a modification of defensive reflexes that is considered a 
simple form of memory (Byrne and Kandel , 1996; Greenberg et a l., 1987). 
Sustained sensory neurone activation induces the dissociation of PKA regulatory 
subunits and the translocation of the constitutively active free catalytic subunits to 
the cell nucleus. A stable change in the R:C ratio is believed to account for the long 
lasting persistent activation of the kinase seen in LTF, and implies the existence of an 
important mechanism for regulating the ratio of PK.A subunits. 
In Aplysia sensory neurones there is increasing evidence suggesting that the 
ubiquitin-proteasome system plays a vital role in the regulation of PK.A activity by a 
mechanism involving generation of persistently active autonomous PKA (Chain et 
al., 1999; Hegde et al., 1997). The ubiquitin-proteasome system is a major non-
lysosomal proteolytic pathway that degrades diverse cellular proteins, including a 
number of proteins with impo1tant roles in the regulation of cell growth or function. 
The functional activity of the proteasome is enhanced by the UCH family of 
isopeptidases (for example UCH-Ll), which appear to play a crucial role in 
maintaining activity by preventing accumulation of inhibitory polyubiquitin chains 
(Wilkinson, 1997). Hegde et al., (1997) demonstrated that the induction of UCH in 
Aplysia is impo11ant for LTF and the hydro lase enhances proteasome-mediated 
substrate degradation in vitro. The ubiquitin-proteasome system appears to regulate 
PK.A activity by degrading its regulatory subunits, which normally maintain PKA in 
an inactive state. Stimulus-induced degradation of PK.A regulatory subunits is thus 
thought to lead to persistent activation of the kinase and maintenance of the synapse 
in a facilitated state until cAMP is provided (Greenberg et al. , 1987; Chain et al., 
1999). Therefore, protein degradation by this pathway is considered to be important 
for the control of PKA activity observed in the switch from short to long term 
facilitation and the establishment of a persistently active PKA (Hegde et al., 1993). 
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5.4 Aims of the Present Experiments 
Given the role of targeted proteolysis of the R subunits of PKA in LTF in Aplysia, 
and the similarities between the role of PKA in LTF and central sensitisation, 
experiments sought to identify the possible contribution made by the ubiquitin-
proteasome system to the persistent activation of PKA observed in central 
sensitisation following peripheral nerve injury and in the maintenance of abnormal 
behaviours following CCI. The effects of selective inhibitors of the ubiquitin-
proteasome system were examined on the sustained firing of dorsal horn neurones 
and on reflex withdrawal responses. The levels of the rat homologue of Aplysia 
UCH (UCH-Ll) were also examined at both the mRNA level and protein level. 
10-14 days following CCI surgery, electrophysiological techniques were employed 
to determine the role of the ubiquitin-proteasome system in the transmission of 
sensory information. Extracellular recordings were made from individual spinal 
dorsal horn neurones while inhibitors of the proteasome (MG-132 and lactacystin) 
were ionophoretically applied nearby. Neuronal activity was induced by (i) light 
brushing of the cutaneous receptive field, (ii) cold stimulation via a thern1al Peltier 
probe or (iii) topical application of the chemical algogen mustard oil. 
To assess the contribution of the ubiquitin-proteasome system in the maintenance of 
thermal hyperalgesia, mechanical and cold allodynia following CCI the effects of 
spinally administered proteasome inhibitors were examined. In conscious rats, 
inhibitors of the ubiquitin-proteasome system (MG-132 and epoxomicin) were 
administered intrathecally 10-14 days following CCI surgery (at the peak of 
behavioural changes) and reflex withdrawal responses to heat, mechanical and cold 
stimuli were recorded. Responses were also obtained from nmmal rats for 
comparison. 
To assess any alterations in the levels of expression of UCH-Ll in the lumbar dorsal 
horn following CCI, in situ hybridisation histochemistry and Western blot analysis of 
the expression of mRNA and protein for UCH-Ll were carried out. Levels of UCH-
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Ll mRNA and protein were also measured in the lumbar dorsal horn of CCI rats and 
normal and sham-operated rats. The methods are described in detail in chapter 2. 
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5.5 Results 
5.5.1 Sensory Responses of Single Dorsal Horn Neurones: Application 
of Inhibitors of the Proteasome Complex 
These results are based on data obtained from a total of 35 neurones in 35 rats,(n=l3 
CCI, n= l 5 normal and n=7 sham-operated). Extracellular recordings were made 
from single dorsal horn neurones situated in lamina IH-V. Microelectrode depths 
ranged from 200- lOOOµm from the surface of the spinal cord, which was measured 
using electrode contact at the dorsal surface and dye spot deposition in histological 
sections following experimentation. 
Multireceptive neurones were studied in this investigation. To facilitate neuronal 
classification and to obtain sustained neuronal activation following mustard oil 
application, only neurones with receptive fields on the hairy skin of the hind limb 
were investi gated, corresponding to the area innervated by the const1icted pa.it of the 
sciatic nerve (Schmalbruch, 1986). 
5.5.1.1 Effects of Ubiquitin-Proteasome Inhibitors on Sustained 
Neuronal Firing Induced by Brush, Cold or Mustard Oil 
Application 
Neuronal firing was induced by stimulating the cutaneous receptive field using (i) a 
motorised rotating brush, (ii) a thermally maintained Peltier device or (iii) topical 
application of mustard oil. Generally 1 min of activity was recorded before 
ionophoresis of inhibitors commenced. Neuronal activation to either application of 
innocuous brush or mustard oil stimuli to the peripheral receptive field was found in 
the majority of neurones recorded. However, activation of neurones to cold stimuli 
(4°C) was only found in neuropathic animals, which is in agreement with the 
observation that it is only neuropathic animals that develop a paw withdrawal 
response to cold (Simone and Kajander, 1996). The spontaneous firing rates of 
neurones were low (l-2Hz) and those in response to the stimuli were between 12 and 
50Hz. For each neurone, in the majo1ity of cases, the rates of firing in response to 
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the different stimuli , prior to drug application, was within 15Hz. No significant 
change in activity was ever observed during control ejection of saline (up to 60nA 
for 5 min). 
5.5.1.2 Brush-Induced Activity 
In normal animals, ionophoretic application of the proteasome inhibitors lactacystin 
and MG-132 showed negligible effects when applied to the sustained brush-induced 
activity of dorsal horn neurones. However, application of lactacystin and MG-132 
significantly inhibited brush-induced activity of dorsaJ horn neurones, ipsilateral to 
the nerve injury in CCI animals (Figure 5.2). 
5.5.1.3 Cold-Induced Activity 
Over half of the dorsal horn neurones tested responded strongly to a cold stimulus. 
There was some variabil ity in the firing responses of the dorsal horn neurones tested, 
with some neurones being more susceptible to the decreasing temperature whi le 
others had a greater firing activity during the sustained cold response. However, all 
neurones used produced consistent responses following each cold stimulus, giving 
reproducible peaks of activity of 5-28Hz. The proteasome inhibitors lactacystin and 
MG-132 showed significant inhibitory effects when applied during the repeated cold-
induced activity (Figure 5.3). 
5.5.1 .4 Mustard Oil-Induced Activity 
In normal animals, ionophoretic application of the proteasome inhibitors lactacystin 
and MG-132 caused significant inhibition of mustard oil-induced activity of dorsal 
horn neurones. However, application of lactacystin and MG-132 inhibited mustard 
oil-induced activity to a consistently greater extent in CCI animals (Figure 5.4). 
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Table 5.1 is a summary table of the results indicating the overall effects of lactacystin 
and MG-1 32 on stimulus-evoked activity of dorsal horn neurones in normal, sham-
operated and neuropathic animals with analysis of the statistical significance of 
effects. 
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Figure 5.2 Effects of lonophoretic Application of the Proteasome 
Inhibitors Lactacystin and MG-132 on Sustained Brush-Induced 
Responses of Dorsal Horn Neurones in Normal and CCI Rats 
Records of ongoing firing of individual neurones are displayed as number of action 
potentials per second (A/s), integrated over lO00msec bins, plotted against time. 
Traces (A) and (B) show the observed lack of effect of ionophoretic application of 
selective proteasome inhibitors lactacystin and MG-132 on the sustained neuronal 
fiting induced by a motorised rotating brush in normal animals. Traces (C) and (D) 
show the inhibitory effect of ionophoretic application of lactacystin and MG-132 on 
brush-evoked activity in neuropathic animals. These results are typical for the 
neurones tested in this study. 
Drugs were ejected ionophoretically at l0nA increments from a minimum of lOnA 










10 20 I 30 I 40 I 50 1sonA1 
lactacystin 







I 10 I 20 I 30 I 40 I §9 1sonA1 
MG-132 
I 1 o I 20 I 30 I 40 I 50 I sonAI 
1 min 
Figure 5.3 Effects of lonophoretic Application of the Proteasome 
Inhibitors Lactacystin and MG-132 on Cold-Induced Firing of Dorsal 
Horn Neurones in CCI Rats 
Records of ongoing firing of individual neurones are displayed as number of action 
potentials per second (Ns), integrated over l 000msec bins, plotted against time. 
Traces (A) and (B) show the typical inhibitory effects of ionophoretic application of 
selective proteasome inhibitors lactacystin and MG-132 on 10s pulses of neuronal 
activity induced by repeated stimulation of the cutaneous receptive field by a cold 
Peltier device at 5°C (■). The X-axis breaks represent the 5 min recovery petiod 
required for neuronal firing rates to return to pre-drug control levels. These results 
are typical for the population of cells tested in this study. Intense responses to the 
cold stimulus were absent from non-neuropathic animals. 
Drugs were ejected ionophoretically at lOnA increments from a minimum of lOnA 




















Figure 5.4 Effects of lonophoretic Application of the Proteasome 
Inhibitors Lactacystin and MG-132 on Sustained Mustard Oil-Induced 
Activity of Dorsal Horn Neurones in Normal and CCI Rats 
Records of ongoing firing of individual neurones are displayed as number of action 
potentials per second (A/s), integrated over lO00msec bins, plotted against time. 
Traces (A) and (B) represent the significant inhibitory effects of ionophoretic 
application of selective proteasome inhibitors lactacystin and MG-132 respectively 
on the sustained mustard oil-induced neuronal filing in normal animals. Traces (C) 
and (D) represent CCI animals and showed an apparently increased inhibition of 
sustained mustard oil-induced activity following ionophoretic application of 
lactacystin and MG-132 respectively. Each trace is from a different neurone and is 
typical of the results obtained from these experiments. 
Drugs were ejected ionophoretical ly at lOnA increments from a minimum of lOnA 






























Table 5.1 Effects of lonophoretically Applied Proteasome Inhibitors on 
Sensory Responses of Single Dorsal Horn Neurones in Normal and CCI 
Rats 
Summarised data representing the effects of proteasome inhibitors lactacystin and 
MG-132 on single dorsal horn neurone sensory responses. Data is expressed as 
mean ± SEM together with number of cells recorded. The range of ionophoretic 
currents required to reach a steady state of depression of firing rate are indicated. 
Using mean firing rates over 15s time bins, the statistical sign ificance of differences 
between maximally inhibited firing rates in the presence of drug and fixing rates 
immediately prior to ionophoresis were calculated using Kruskal-Wallis one way 
ANOVA, fo llowed by D unn's post-hoe test(* p ~ 0.05). The range of ionophoretic 
currents requ ired to reach a maximal depression of firing rate are indicated. Further 
increases in currents beyond these values caused no greater inhibition. 
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Drug Condition % of Stimulus-Evoked Response Remaining 
Brush Mustard oil Cold 
Lactacysti n 87.5 ± 5.9 58.6 ± 7.1* 
Normal (n=8) (n=7) -
(10-60nA) (10-60nA) 
79.2 ± 1.6 50.1 ± 6.2* 
Sham (n=3) (n=4) -
(50-60nA) (10-40nA) 
60.8 ± 4.2* 34.1 ± 5.1 * 58.7 ± 4.7* 
CCI (n=4) (n=6) (n=3) 
(20-60nA) (20-40nA) (10-30nA) 
MG-132 76.4 ± 2.5 57.1 ± 8.8* 
Normal (n=4) (n=4) -
(10-40nA) (20-40nA) 
66.4 ± 5.4* 31.6 ± 2.1 * 48.3 ± 7.4* 
CCI (n=4) (n=7) (n=3) 
(30-60nA) (10-30nA) (10-30nA) 
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5.5.2 Effects of lntrathecal Administration of the Selective Proteasome 
Inhibitors MG-132 and Epoxomicin on Sensory Reflex Withdrawal 
Responses in Normal and CCI Rats 
Results were obtained from a total of 47 rats, (n=39 CCI and n=8 normal). 
Intrathecal administration of the selective proteasome inhibitors MG-132 and 
epoxomicin was carried out as described previously (chapter 2 section 2.3.4.). In rats 
exhibiting peak behavioural changes following CCI, both proteasome inhibitors 
significantly reversed the increased reflex withdrawal responses to noxious heat, 
innocuous mechanical stimulation and innocuous cold that are indicative of the1mal 
hyperalgesia, mechanical and cold allodynia respectively (Figure 5.5, 5.6 and 5.7). 
This inhibition was monitored over a 90 minute testing period. Control intrathecal 
administration of vehicle in CCI rats had no significant effect on reflex responses in 
all three sensory tests (Figure 5.5C, 5.6C and 5.7C) and administration of the 
proteasome inhi bitors in normal animals also had no significant effect (Figure 5.8, 
5.9). Intrathecal administration of the selective NF-KB inhibitor pa11helonide was 
carried out as a pilot investigation to assess the possibi lity of NF-KB involvement 
since the ubiquitin-proteasomal system can degrade the inhibitory partner 1-KB and 
lead to NF-KB (Figure 5. 10). 
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Figure 5.5 Effects of lntrathecal Administration of the Proteasome 
Inhibitors Epoxomicin, MG-132 and Vehicle on Reflex Withdrawal 
Responses to Noxious Heat in CCI Rats 
Data are represented as mean paw withdrawal latency (s) for ipsilateral and 
contralateral paws plotted against time (min) pre and post-injection. Arrow marks 
intrathecal drug administration. In rats exhibiting peak behavioural changes 
following CCI, paw withdrawal latency to noxious heat ipsilateral (but not 
contralateral) to nerve injury showed significant differences between pre- and post-
drug administration values (t p::; 0.05; one-way ANOVA followed by Neuman-
Keuls post-hoe test). Significant differences between contralateral and ipsi lateral 
paw withdrawal latency are indicated(* p::; 0.05; Student's paired t-test). (A) 
Effects of intrathecal administration of epoxomicin [0.75nmol in 50µ1], (n=8). (B) 
Effects of intrathecal administration of MG-132 [5nmol in 50µ1], (n=8). (C) Effects 
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Figure 5.6 Effects of lntrathecal Administration of the Proteasome 
Inhibitors Epoxomicin, MG-132 and Vehicle on Reflex Withdrawal 
Responses to Innocuous Mechanical Stimuli in CCI Rats 
Data are represented as mean paw withdrawal threshold (mN/mm2) for ipsilateral and 
contralateral paws plotted against time (min) pre and post-injection. Arrow marks 
intrathecal drug administration. In rats exhibiting peak behavioural changes 
following CCI, paw withdrawal threshold to innocuous mechanical stimulation 
ipsilateral (but not contralateral) to nerve injury showed significant differences 
between pre- and post-drug administration values (t p::;; 0.05; Kruskal-Wallis 
ANOVA followed by Dunn's post-hoe test). Significant differences between 
contralateral and ipsilateral paw withdrawal thresholds are indicated(* p::;; 0.05; 
Mann-Whitney U test). (A) Effects of intrathecal administration of epoxomicin 
[0.75nmol in 50µ1] , (n=8). (B) Effects of intrathecal administration of MG-132 
[5nmol in 50µ1] , (n=8). (C) Effects of intrathecal administration of vehicle (50µ1 of 
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Figure 5.7 Effects of lntrathecal Administration of the Proteasome 
Inhibitors Epoxomicin, MG-132 and Vehicle on Reflex Withdrawal 
Responses to Innocuous Cold Stimuli in CCI Rats 
Data are represented as mean suspended paw elevation time (SPET (s)) for ipsilateral 
and contralateral paws plotted against time (min) pre and post-injection. Arrow 
marks intrathecal drug administration. In rats exhibiting peak behavioural changes 
following CCI, suspended paw elevation time ipsilateral (but not contralateral) to 
nerve injury showed significant differences between pre- and post-drug 
administration values (t p::; 0.05; one-way ANOVA followed by Neuman-Keuls 
post-hoe test). Significant differences between contralateral and ipsilateral paw 
elevation time are indicated(* p::; 0.05; Student's paired t-test). (A) Effects of 
intrathecal administration of epoxomicin [0.75nmol in 50µ1], (n=8). (B) Effects of 
intrathecal administration of MG-132 [5nmol in 50µ1], (n=8). (C) Effects of 
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Figure 5.8 Effects of lntrathecal Administration of the Proteasome 
Inhibitor Epoxomicin on Reflex Withdrawal Responses to Noxious Heat 
and Innocuous Mechanical Stimuli in Normal Rats 
Data are represented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN/mm2) to innocuous mechanical stimuli (B) for 
ipsilateral and contralateral paws plotted against time (min) pre and post-injection. 
Arrow marks intrathecal drug administration. 
In normal unoperated rats, paw withdrawal latency to noxious heat and paw 
withdrawal threshold to innocuous mechanical stimulation was unaltered following 
intrathecal administration of epoxomicin. Epoxomicin was administered at a dose of 
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Figure 5.9 Effects of lntrathecal Administration of the Proteasome 
Inhibitor MG-132 on Reflex Withdrawal Responses to Noxious Heat and 
Innocuous Mechanical Stimuli in Normal Rats 
Data are represented as mean paw withdrawal latency (s) from noxious heat (A), and 
mean paw withdrawal threshold (mN/mm2) to innocuous mechanical stimuli (B) for 
ipsilateral and contralateral paws plotted against time (min) pre and post-injection. 
Arrow marks intrathecal drug admfoistration. 
In normal unoperated rats, paw withdrawal latency to noxious heat and paw 
withdrawal threshold to innocuous mechanical stimulation was unaltered fo)lowing 
intrathecal administration of MG-132. MG-132 was administered at a dose of 
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Figure 5.10 Effects of lntrathecal Administration of the NF-KB Inhibitor 
Parthelonide on Reflex Withdrawal Responses to Noxious Heat and 
Innocuous Mechanical Stimuli in CCI Rats 
Data are represented as mean paw withdrawal latency (s) to noxious heat (A), and 
mean paw withdrawal threshold (mN/mm2) to innocuous mechanical stimuli (B) for 
ipsilateral and contralateral paws plotted against time (min) pre and post-injection. 
AJTow marks intrathecal drug administration. 
(A) In rats exhibiting peak behavioural changes following CCI, paw withdrawal 
latency to noxious heat ipsilateral (or contralateral) to nerve injury showed no 
significant differences between pre- and post-drug administration values (one way 
ANOVA). Significant differences between contralateral and ipsilatera1 paw 
withdrawal latency and paw withdrawal latencies are indicated(* p ~ 0.05; Student' s 
paired t-test). Parthelonide was administered at a dose of [1.5nmol in 50µ1] , (n=3). 
(B) In rats exhibiting peak behavioural changes following CCI, paw withdrawal 
threshold to innocuous mechanical stimuli ipsilateral (or contralateral) showed no 
significant differences between pre- and post-drug administration values (Kruskal-
Wallis ANOVA). Significant differences between contralateral and ipsilateral paw 
withdrawal thresholds are indicated(* p ~ 0.05, Mann-Whitney U test). Parthelonide 
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5.5.3 Regulation of Constitutive Spinal Cord PKA Activity by the 
Ubiquitin-Proteasome System 
In order to obtain a read-out of the function of the ubiquitin-proteasome system in 
spinal cord, PKA enzymatic activity was monitored, the activity of which is known 
to be regulated through degradation of the regulatory subunits by the proteasome 
(Hegde et al., 1997; Chain et al., 1999). Degradation of regulatory subunits, leaving 
a relative excess of unrestrained catalytic subunits is thought to lead to an elevated 
level of constitutive enzyme activity, which can be monitored by ex vivo enzyme 
assays (Roskoski, 1983). Table 3 shows that the fraction of PKA activity that was 
constitutive was elevated in spinal cord ipsilateral to CCI, and that this elevation was 
prevented by local admin istration of the selective proteasome inhibitors epoxomicin 
and MG-132 to the spinal cord. This matches other molecular and physiological data 
in suggesting that the activity of the ubiquitin-proteasome system is elevated in 
response to nerve injury. 
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Table 5.2. Effects of Topical Administration of the Proteasome 
Inhibitors Epoxomicin and MG-132 on Constitutive Activation of Protein 
Kinase A (PKA) Induced by CCI 
Following topical administration under anaesthesia of 500 µI epoxomicin (15 µM), 
MG-132 (100 µM) or vehicle (0.5% dimethylfonnamide in saline), relevant spinal 
segments were removed and hemisected, before homogenisation in cold buffer. 
Samples were assayed for authentic PKA [33P] phosphotransferase activity under 
constitutive and maximal cAMP-evoked conditions. Total authentic PKA activity 
was in the order of 100-200 pmol/min/mg tissue under these conditions and similar 
between ipsilateral and contralateral CCI tissue. Values are expressed as means± 
SEM (n=6-8). 
* indicates significantly greater than coJTesponding contralateral CCI values and 
no1mal control values (p ~ 0.05), Wilcoxon test and Mann-Whitney U test 
respectively. t indicates significantly less than corresponding vehicle-treated tissue 
ipsilateral to CCI (p ~ 0.05 Mann-Whitney U-test). 
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PKA Activity of Spinal Cord Homogenates 
(Constitutive Activity as % of Total) 
Topical Administration Normal control CCI 
lpsilateral Contra lateral 
Nil 9.5 ± 1.0 15.7 ± 1.2 * 8.5 ± 0.5 
Vehicle 7.9 ± 0.8 14.4 ± 1.5 *t 9.1 ± 0.5 
Epoxomicin 8.4 ± 1.0 9.9 ± 0.8 t 8.1 ± 1.1 
MG-132 - 7.8 ± 0.2 t 8.6 ± 0.5 
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5.5.4 Distribution of mRNA for UCH-L 1 Within the Spinal Dorsal Horn 
of Normal and CCI Rats 
In accordance with the wide expression of UCH protein throughout eukaryotic cell 
types and in line with its role in the activity of the multifunctional proteasome 
pathway, the mRNA for the rat homologue of mammalian UCH neuronal isozyme 
UCH-Ll was distributed widely in spinal cord of both n01mal and neuropathic 
animals. Following CCI of the rat sciatic nerve, changes in the expression of mRNA 
for UCH-Ll were apparent in the dorsal horn ipsilateral to nerve injury. When 
compared to contralateral and control values, the total number of neurones positively 
expressing mRNA for UCH-Ll was significantly increased in the ipsilateral dorsal 
horn, both mediolaterally in laminae I, II and 111 and laterally in laminae I and II 
(Table 5.3, Figure 5.11). Silver grain density was significantly increased 
mediolaterally in laminae I, II, III and V, and laterally in laminae I, II and III (Figure 
5.12). There were no significant differences in either cell counts or si lver grain 
densities between contralateral and normal values. Within the ventral horn of nonnal 
animals, labelling of motoneurones was especially intense, but showed no significant 
change following CCI treatment. 
5.5.4.1 Controls 
To ve1ify the sensitivity of both the oligonucleotide for UCH-Ll and the assay 
conditions control experiments were carried out using sections pre-treated with 
Rnase A (section 2.3.7.8). No positively labelled cells were detected in these spinal 
cord sections. This treatment produced a low and even background dist1ibution of 
silver grains equivalent to the non-specific background observed in the positive 
controls (data not shown). 
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Figure 5.11 UCH-L 1 Subunit mRNA Expression in Lamina I, Ill and 
Motoneurones of the Rat Lumbar Spinal Dorsal Horn in CCI (lpsilateral 
and Contralateral), Normal and Sham-Operated Rats 
Highpower lightfield, black and white photomicrographs showing typical levels of 
UCH-Ll mRNA expression in the mediolateraJ area of lamina I and III and 
motoneurones of rat lumbar spinal dorsal horn (scale bars lOµm). Photomicrographs 
show typical examples of the expression ipsilateral and contralateral to nerve injury 
and in normal control rats respectively. Positively labelled neurones were identified 
by a dense accumulation of silver grains (approximately >5 times background 
expression) over and around haematoxylin stained nuclei. 
Analysis of quantitative densitometry data demonstrated a significant increase in the 
expression of UCH-Ll subunit mRNA ipsilateral to nerve injury when compared to 
contralateral and control tissue in the superficial laminae of the dorsal horn (A). 
However, in motoneurones (B) there was no significant alteration in the expression 
of UCH-Ll mRNA ipsilateral to nerve injury when compared to contralateral as 
revealed by cell counts and silver grain density. There were no significant 
differences between contralateral and control levels of mRNA expression as revealed 









































Table 5.3 Mean Number of Dorsal Horn Neurones Positively Expressing 
UCH-L1 mRNA 
Summary table showing the average number of dorsal horn neurones within a 
graticule area of l 75-l 75µm2 positively expressing UCH-L l mRNA in lamina I, II, 
III, IV, and V in mediolateral and lateral locations of the dorsal horn. 
Values ipsilateral to nerve injury are shown compared to contralateral sham-operated 
and normal control values. 
The mean number of cells expressing mRNA for UCH-Ll was significantly 
increased ipsilateral to nerve injury in laminae I, II and III(* p ~ 0.05; Kruskal-
Wallis ANOVA followed by Dunn's post-hoe test) with no significant change in 
laminae IV and V when compared to contralateral values and to normal, unoperated 
values. For all laminae analysed there was no significant alteration in the relative 
expression of UCH-Ll mRNA when comparing contralateral values to normal 
values. 
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Cell Counts per 175 x 175 µm2 
Mediolateral Lateral 
lpsilateral Contra lateral Normal lpsilateral Contra lateral Normal 
Lamina I 35.5 ± 1.2 * 26.6 ± 0.5 25.9 ± 1.1 32.2 ± 1.4 * 24.4 ± 1.1 22.5 ± 2.5 
Lamina II 35.2 ± 1.8 * 25.5 ± 1.2 25.5 ± 1.4 34.2 ± 1.8 * 28.2 ± 2.1 30.1 ± 1.3 
Lamina Ill 37.1 ± 1.9 * 30.5 ± 1.2 30.5 ± 1.5 36.5 ± 3.1 32.5 ± 2.5 35.6 ± 2.2 
Lamina IV 42.2 ± 2.2 38.2 ± 3.2 38.8 ± 3.4 41.1 ± 2.1 40.5 ± 1.4 40.1 ± 1.3 
Lamina V 38.9 ± 1.4 36.5 ± 1.8 37.5 ± 2.2 32.5 ± 1.2 32.1 ± 0.6 32.4 ± 1.0 
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Figure 5.12 Mean Silver Grain Density of Dorsal Horn Neurones 
Positively Expressing UCH-L 1 mRNA 
Summary histogram showing the mean silver grain density for dorsal horn neurones 
positively expressing UCH-Ll rnRNA in lamina I, II, III, IV and V in mediolateral 
and lateral locations of the spinal cord. 
Values ipsilateral to nerve injury are shown compared to contralateral and normal 
control values. 
The relative silver grain density per positively expressing cell, indicative of the 
expression of UCH-Ll rnRNA, was significantly increased ipsilateral to nerve injury 
in lamina I, II, III (and mediolateral V) (*p::;; 0.05, Kruskal-Wallis ANOVA followed 
by Dunn's post-hoe test) but was unaltered in lamina IV and (and lateral V) when 
compared to contralateral values and to normal, unoperated values. For all laminae 
analysed, there was no significant alteration in the relative expression of UCH-Ll 
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5.5.5 Determination of Protein Levels of UCH-L 1 Following CCI 
In order to dete1mine whether the increase in UCH-Ll rnRNA following CCI leads 
to an overall increase in the translation of its protein product, Western blot analysis 
was carried out. 
Results were obtained from a total of (12) rats (n=4 CCI, n=4 sham-operated and n=4 
normal). Using mate1ials and methods described in detail elsewhere (chapter 2, 
section 2.3.8.5). Spinal cord samples were homogenised and SDS-PAGE canied out 
to resolve the protein bands. Following transfer to PVDF, blots were probed using a 
HRP-conjugated p1imary antibody specific to UCH-Ll (Table 2.1) and a HRP-
conjugated secondary antibody with visuali sation by ECL. Blots were also probed 
with an antibody specific to the ubiquitous ce llular housekeeper enzyme GAPDH 
(Table 2.1). Samples were normalised in relation to GAPDH and values expressed 
as the percentage GAPDH expression (Figure 5.13). 
Densitometry of immunoreactive bands revealed an increase in the levels of UCH-Ll 
in the spinal cord ipsilateral nerve injury when compared to contralateral, sham-
operated and normal sample values (Figure 5.13). 
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Figure 5.13 Western Blot Analysis of UCH-L 1 and GAPDH Protein 
Expression in the Rat Lumbar Spinal Cord in CCI (lpsilateral and 
Contralateral), Normal and Sham-Operated Rats 
(A) Western blots of hemisected lumbar spinal cord tissue showing UCH-Ll 
(29kDa) protein expression and the housekeeping protein GAPDH (36kDa). Scanner 
print-outs from the ECL films show typical examples of UCH-Ll and GAPDH 
expression within the same lanes. The positions of the molecular weight markers are 
shown. The expression of UCH-Ll protein ipsilateral to nerve injury (I) appeared 
consistently greater than that in contralateral (C), normal (N) and sham-operated (S) 
tissue. 
(B) Table represents UCH-Ll expression as a percentage of GAPDH expression in 
terms of relative grey scale values following quantitative densitometry of ECL films. 
Data are presented as mean ± SEM (n=4). * p ~ 0.05 Student's unpaired t-test 
compared to contralateral, sham-operated and normal rats. 
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A UCH-L1 GAPDH 
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- 32kDa 
B 
UCH-L 1 lmmunoreactivity (% of GAPDH) 
lpsilateral Contra lateral Normal Sham 
112±10.6* 85.4 ± 11.1 88.2 ± 3.0 85.7 ± 7.3 
Mean ± SEM 
5.6 Discussion 
Injury in afferent nerves can elici t their sustained firing and result in phenotypic and 
functional changes both within dorsal root ganglia and in the dorsal horn of the 
spinal cord. The resulting state of central sensitisation plays a key role in bringing 
about the hyperalgesia and allodynia, as well as sensitivity to cold, that characterise 
neuropathic pain states. PKA is implicated in spinal sensitisation and pain (Ceme et 
al., 1993; Sluka, 1997) and evidence presented in chapter 4 suggests that PKA may 
play a role in the central sensitisation that follows peripheral nerve injury. The 
increase in the activity of PKA demonstrated in the previous chapter may be in pait 
due to an increase in the levels of the catalytic subunits and the parallel decrease in 
the levels of the regulatory subunit(s) of PKA. A stable change in the R:C ratio may 
lead to a long lasting and persistent activation of the kinase as seen in long-term 
facilitation in Aplysia sensory neurones (Hegde et al., 1997; Chain et al., 1999), and 
implies the existence of an important mechanism for regulating the ratio of PKA 
subunits. Results show that targeted proteolysis by the ubiquitin-proteasome system 
(involving in part processes that bring about constitutive activation of PKA) is an 
essential component of the cellular mechanisms underlying neuropathic sensitisation 
fo llowing CCI. 
The proteasome appears to contribute to the no1mal spinal processing of noxious but 
not innocuous sensory stimuli as dorsal horn neurone filing induced by the 
application of mustard oil was inhibited by both MG-132 and lactacystin, and 
responses to innocuous brush evoked activity were unaffected in normal rats. After 
CCI, previously innocuous stimuli such as brush and cold elicited greatly 
accentuated responses in dorsal horn neurones. These responses displayed sensitivity 
to blockade by the proteasome inhibitors MG-132 and lactacystin, which specifically 
inhibited dorsal horn neurone firing in response to cold, brush and mustard oil-
induced activity. Intrathecal administration of the proteasome inhibitors MG-132 
and epoxomicin in rats exhibiting peak behavioural changes following CCI, 
dramatically attenuated reflex withdrawal responses to noxious heat, mechanical 
stimulation and cold with no effect in normal unoperated rats. The contribution of 
the ubiquitin-proteasome system to sensitisation was paralleled by increased 
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expression (ipsilateral to nerve injury) of mRNA for UCH-Ll, as analysed using 
ISHH, and increased levels of immunoreactive UCH-Ll protein as measured by 
Western blot. 
Aspects of the change into a potentiated sensory system that occur following nerve 
injury appear to parallel the activity-dependent changes that contribute to the 
persistence of both LTF in Aplysia sensory neurones and LTP in central mammalian 
neurones. This implies that spinal neuropathic sensitisation may constitute a form of 
pain "memory". Although the precise nature and origin of the alterations in LTF and 
LTP differ from those here, they may share a number of common features with the 
central sensitisation that occurs within the spinal cord in response to chronic 
activation of nociceptive inputs. Activity-dependent synaptic changes associated 
with altered states of responsiveness and "synaptic memory" have been investigated 
in LTF (Bailey and Kandel, 1993) and LTP (Bliss and Colling1idge, 1993). 
The contribution of the ubiquitin-proteasome system here, particularly the ubiquitin 
recycling enzyme UCH-Ll is consistent with experimental evidence investigating the 
contribution of the ubiquitin-proteasome system in LTF in Aplysia (Hegde et al., 
1997; Chain et al., 1999). The steady state elevation of UCH-Ll expression 
observed here is less than the acute rise seen within 4 hours following LTF in Aplysia 
(Hegde et al. , 1997). This may relate in part to the higher basal levels of UCH-Ll in 
mammalian neurones (Wilkinson et al. , 1989). Furthermore, the CCI sensitisation 
model differs from LTF in that changes in spinal neuronal function develop slowly 
and are maintained over many days. If optimal UCH-Ll activity is required for 
operation of the ubiquitin-proteasome system, and this pathway plays a greater 
functional role following CCI (as demonstrated) then even small changes in UCH-Ll 
may be functionally significant. 
UCH-Ll plays an essential role in the turnover of ubiquitin tags, which is necessary 
to maintain adequate rates of proteasome-mediated degradation of proteins. The 
regulatory subunits of PKA are an example of such a known proteasome target. 
Elevated levels of cAMP lead to the dissociation of the regulatory and catalytic 
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subunits of PKA, which in tum leads to the activation of PKA. PKA remains active 
until cAMP returns to basal levels, largely due to the action of phosphodiesterases, 
and the regulatory and catalytic subunits of PKA reassociate. Degradation of the 
regulatory subunits of PKA by the ubiquitin-proteasome system is thought to lead to 
the formation of persistently active PKA that is no longer dependent on elevated 
levels of cAMP (Bergold et al., 1990; Hegde et al., 1993). These two forms of 
regulation of PKA activity are likely to operate in conceit. 
In the LTF model in Aplysia, PKA appears to play a key role in increased 
responsiveness and substantial evidence indicates that an imbalance of PKA 
regulatory and catalytic subunits, mediated by proteasome degradation of the former, 
is a crucial factor (Hegde et al., 1993; Chain et al. , 1999). The authors speculate that 
Aplysia UCH (Ap-UCH) is required for degradation of the inhibitory regulatory 
subunit of PKA, and that the resultant activation of PKA leads to transcriptional 
activation of numerous CREE-responsive genes necessary for the persistence of the 
"learned" behaviour. Thus, the increase in UCH activity upon 5-HT treatment may 
relieve the inhibition of the regulatory subunit and al low more efficient degradation 
of the regulatory subunit of PKA, leading to the persistent activation of PKA (Hegde 
et al., 1993; Chain et al., 1999). The dissociation of the PKA holoenzyme is 
necessary but not sufficient for degradation by the ubiquitin-proteasome system 
(Chain et al. , 1999). A high concentration of cAMP is initially required to convert 
the normally stable regulatory subunit into a substrate for ubiquitin ligation, and 
because in Aplysia sensory neurones the levels of cAMP are elevated for relatively 
short pe1iods, the degradation of the regulatory subunits is an essential stage in the 
generation of a persistently active kinase (Chain et al., 1999). This matches c losely 
the proteasome-dependent generation of constitutively active PKA observed in the 
present study ipsilateral to CCI that was prevented by proteasome inhibitors. In the 
Aplysia model, expression of the homologue of UCH-Ll is rapidly increased in the 
facilitation paradigm (Hegde et al., 1997), again closely paralleling the observations 
here with neuropathic sensitisation, except that the full development of the sensitised 
state here occurs over a more prolonged time period. 
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The rapid and marked inhibition by ubiquitin-proteasome inhibitors of the abnormal 
behavioural responses both electrophysiologically and by intrathecal administration 
suggests two things. Firstly that the ubiquitin-proteasome system is involved in the 
mechanisms underpinning neuropathic sensitisation, and secondly that ubiquitin 
proteasomal degradation is imp011ant at the peak of neuropathy. This data taken with 
the observation that mRNA and protein levels for UCH-Ll are raised during peak 
behavioural changes following CCI suggests that protein degradation via the 
ubiquitin-proteasome system may contribute to the cellular mechanisms that 
maintain neuropathic sensitisation at the peak of neuropathy. 
An obvious target for this degradation may be the regulatory subunit of PKA as 
discussed. However, there are also several other serine/threonine kinases that are 
thought to become activated in LTF sensitisation: eg. ca2+, calrnodulin-dependent 
protein kinase (CaM k.inase) (Yamamoto et al., 1999), protein kinase C (PKC) 
(Sacktor and Schwartz, 1990; Sossin et al. , 1994) and rnitogen-activated protein 
kinase (MAP kinase) (Michael et al. , 1998). The catalytic subunits of PKA and 
activated MAP kinase (Ma11in et al. , 1997) may be impo11ed into the nucleus and 
phosphorylate transcription factors , which then initiate gene expression (Dash et al., 
1990; Bartsch et al., 1998), wi th the resultant upregulation of genes such as the gene 
encoding UCH-Ll. It is an open question as to whether the function of any of these 
k.inases may be directly or indirectly influenced by the proteasome, although it is 
established for PKC for example, that the proteasome can mediate a pathway for its 
breakdown (Lee et al., 1996). 
An alternative pathway known to be subject to proteasorne regulation is that of the 
transcription factor, nuclear factor kappa B (NF-KB). NF-KB exists in a latent form 
in unstimulated cells, complexed to the inhibitory protein, I-KB. Inflammation-
associated molecules such as cytokines can induce I-KB phosphorylation leading to 
its ubiquitination and degradation by the proteasome (Karin and Delhase, 2000). 
Dissociated NF-KB can then regulate the expression of a variety of target genes 
including the inducible enzymes cyclo-oxygenase-2 and nitric oxide synthase, 
adhesion molecules, cytokines and neuropeptides (O'Neill and Kaltschmidt, 1997). 
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Although NF-KB expression decreases acutely following nerve injury (Doyle and 
Hunt, 1997) NF-KB immunoreactivity has been reported to increase within ipsilateral 
DRG neurones two weeks after nerve injury (Ma and Bisby, 1998). In pilot 
experiments with intrathecal administration of the selective NF-KB inhibitor, 
parthenolide in CCI rats no detectable change was observed in behavioural responses 
to heat, or mechanical stimuli. Such doses would be predicted to cause clear 
inhibition of NF-kB-mediated responses suggesting that while certain proteasome 
targets, like PKA may play an impmtant role in neuropathic sensitisation, others like 
the NF-KB / I-KB complex may not be important. However, because authentic NF-
KB-mediated responses were not evaluated in parallel in these experiments, a role for 
NF-KB in CCI sensitisation cannot definitively be excluded. Nevertheless, more 
extensive studies on these and other pathways will be necessary before it is c lear how 
the proteasome plays out its key role in enabling neuropathic sensitisation. 
Although direct evidence is lacking, ubiquitin-dependent processes appear to be 
important in regulating many aspects of signal transduction (lsaksson et al., 1996), 
including the actions of many receptors such as the receptor tyrosine kinases (Mori et 
al., 1995), heterot1ime1ic G protein systems (Madura and Varshavsky, 1994); protein 
kinases such as PKA (Hegde et al., 1997), and PKC (Lee et al., 1996); transcription 
factors (Pahl and Baeuerle, 1996) including p53 (Maki et al., 1996), fos/jun (Ja1iel-
Encontre et al., 1997) and as described NF-KB (Rofl et al., 1996; Palombella et al., 
1994). Thus, many further targets beyond PKA and NF-KB could potentially 
contribute to the actions of the ubiquitin-proteasome system here. In summary, 
results novelly demonstrate that proteasome inhibitors can selectively inhibit 
neuropathic sensitisation, which is likely to underlie the development of chronic 
intractable pain following nerve injury. Importantly, proteasome inhibitors attenuate 
neuropathic allodynia without impairing normal sensory responses to low intensity 
peripheral stimuli ; a particularly advantageous therapeutic profile. Expression of a 
key enzyme in ubiquitin-proteasome function is increased in spinal dorsal horn 
ipsilateral to injury, as is the activity of a known target of the complex (PKA), which 
is expected to display de-regulated constitutive activity following proteasome action 
(collaborative studies in the laboratory). 
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These findings suggest that proteasome inhibitors may have therapeutic potential in 
neuropathic pain. As a result of the diverse cellular roles of the proteasome 
including the regulation of cell survival and proliferation, proteasome inhibitors are 
under phase I t1ials as anti-cancer drugs (Lee and Goldberg, 1998). In many cases, 
advanced development of tumours leads to local inflammation and pressure trauma 
to afferent nerves, resulting in a neuropathic component to cancer pain. The present 
study predicts that in addition to any direct effect on cancer cells, proteasome 
inhibitors would exert a useful additional role in attenuating the central sensitisation 
that leads to chronic hyperalgesia and allodynia. 
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CHAPTER 6: SUMMARY AND CONCLUSIONS 
Neuropathic pain due to nerve injury may occur as a result of peripheral tissue 
damage due to disease or trauma, or may be a direct result of nerve transection , 
crushing or constriction. The chronic pain states which develop include spontaneous 
pain, hyperalgesia and allodynia, and they may persist long after the initial injury has 
healed (Scadding, 1984). These abnormal pain states show a reduced sensitivity to 
classical opioid analgesics (Amer and Meyerson, 1988; Mao et al., 1995). The 
mechanisms underlying the development of neuropathic pain are poorly understood, 
but inflammatory mediators released at the site of nerve injury (Tracey and Walker, 
1995) and central changes within the spinal cord (Woolf and Costigan, 1999), are all 
thought to contribute. Several studies have implicated the VPAC2 receptor in the 
modulation of nociceptive processing in neuropathic pain (eg. Dickinson et al., 
1999). The signal transduction mechanisms (via G protein-coupled receptors) 
involving the activation of adenylate cyclase and the subsequent activation of PKA, 
downstream of VPAC / PAC receptors have also been implicated in the underlying 
mechanisms of nociceptive sensitisation (Coderre et al., 1993; Malmberg, 2000). 
The present study simultaneously addressed the role of the VPAC2 receptor, the 
cAMP-dependent signal transduction cascade and the persistent activation of PKA 
by the ubiquitin-proteasome system in neuropathic sensitisation following CCI. 
6.1 The Role of the VPAC2 Receptor in Neuropathic Pain 
The current investigation utilised behavioural reflex techniques to further elucidate 
the specific role of the VPAC2 receptor in neuropathic sensitisation following 
peripheral nerve injury. There is a growing body of evidence implicating the VPAC2 
receptor in nociceptive processing (Dickinson and Fleetwood-Walker, 1999). 
However, the precise involvement of the VPAC2 receptor in the injury-induced 
sensitisation following peripheral nerve injury has not yet been adequately addressed. 
This was initially assessed using wild-type mice and mutant mice lacking the VPAC2 
receptor (VPAC2R (-t-)). CCI was carried out in wild-type and VPAC2R (-t-) mice and 
the development and maintenance of the abnormal behavioural responses that occur 
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following CCI were compared. To further assess the contribution of the VPAC2 
receptor to the maintenance of the abnormal behavioural responses within the spinal 
dorsal horn at the peak of neuropathy, a selective antagonist of theVPAC2 receptor 
was administered intrathecally at the level of the lumbar spinal cord in wild-type and 
VPAC2R<·
1·> mice exhibiting peak behavioural changes following CCL In wild-type 
mice, intrathecal injection of the VPAC2 receptor antagonist significantly reversed 
the accentuated reflex withdrawal responses that develop following CCI that are 
believed to be indicative of neuropathic pain. This inhibition was specific to the 
ipsilateral limb and showed no effect on the contralateral limb or in the VPAC2R (·'·) 
mice. Subsequently, the effects of intrathecal administration of a selective agonist of 
the VPAC2 receptor were examined in both wild-type and VPAC2R<·
1·> mice. 
Following injection of the VPAC2 receptor agonist, the latency/threshold for reflex 
withdrawal responses to noxious heat and innocuous mechanical stimuli decreased 
progressively and reached peak behavioural change (ipsilateral vs. contralateral) at -
day 12 post-operatively. In VPAC2R<·
1·> mice however, the decreases in reflex 
withdrawal latency/threshold following CCI were dramatically attenuated when 
compared to wild-type mice. These results taken together with previous findings 
(Dickinson and Fleetwood-Walker, 1999) suggest that there may be an increased 
involvement of the VPAC2 receptor in spinal sensory processing following nerve 
injury that may participate in the development and maintenance of neuropathic pain. 
In the present behavioural study, the sensitisation attenuating effects of the VPAC2 
receptor antagonist and of the VPAC2 receptor knockout were more marked on 
responses to heat than to mechanical stimuli. This suggests that VPAC2 receptor 
antagonists might be useful to target selectively the C fibre-mediated hyperalgesia 
seen in neuropathic pain. 
This project provides new insights into the role of VPAC2 receptor within the spinal 
dorsal horn, and underlines the potential importance of the VPAC2 receptor 
antagonists as new analgesic agents for use in currently intractable neuropathic pain 
states. The VPAC2 receptor is clearly very different from that of other modulators of 
sensory processing, such as the opioid and tachykinin receptors (Fleetwood-Walker 
et al., 1988; 1993) as neuropathic pain appear to be less responsive to classical opioid 
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analgesics than are acute or inflammatory pain states (Amer and Meyerson, 1988; 
Mao et al., 1995). 
6.2 The Role of Cyclic-AMP Dependent Protein Kinase in Neuropathic 
Pain 
The cAMP I PKA signal transduction pathway was investigated using behavioural 
and molecular techniques to reveal its contribution to the central sensitisation that 
manifests following nerve injury. Activation of PKA by increased levels of cAMP 
downstream of G protein-coupled receptor activation has been implicated in the 
mechanisms underpinning persistent nociception in alternative centrally and 
peripherally-mediated models (Coden-e et al., 1993; S luka 1997; Taiwo et al., 1999), 
as well as in parallel mechanisms of synaptic plasticity (Cerne et al., 1992; 1993; 
Hegde et al 1993). However, the importance of PKA in central neuropathic 
sensitisation following peripheral nerve injury has not been investigated. 
This issue was initially assessed by observing the effect of intrathecal administration 
of selective PKA inhibitors on the abnormal behavioural responses in rats at the peak 
of neuropathy. The effects of the selective PKA antagonists on reflex withdrawal 
responses to noxious heat, innocuous mechanical stimulation and innocuous cold 
were assessed. A Western blot study was used to investigate the levels of expression 
of the regulatory and catalytic subunits of PKA within the spinal dorsal horn, and to 
ascertain as to whether the expression of any of these subunits were altered following 
CCI. Finally, a complementary in situ hybridisation histochemistry study was 
carried out to investigate the distribution of mRNA for the regulatory and catalytic 
subunits of PKA within the spinal dorsal horn, and to ascertain as to whether their 
expression was altered following CCI. Results from chapter 4 demonstrate that PKA 
inhibitors act to selectively reverse neuropathically sensitised responses, markedly 
reversing the accentuated responses to heat and mechanical stimuli following nerve 
injury. Taken together with the increased expression of mRNA and protein levels for 
the catalytic subunits (Ca and Cj3) the observations suggest that persistent activation 
of PKA following nerve injury may play a key role in the sensitised responses to heat 
and mechanical stimuli. This suggests that there may be an increase in the activity of 
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PKA following nerve injury that may participate in the development and 
maintenance of neuropathic pain. The continued sensitivity to an inhibitor of cAMP-
dependent PKA activation suggests that ongoing activity of relevant receptors such 
as the VPAC I PAC receptors may play a key role in the ongoing maintenance of the 
neuropathic pain state. 
The potential of the mechanisms of action of PKA as a target from novel neuropathic 
analgesics may be promising in the longer term. However, the idea of targeting PKA 
isofonns themselves for therapeutic value would not be a sensible approach as the 
ubiquitous nature and the great variety of important physiological roles that PKA is 
implicated in would speak against PKA being a suitable target in itself. However, 
mechanisms uncovered in this project may facilitate further research on PKA related 
targets which may underpin neuropathic sensitisation. 
6.3 The Role of the Ubiquitin-Proteasome System in Neuropathic Pain 
Persistent activation of PKA is widely believed to underpin the mechanism of long 
term memory formation in Aplysia (Greenberg et al. , 1997) and in the mammalian 
hippocampus (Frey et al., 1993). Increasing evidence has suggested that targeted 
protein degradation of the regulatory subunits of PKA by the ubiquitin-proteasome 
system, thus leading to a persistently active kinase, may be responsible (Hegde et al. , 
1993; 1997; Chain et al., 1999). 
In light of the interesting findings in chapter 4 implicating persistently active PKA in 
the underlying mechanisms of central neuropathic sensitisation, electrophysiological, 
behavioural and molecular biological techniques were adopted to address the role of 
the ubiquitin-proteasome system in central neuropathic sensitisation following 
peripheral nerve injury. Firstly, an electrophysiological study was carried out using 
selective antagonists of the ubiquitin-proteasome system. The effects of these 
antagonists were investigated on the sustained neuronal activity of individual dorsal 
horn neurones induced by sensory stimuli in normal rats and in neuropathic rats at 
the peak of neuropathy. Complementary experiments investigating the effects of 
intrathecal administration of selective ubiquitin-proteasome inhibitors on the 
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abnormal reflex responses that develop in rats at the peak of neuropathy following 
CCI were carried out confirming selective attenuation of the neuropathically 
sensitised responses. A Western blot study was used to investigate the levels of 
expression of a key enzyme of the ubiquitin-proteasome system, UCH-Ll within the 
spinal dorsal horn, and to ascertain as to whether the expression of this enzyme was 
altered following CCI. Finally, a complementary ISHH study was carried out to 
investigate the distribution of mRNA for UCH-Ll within the spinal dorsal horn, and 
to ascertain whether the expression was altered following CCI. Results from chapter 
5 suggest that in the normal state the ubiquitin-proteasome system inhibitors were 
selectively antinociceptive (markedly inhibiting only the sustained C-fibre activity 
induced by topical application of the chemical irritant mustard oil). In contrast, the 
proteasome appeared to play an enhanced role following CCI (with inhibitors 
markedly attenuating not only the C fibre activity-induced by topical application of 
mustard oil, but now also the innocuous brush evoked activity). The findings that 
intrathecal administration of proteasome inhibitors markedly reverse the sensitised 
responses to heat and mechanical stimuli following nerve injury, together with the 
marked upregulation ipsilateral to nerve injury of mRNA and protein levels for the 
ubiquitin recycling enzyme UCH-Ll suggest that protein degradation (via the 
ubiquitin-proteasome pathway) may underpin the persistent activation of PKA and 
the sensitivity to heat and mechanical stimuli that follow nerve injury. 
It has been demonstrated that proteasome inhibitors can selectively inhibit 
neuropathic sensitisation, which is likely to underlie the development of chronic 
intractable pain following nerve injury. Importantly, proteasome inhibitors attenuate 
neuropathic allodynia without impairing normal sensory responses to low intensity 
peripheral stimuli; a paiticularly advantageous therapeutic profile. Expression of a 
key enzyme in ubiquitin-proteasome function (UCH-Ll) is increased in spinal dorsal 
horn ipsilateral to injury, as is the activity of a known target of the complex (PKA), 
which is expected to display de-regulated constitutive activity following proteasome 
action. Proteasome dependent activation of PKA in neuropathic sensitisation closely 
parallels that in LTF in Aplysia. Proteasome inhibitors are under phase I trials as 
anti-cancer drugs (Lee and Goldberg, 1998). In many cases, advanced development 
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of tumours leads to local inflammation and pressure trauma to afferent nerves, 
resulting in a neuropathic component to cancer pain. The present study predicts that 
in addition to any direct effect on cancer cells, proteasome inhibitors would exert a 
useful additional role in attenuating the central sensitisation that leads to chronic 
hyperalgesia and allodynia. 
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